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Synthesis of Thiourea and Urea Organocatalysts by Opioids 
By Bo Liu 
Abstract 
Organocatalysis is one of the fastest growing fields of research in organic chemistry. 
The many advantages of organocatalysts include their low costs, low toxicity, the ready 
availability of natural resources and in many cases, low reactivity with moisture and 
oxygen. These traits can be preferable to some classes of metal-based catalysts 
although a case-by-case comparison is required. When benefits over metal-based 
catalysts are realized, organocatalysts can make a contribution to green chemistry. One 
major advantage is that metal residues, which are difficult to remove from products 
when using metal-based catalysts, are avoided by an organocatalytic step which is of 
significance to the synthesis of pharmaceutical products, where metal content is strictly 
controlled. 
 
Effective chiral organocatalysts can be derived from natural molecules from the chiral 
pool, which are a primary source of enantiomerically pure stereoisomers. Proline and 
the cinchona alkaloids are two key examples of organocatalyst precursors which have 
been widely studied. This work expands the scope of natural alkaloid precursors to 
include opiates. 
 
Opiates, such as morphine and codeine, are abundant alkaloids readily available from 
the opium poppy and industrial plants and means by which to extract these compounds 
are well established. This is due to their ubiquitous use as analgesic drugs to relieve 
pain. The aim of this project was to prepare novel thiourea and urea organocatalysts 
from a series of opioid derivatives and study their performance in model asymmetric 
synthetic reactions suited to thiourea catalysts. The selected reaction was a Michael 
addition reaction between diethyl malonate and trans-β-nitrostyrene. One urea and one 
thiourea organocatalyst were prepared, both of the C2-symmetric group, and 
characterized by NMR, IR, melting point, optical rotation, MS and the compound 
structures were unambiguously assigned based on single crystal XRD results. The 
thiourea derivative catalyst gave high yields for the Michael addition reaction however, 
enantioinduction was poor, with less than 10% ee observed.
 1 
 
 
 
 
 
 
 
Chapter 1 Literature Review 
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1.1 Chiral compounds 
The majority of new drugs are chiral; it is expected that approximately 95% of 
pharmaceutical drugs will be chiral compounds by 2020.
1
 The reason why chiral 
compounds are so important to the pharmaceutical industry, is mainly due to the 
multitude of chiral target sites in the body, where a chiral drug can interact with 
high-binding affinity compared to an achiral compound. Although this is not true in all 
cases, it is often a starting point for drug design and development. Demand for 
enantiopure chiral compounds is expected to continue to rise, primarily for the 
pharmaceutical industry, but also in other sectors including: flavour and aroma 
chemicals (such as hair spray additives), clothing, specialty materials and 
agrochemicals.
2
 One such example where enantiomers have different biological 
activities was observed with mecoprop-P and dichlorprop. The (S)-enantiomers were 
preferentially degraded in most species of broadleaf weeds compared to the 
(R)-enantiomers which showed more resistance to degradation (Fig. 1.1).
3
 This is but 
one of many diverse examples of the importance of chirality within the design of novel 
molecules. 
 
 
 
Fig. 1.1 Chemical structure of mecoprop-P and dichlorprop enantiomers.
3
 
 
 
1.2 Primary sources of chiral compounds 
The synthesis of enantiomerically pure compounds is an important area of chemistry. 
In 1980, Prof. Seebach introduced the term “synthesis of enantiomerically pure 
compounds” to include all the processes for obtaining chiral enantiopure compounds.4 
The three main approaches for the synthesis of enantiomerically pure chiral 
 3 
compounds are; 1) resolution of racemates, 2) asymmetric synthesis by catalytic or 
stoichiometric processes and 3) the chiral pool approach. 
 
1.2.1 Resolution of racemates 
Resolution techniques were the first methods for resolving racemic mixtures and this 
method is still popular for process-scale operations in the industry today. Resolution 
techniques can be subdivided into three methods: 
1. Crystallization: The oldest method of separating enantiomers from their racemates. 
A pair of diastereomeric salts exhibits different physical and chemical properties 
such as solubility, melting points, boiling points, adsorptions and phase distribution 
characteristics. Consequently, diastereomers can be separated. Several methods 
may be applied to convert a racemic mixture to a mixture of diastereomers, 
including salt formation with an enantiomerically pure acid or base, or use of a 
chiral auxiliary which can be removed after resolution. Another technique is to 
manually separate two kinds of crystals of tartaric acid isomers from supersaturated 
solution sodium ammonium tartrate, where differences in morphology can be 
observed under a microscope, which was historically performed by Louis Pasteur 
in 1849.5,6 The resolution of binaphthol by cholesterol esterase is another example 
utilising combined kinetic resolution (see the following section) with selective 
crystallization. The racemic binaphthol is first converted into a diester, then kinetic 
resolution using a cholesterol esterase results in selective hydrolysis to yield the 
(S)-BINOL product which precipitates. The remaining diester in the mother liquid 
undergoes basic hydrolysis to give (R)-BINOL (Scheme 1.1).
7,8
 
 
2. Chromatography: Widely used in development laboratories and separation of 
enantiomers can be achieved by employing a chiral column. However, the 
disadvantage of this method is the high cost of the columns used. 
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Scheme 1.1 Resolution of 1,1'-bi-2-naphthol by crystallization and kinetic 
resolution.
7,8 
 
3. Kinetic resolution: with a chiral reagent, one of the enantiomers of a racemic 
mixture is transformed into the corresponding product faster than the other, due to their 
different consumption rates in a chemical reaction. However, the maximum theoretical 
yield of 50% is the critical drawback of the method. The dynamic kinetic resolution, 
which is an important extension of kinetic resolution, can convert the achiral reactant 
with 100% completion, because both enantiomers are connected in a chemical 
equilibrium. In this way, the faster-reacting enantiomer is replenished during the 
reaction with the expense of the slower-reacting enantiomer.
9
 One of the more classic 
applications of the dynamic kinetic resolution is Noyori asymmetric hydrogenation.
10
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1.2.2 Asymmetric synthesis 
Asymmetric synthesis is a process in which a compound with a defined stereogenic 
center is selectively formed.
11
 The techniques used can be divided into three 
approaches: the substrate-controlled approach, the use of chiral auxiliaries and directed 
catalytic methods. 
 
The substrate-controlled approach is a reaction where the formation of a new 
stereogenic center is controlled by another chiral center already present in the substrate. 
The limitation of the substrate-controlled approach is that enantiopure starting 
materials are limited and may not suit a selected target molecule synthesis. 
 
The chiral auxiliary approach is similar to the substrate-controlled approach, in which 
chirality is induced into an achiral molecule by using an appended chiral entity, usually 
through a new covalent bond to the achiral starting material. The auxiliary is 
subsequently removed at the end of reaction as an additional step. 
 
The catalyst approach is a catalytic transformation promoted by a chiral catalyst 
generally used with low catalyst loadings, therefore enhancing the economic value of 
the process. The approach of using chiral catalysts capable of making chiral products 
from various substrates is the most significant advance in asymmetric synthesis. The 
catalyst can be a chiral Lewis acid or base, a chiral organocatalyst, a chiral 
organometallic complex or a biocatalyst. A simplified overview of typical asymmetric 
synthetic methods is shown in Fig. 1.2. 
 
 
 
Fig. 1.2 Three approaches of asymmetric synthesis (chirality denoted by * symbol). 
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1.2.3 Chiral pool approach 
The chiral pool is a versatile tool which allows naturally occurring chiral molecules to 
be synthetically transformed into the desired target molecules.
12
 Natural sources have 
provided a variety of chiral pool materials in high enantiomeric purity and frequently 
at low costs, such as natural amino acids, hydroxyl acids, terpenes, carbohydrates and 
alkaloids (Fig. 1.3). They have been widely used as chiral building blocks in the 
organic synthesis of natural products; additionally, some bioactive compounds have 
been used in various industrial applications. 
 
 
 
Fig. 1.3 Examples of natural chiral compounds. 
 
Amino acids are the basic organic compounds, which are essential for all life processes. 
Chiral amino acids are not only extensively used by pharma industries, because of their 
ready availability in enantiomerically enriched forms, they can also be used as starting 
building blocks for transformations into other compounds, such as heterocycles, due to 
the diversity of functional groups present.
13
 For instance, Samanta et al. reported the 
synthesis of amino acid derived chiral aziridines from α-amino acids following a 
four-step synthetic procedure.
13,14
 Additionally, Rao et al. developed a versatile and 
efficient method for the synthesis of (2S)-2-(hydroxymethyl)-N-Boc-2,3-dihydro-4- 
pyridone from ʟ-(−)-phenylalanine from ʟ-phenylalanine (Scheme 1.2).13,15 
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Scheme 1.2 Synthesis of heterocyclic building blocks using amino acids. a) Synthesis 
of chiral aziridines. b) Synthesis of (2S)-2-(hydroxymethyl)-N-Boc-2,3-dihydro-4 
-pyridone from ʟ-(−)-phenylalanine.13-15 
 
Furthermore, synthesis of a wide range of natural and non-natural products using 
α-amino acids as the chiral pool in a substrate-controlled manner have also been 
reported. Srihari et al. achieved the stereoselective total synthesis of a securinega 
alkaloid (−)-allonorsecurinine. The stereocenter in the lactone moiety of the final 
product was readily prepared from the chiral inducer ʟ-proline (Scheme 1.3).16,17 
 
 
 
Scheme 1.3 Total synthesis of (−)-allonorsecurinine by a chiral inducer ʟ-proline.16,17 
 
Terpenes are a large and diverse class of organic compounds obtained from plants. 
Pharmaceutical, food, agricultural and chemical industries have exploited many 
important terpenes for their potential and effectiveness as medicines, flavor enhancers, 
pesticides, and fine chemicals, respectively. Important terpenes include carvone 
(flavor), menthol and camphor (flavor, repellent, nonprescription drug), etc.
18
 Natural 
optically active monoterpenes have also been applied as catalysts or building blocks 
 8 
and considered as good chiral starting materials or substrates for the synthesis of 
targeted and natural compounds such as the pharmacological import β-amino acid 
derivatives. For example, Szakonyl et al. reported the total synthesis of carane-based 
β- and γ-amino acid derivatives from the monoterpene perillaldehyde. They 
synthesised β- and γ-amino acid derivatives via a conjugate addition reaction using two 
intermediates (A and B in Scheme 1.4), respectively, both prepared from 
(−)-(4S)-perillaldehyde.19 
 
 
 
Scheme 1.4 Total synthesis of β- and γ-amino acid derivatives by 
(−)-(4S)-perillaldehyde.19 
 
Likewise, the cinchona alkaloid quinine is another example. It is isolated from the bark 
of the cinchona tree, has demonstrated its applicability as a chiral scaffold in 
asymmetric synthetic catalyst design, as well as being commercialised as a potent 
antimalarial agent.
20
 
 
The limitation of the chiral pool approach is that only a few compounds are available 
in optically pure forms from nature on a large scale. It is usually the case that chiral 
pool building blocks are incorporated into chiral ligands which then enable the transfer 
of chirality from a natural source to the desired target molecules.
21
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1.3 Other sources of chiral compounds 
In the last few decades, green chemistry has been recognized as a subject and 
methodology for achieving sustainable development and has also been able to promote 
innovative technologies that eliminate or reduce the use and generation of hazardous 
substances. Since the twelve principles of green chemistry were developed by Paul 
Anastas and John Warner,
22
 catalysis has been one of the fundamental pillars of green 
chemistry and also been regarded as the heart of modern synthetic chemistry, because 
almost commercial chemical reactions involve at least one catalytic steps. Furthermore, 
with being driven by factors such as growing consumption of petroleum products, 
environmental regulations, technology developments, the global catalyst market has 
grown steadily over the past seven year’s decades and is expected to reach US $34.3 
billion by 2024, according to a new report from the Grand View research, Inc.
23
 In 
comparison with historical approaches, such as chiral pool synthesis and chiral 
reagents, the design and application of new catalysts can pursue the “ideal” synthetic 
process to produce useful compounds in 100% yield with 100% selectivity in an 
economical, energy-saving, environmentally benign and sustainable way.
23,24
 Catalysts 
are generally divided into three main types: homogeneous catalysts, heterogeneous 
catalysts, and biocatalysts. Transition metal catalysts, organocatalysts, and 
organometallic catalysts have become an important role in the field of homogeneous 
catalysis as being well studied, particularly for fine chemicals and pharmaceuticals due 
to being more active and selective compared to heterogeneous catalysts.
25
 
 
1.3.1 Transition-metal catalysts 
Chiral ligands are enantiopure organic compounds that chelate with a metal center to 
form asymmetric catalysts. Thus, the transfer of chirality from the catalyst to the 
product of a reaction can be brought about by chiral ligands surrounding the metal core. 
A general representation of a chiral metal-based catalyst is shown in Fig. 1.4. 
 
 
 
Fig. 1.4 General representation of chiral metal-based catalyst. 
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The design and synthesis of new chiral ligands (including phosphine based examples) 
are crucial for the development of transition-metal-catalyzed asymmetric catalysis. 
Most of the commonly utilized transition metals include palladium, ruthenium and 
rhodium complexes, bearing chiral ligands to provide a chiral environment for 
asymmetric induction. For instance, rhodium (I) complexes containing chiral 
phosphine ligands are used extensively as asymmetric hydrogenation catalysts. The 
first was the discovery by Wilkinson et al. of the properties of the rhodium complex 
RhCl(PPh3)3 as a hydrogenation catalyst for unhindered olefins.
26
 Based on the 
structure of the rhodium catalyst, Knowles et al. replaced the achiral 
triphenylphosphine ligands in the rhodium complex with the chiral phosphine ligand 
methylpropylphenylphosphine (69% ee of (−)-methylpropyl phenyl phosphine). This 
created the first asymmetric hydrogenation catalyst (1) and was then applied to an 
asymmetric hydrogenation reaction to give hydratropic acid in 15% ee (Scheme 1.5).
27
 
 
 
 
Scheme 1.5 Hydrogenation of α-phenylacrylic acid by Knowles's catalyst (1): a 
rhodium catalyst containing (−)-methylpropylphenylphosphine (69% ee) to give 
(+)-hydratropic acid in 15% ee.
27
 
 
The Knowles group also used a rhodium complex catalyst (2) containing phosphine, 
with the DiPAMP ligand increasing enantioselectivity to 95% in the hydrogenation of 
dehydroamino acids.
28
 The methodology was used on a commercial scale for the 
synthesis of ʟ-DOPA (3,4-dihydroxy-ʟ-phenylalanine), a drug used for the treatment of 
Parkinson’s disease (Scheme 1.6).29 
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Scheme 1.6 Synthesis of ʟ-DOPA using DiPAMP catalyst (2).28 
 
Kagan and Dang bridged two monodentate phosphines to form the first chiral bidentate 
phosphine ligand, which is the first example of a C2-symmetric phosphine ligand. Up 
to 72% ee was reported in the hydrogenation of unsaturated acids with the use of the 
rhodium complex containing the ligand DIOP (Scheme 1.7).
30
 
 
 
 
Scheme 1.7 Asymmetric hydrogenation of unsaturated acids by the catalyst (3).
30 
 
This work on metal-based catalysts significantly expanded the scope of asymmetric 
hydrogenation. Noyori et al. made the first breakthrough in using BINAP-Ru(II) 
dicarboxylate complexes.
31
 These chiral Ru complexes serve as catalyst precursors for 
the highly enantioselective hydrogenation of carbon-carbon double bonds, the 
asymmetric hydrogenation of which had been difficult to achieve by rhodium catalysts 
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reported until then. An example is the hydrogenation of ketones by RuCl2 (BINAP) 
catalyst (4) to give high enantioselectivity for the β-hydroxy ester product, shown in 
Scheme 1.8. 
 
 
 
Scheme 1.8 Asymmetric hydrogenation of β-keto ester by RuCl2[(R)-BINAP].
31
 
 
With the development and application of a number of transition-metal catalysts, most 
industrial development projects aimed at scaling up transition-metal-catalyzed-reaction 
for increasing the turnover numbers.
32
 However, the use of such catalysts has shown 
some disadvantages: 
 Metal catalysts may not be stable to oxygen or moisture. 
 Product inhibition can become a problem due to binding of the product to the 
catalyst.
33
 
 Catalyst disposal can be problematic, especially if a high toxicity metal is 
present. 
 The high cost in many cases makes catalyst recycling essential, which is not 
always possible due to degradation. 
 
1.3.2 Organocatalysis  
Naturally occurring enzymes have been considered powerful biocatalysts for organic 
transformations, providing products with high yield and enantioselectivity under mild 
conditions because of their wide substrate tolerance.
34
 The use of analogous small 
organic molecules as catalysts has attracted a large amount of research groups’ interest 
over the last 15 years. Complementing biocatalysis and transition metal catalysis, 
asymmetric organocatalysis, defined as the use of small organic molecules as catalysts 
for asymmetric reactions, recognised as an independent synthetic tool for the synthesis 
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of chiral organic molecules. Advantages over transition-metal catalysts include:
24
 
 High tolerance to air and moisture, thus specialist equipment such as vacuum 
lines are not necessary. 
 Easy to handle even on a large scale and a potential for lower toxicity due to 
the absence of metals which is attractive for the synthesis of pharmaceutical 
products. 
 Inexpensive, with many materials being readily available from natural products 
compared to transition metals, such as ʟ-proline and other natural amino acids. 
 Easy to scale-up and easy screening. 
 Some organocatalysts are bio-derived and biodegradable. 
 
Therefore, the use of organocatalysts can be considered a convenient synthetic 
philosophy, and a complementary synthetic toolkit alongside transition metal catalysts. 
Transition metal catalysts are a valuable class of compounds due to the wide scope of 
possible reactions, very high activity and large knowledge base available. Both areas 
will complement each other for years to come. 
 
1.3.3 Classification of organocatalysis 
Organocatalysts are synthesised from organic compounds generally originating from 
biological sources. They donate or remove electrons or protons as their activation 
mode.
35
 Hence, according to Benjamin List,
 
organocatalysis can be broadly classified 
as: Lewis base catalysis, Lewis acid catalysis, Brønsted base and Brønsted acid 
catalysis;
35,36
 while organocatalysis can also be sub-classified into covalent and 
non-covalent catalysis, according to the interaction between the substrate and the 
catalyst.
37
 The working principles of that organocatalysis will be described 
accordingly. 
 
1.3.3.1 Lewis base catalysis 
Lewis base catalysis reactions start with a nucleophilic addition of the Lewis base (B:) 
to the substrate S, which leads to a donation of a pair of electrons from the Lewis base 
(B:) to form a covalent bond with the substrate S and the formation of the adduct 
B
+
-S
−
. This adduct undergoes a reaction to give the intermediate species B
+
-P
−
, from 
which the product P is released. The catalyst (B:) then re-enters the catalytic cycle (Fig. 
1.5). 
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Fig. 1.5 Simplified catalytic mechanisms of Lewis base catalysis
36
 (S = Substrate, B: = 
Lewis base catalyst, P = Product). 
 
These catalysts are nitrogen, carbon, oxygen, phosphorus and sulfur based Lewis bases 
such as amines, carbenes, formamides, phosphoramides, phosphanes, and sulfides. 
Among these catalysts, the nitrogen-based and phosphorus-based compounds are the 
most studied, partly due to their ready availability from the chiral pool.
38
 For instance, 
nitrogen-based Lewis organocatalysts convert the substrates into either activated 
nucleophiles or electrophiles via diverse mechanisms with reactive intermediates,
39
 
such as iminium ions, enamines,
40
 acyl ammonium ions,
41
 and 1-, 2-, 3- ammonium 
enolates,
42
 etc. Typical examples of such catalytic processes include enamine catalysis, 
reported by List et al., which classically involve an intermolecular aldol reaction of 
isobutyraldehyde with acetone (20 vol.%) by the amino acid ʟ-proline (5), via 
formation of an enamine intermediate.
36,43
 MacMillan et al. reported iminium catalysis 
in a Diels-Alder reaction of α,β-unsaturated aldehydes with dienes by imidazolidinone 
(6), via an iminium ion which is generated from the reaction of an amine catalyst with 
a carbonyl substrate (Scheme 1.9).
36,44
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Scheme 1.9 a) Intermolecular aldol reaction catalyzed by ʟ-proline via enamine 
intermediate;
43 
b) Chiral imidazolidinone catalyzed Diels-Alder reaction of 
cinnamaldehyde with cyclopenta-1,3-diene via iminium ion catalysis.
44 
 
Both these examples of Lewis base catalysis utilise the amine catalysts as 
nucleophiles, where a nucleophilic attack by the catalyst on a substrate it activates a 
reaction with either intermediate nucleophilic enamines or intermediate electrophilic 
iminium ions.
45,46
 After the initial recognition of activation of carbonyl compounds via 
enamine and iminium ion intermediates by chiral amines, several new modes of 
chemical activation in aminocatalysis have been discovered. Today’s aminocatalytic 
transformations of carbonyl compounds via iminium ion and enamine intermediates by 
chiral amines has been categorised in three distinct activation modes: LUMO-lowering, 
HOMO-raising, and SOMO-activations, according to functionalization of the α, β, γ 
and ε positions of carbonyl compounds.47,48 As shown in Scheme 1.10, these three 
activations have in common the formation of an iminium ion by reversible 
condensation of the chiral amine. The LUMO-lowering activation is the basic principle 
of iminium ion catalysis. This activation is based on the formation of an electrophilic 
iminium ion species by LUMO-lowering at the β-carbon of an α,β-unsaturated 
carbonyl compound, making it capable of β-functionalization with a nucleophilic 
 16 
attack.
49
 In contrast, the HOMO-raising activation involves the formation of the 
enamine and dienamine that increases the MOMO energy, delivering 
α-functionalization50 and γ-functionalization51 by a range of electrophiles, respectively. 
Moreover, trienamine catalysis was established by Chen et al. recently and provided an 
extension of the HOMO-raising activation strategy for amine catalysis. The key feature 
of the strategy is the simultaneous activation of both the γ- and ε-positions by raising 
of the HOMO of the trienamine intermediates and selective reactivity at the ε-carbon 
position in the Diels-Alder and tandem reaction.
52,53
 SOMO-activation relies on the 
formation of an electrophilic 3π-electron radical cation, provided by single-electron 
oxidation of the enamine intermediate.
54
 
 
 
 
Scheme 1.10 Aminocatalytic activation modes (E: electrophile; Nu: nucleophile; X = Y: 
dienophile). 
 
Recently, Kappler et al. used a formamide derivative catalyst (7) as a Lewis base 
catalyst for chlorination of alcohols with an inherently safe sole reagent benzoyl 
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chloride.
55
 Using this novel method, chiral substrates can be converted in excellent 
yields and stereoselectivities, and the reactions can even be performed under 
solvent-free conditions. Additionally, the primarily formed chlorides in the reaction 
mixture can be further transformed into a range of amines, azides, ethers, sulfides and 
nitriles in a one-pot synthetic route, avoiding isolation of the intermediate alkyl 
chlorides-formed. Synthesis of the drug S-Fendiline with 95% stereoselectivity is an 
example. Hence, the authors claimed that this method would meet one of the major 
demands of the chemical industry and the principles of sustainable chemistry. 
 
 
Scheme 1.11 One-pot chlorination by formyl pyrrolidine and subsequent trapping with 
nucleophiles.
55
 
 
1.3.3.2 Lewis acid catalysis 
A Lewis acid (A) is an atom or a molecule that can accept a pair of electrons and form 
an ionic interaction or a hydrogen-bond. It activates the nucleophilic substrate (S:) to 
give the adduct A
−
-S
+
. This adduct is converted into an intermediate species A
−
-P
+
 and 
is then followed by elimination of the product P. The catalyst A is free to re-enter the 
next catalytic reaction in the same manner (Fig. 1.6). 
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Fig. 1.6 Simplified catalytic mechanism of Lewis acid catalysis
36
 (S = Substrate, A = 
Lewis acid catalyst, P = Product). 
 
A key subset of Lewis acidic organocatalysts is phase transfer catalysts. This type of 
catalyst is designed to be soluble in both the organic and aqueous phase so that the 
catalyst can bind to a reactant from one phase, as an ion pair, and shuttle it into the 
phase which contains the other reactant. Phase-transfer catalysis has been recognised 
as a versatile methodology for organic synthesis in both academia and industry, as it 
features simple experimental operations, mild reaction conditions, use of and 
environmental benign reagents and solvents, and the possibility to conduct large-scale 
reactions.
56
 Therefore, phase-transfer catalysis is often considered as a useful tool to 
develop greener and more sustainable processes with comparison to alternative 
synthetic methodology.
57
 
 
Cinchona alkaloids have a long history in medicine and have also been proven to be a 
popular for organocatalysts, due to their unique structure, commercial availability and 
low cost.
58
 The first successful use of cinchona alkaloids for chiral phase-transfer 
catalysis was conducted by the Merck group in 1984 for asymmetric methylation of a 
phenylindanone derivative with excellent enantioselectivity. Later on, these types of 
catalysts were successfully utilized for synthesis of α-amino acids by O’Donnell et al.. 
Consecutively, new cinchona alkaloid-derived catalysts bearing an 
N-anthracenylmethyl group were developed by the research groups of Lygo and Corey, 
which led to the establishment of the cinchona alkaloids family for asymmetric 
phase-transfer catalysis.
56
 With functionalization of the C9- and C6’-hydroxyl group, 
and/or quaternization of the bridgehead tertiary amine, diverse generations of cinchona 
quaternary ammonium salts, including from simple monomers to polymeric form, have 
been well developed in recent years, and remarkable selectivities from various 
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asymmetric syntheses were observed.
58,59
 For instance, Yasuda et al. synthesised the 
first example of a cinchona alkaloid-based phase-transfer catalyst (8), which 
isquaternized at both the quinuclidine nitrogen (N) and the quinoline nitrogen (N’).60 
They reported that the novel N,N’-disubstituted cinchona alkaloid-derived phase 
transfer catalyst afforded significant remarkable reactivity and enantioselectivity in the 
intermolecular spirocyclization reaction under mild conditions (a in Scheme 1.12); 
More recently, new dimeric cinchona alkaloid-derived quaternary ammonium salts 
(phase-transfer catalysts) were designed and synthesised by Svia et al.. They used the 
commercially available starting material p-tolualdehyde to prepare the new of type of 
chiral phase-transfer catalyst (9) with high yield, and applied them to the asymmetric 
Henry reaction to convert aldehydes to nitromethane with very good yields and 
excellent enantiomeric excess at room temperature observed (b in Scheme 1.12).
61
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Scheme 1.12 Pioneering work of cinchona alkaloid-derived phase-transfer catalysts 
and examples of recently developed novel cinchona alkaloid-derived quaternary 
ammonium salts by a) Yasuda et al.
60
 and b) Svia et al.
61
, respectively. 
 
As mentioned previously, phosphine compounds are most frequently used as chiral 
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ligands to develop transition-metal catalysts for asymmetric reactions. A variety of 
privileged chiral phosphine ligands has been synthesised which are commercially 
available. Therefore, considering the abundant structural and stereochemical diversity 
of commercially available chiral phosphine compounds, and also the limited scope of 
asymmetric phase-transfer catalysis to quaternary ammonium salts, the creation of a 
new domain in phase-transfer catalysis by exploiting the effective quaternary 
phosphonium salts has become a hot topic, especially in the last few years.
62
 
Regarding the fact that quaternary ammonium salts derived from cinchona alkaloids 
have excellent catalytic performance in various types of reactions, the design of a new 
family of phosphonium phase-transfer catalysts using the chiral pool building block 
amino acids has been recently reported. For instance, Lu et al. reported a bifunctional 
amino acid-derived chiral phosphine catalyst (10) for catalysing the asymmetric 
Michael addition of oxindole to methyl vinyl ketone in high yield and 
enantioselectivity (a in Scheme 1.13). They proposed the key of the catalytic system is 
the in situ formation of the zwitterion (10’) by the reaction of the phosphine catalyst 
(10) to the electrophilic methyl vinyl ketone; which serves as an efficient ion-pairing 
activation mode.
63
 Progressively, based on the method for reactions using an in 
situ-generated phosphonium betaine catalyst (10’) designed by Lu,63 Zhao et al. 
developed a new bifunctional thiourea-phosphine catalyst (11). A highly 
enantioselective Mannich-type reaction with dimethyl 2-fluoromalonate and 
benzaldehyde-derived N-Boc imine was achieved by the in situ-generated zwitterion 
(11’), from the combination of the catalyst (11) and an acrylate (b in Scheme 1.13).64 
Meanwhile, this group also developed dipeptide-derived multifunctional phosphonium 
bromide (12) and they found it was an effective catalyst for the asymmetric cyclization 
via tandem Michael addition/intramolecular SN2 reaction with the conjugate ketone 
and malonate (c in Scheme 1.13).
65
 In both cases, the thiourea moiety of the catalyst 
was necessary to achieve high levels of enantioselectivity in the asymmetric 
reactions.
66
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Scheme 1.13 Examples of bifunctional amino acid-derived quaternary phosphonium 
salts by Lu et al. (a)
63
 and Zhao et al. (b)
64
 and (c)
65
. 
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1.3.3.3 Brønsted base catalysis 
A Brønsted base (B:) can be defined as a molecular entity that can accept a proton 
from an acid or the corresponding chemical species. Brønsted base catalysis is initiated 
by a Brønsted base (B:) via a partial (or sometimes full) deprotonation of the substrate 
S-H to form the intermediates B
+
H-S
− 
and then B
+
H-P
−
. Elimination of the product 
P-H enables the catalyst (B:) to re-enter the catalytic cycle (Fig. 1.7). 
 
 
 
Fig. 1.7 Simplified catalytic mechanisms of Brønsted base catalysis (B: = Brønsted 
base catalyst, S = Substrate, P = Product, H = hydrogen). 
 
Since organic Brønsted bases were recognised as efficient promoters for the formation 
of carbon-carbon and carbon-heteroatom bonds in organic synthesis,
67
 chiral organic 
Brønsted base catalysis has advanced significantly with the development of both 
natural and designed catalysts capable of catalytically controlling reaction 
stereoselectivity.
68
 Several nitrogen-containing functionalities have been used for the 
design of chiral Brønsted bases catalysts, such as tertiary amines, amidines (DBU), and 
guanidines (TBD) are the most prominent, due to their strongest Brønsted basicity.
67
 
Among them, the catalytic performance of some guanidines are much better than the 
other bases, according to the report from Schuchardt et al..
69
 In the Brønsted base 
mechanism, the guanidine accepts a proton from the substrate and catalyzes the 
reaction as the guanidinium cation. Then the guanidinium cation can either activate the 
electrophile via hydrogen-bonding interactions in a monofunctional mode, or both the 
electrophile and nucleophile simultaneously in a bifunctional manner (Fig. 1.8).
70
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Fig. 1.8 Plausible mono- and bifunctional activation modes of guanidine scaffolds in 
Brønsted base catalysis (E = electrophile and Nu
−
 = nucleophile).
70
 
 
With such a unique hydrogen-bonding mode, many chiral guanidine derivatives have 
been reported in the literature and have been used in various asymmetric reactions.
71
 
More recently, Ahmad et al. reported a novel chiral guanidine derived catalyst (13). 
The new catalyst was evaluated in the Pictet-Spengler reaction of tryptamine to 
p-nitrobenzaldehyde, in which the cyclized product was obtained in good yields with 
up to 64% ee using the additives malonic acid with BF3∙Et2O (Scheme 1.14).
72
 
 
 
 
Scheme 1.14 Catalysis of Pictet-Spengler reaction by the novel chiral guanidine 
derivative (13).
72
  
 
Cinchona alkaloids have not only been applied in phase-transfer catalysis, their 
derivatives can also serve as an active center for Brønsted base catalysis. Cinchona 
alkaloids are natural templates for Brønsted bases. Their quinuclidine tertiary amine 
can act as a base to deprotonate a substrate with relatively acidic protons, for example, 
malonates or thiols, forming a contact ion-pair complex by the reaction with the 
resulting anion and protonated catalyst. This interaction provides a chiral environment 
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around the anion and permits enantioselective reactions with electrophiles.
73
 In 
addition, the presence of the C9-hydroxyl group (hydrogen-bond donor site) and 
tertiary amine (hydrogen-bond acceptor site) enables most cinchona alkaloid 
derivatives to be employed in asymmetric reactions as bifunctional Brønsted bases 
catalysts (Fig. 1.9). 
 
 
 
Fig. 1.9 Cinchona alkaloids as catalysts for reactions via chiral contact ion pairs.
73
 
 
Palomo et al. designed novel cinchona-derived bifunctional squaramide catalyst (14) 
for the direct asymmetric α-functionalization of 2-cyanomethylpyridine N-oxide with 
enone in 100% conversion and up to 92% ee (Scheme 1.15), also an improvement on 
the result from the previous report by Fagnou et al. (59% conversion, 10% ee).
74
 
Palomo considered that the N-oxide group of the substrate plays a strategic role as a 
removable activating and stereodirecting element in the conjunction reaction with the 
new Brønsted base bearing a bulky silyl group.
75
 
 
 
 
Scheme 1.15 Conjugate addition of 2-cyanomethylpyridine by the novel cinchona- 
derived bifunctional squaramide catalyst (14).
75
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On the other hand, using 2,3-bis(dicyclohexylamino) cyclopropenimine (15) as an 
organo-superbase, Jørgensen et al. investigated a novel asymmetric cycloaddition 
reaction of 2-acyl cycloheptatriene with an azomethine ylide which proceeds as a [3+2] 
cycloaddition, affording the 1,3-dipolar cycloaddition product in high yield and 
excellent enantioselectivity (up to 99% ee). They proposed that the chiral 
cyclopropenimine Brønsted base catalyst (15) deprotonated the α-proton of the 
azomethine ylide and forms hydrogen-bonds with the carbonyl moiety of 2-acyl 
cycloheptatriene. This coordination contributes the stereochemical outcome of the 
reaction (Scheme 1.16).
76
 
 
 
 
Scheme 1.16 Catalysis of cycloaddition of 2-acyl cycloheptatriene with azomethine 
ylide by the chiral cyclopropenimine Brønsted base (15) and a plausible interaction of 
the catalyst with azomethine ylide and 2-acyl cycloheptatriene.
76
 
 
1.3.3.4 Brønsted acid catalysis 
In contrast to Lewis acid catalysis, Brønsted acid catalysis has become a new type of 
organocatalysis for a range of enantioselective carbon-carbon formation reactions.
77
 
Brønsted acids (A-H) are defined as molecular compounds that are able to lose or 
donate a proton and initiate a catalytic cycle via activation through (partial) 
protonation of a substrate (S:). In general, catalysis by chiral Brønsted acids can be 
understood by two variations in the mechanism; (1) specific (strong) Brønsted acid 
catalysis and (2) general Brønsted acid catalysis. Specific Brønsted acid catalysis is 
where catalysts are strong enough to protonate the substrate fully prior to the 
subsequent transformation (a in Fig. 1.10), such as BINOL derivatives (i.e. chiral 
phosphoric acids). The general Brønsted acid catalysis route is where the catalysts can 
only partially protonate the transition state of the reaction via hydrogen-bonding 
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interactions (b in Fig. 1.10), so it is a characteristic of weak acids, with such catalysts 
including thioureas/ureas and TADDOL derivatives. As well as being neutral 
compounds, these catalysts activate carbonyl compounds by hydrogen-bonding, so 
they are also called hydrogen-bonding catalysts.
78
 It is difficult to make a clear 
distinction between specific Brønsted acid catalysts and general Brønsted acid 
catalysts, because a catalyst that acts as a specific acid in one transformation may act 
as a general acid in another.
79
 Nonetheless, the relative pKa value of the Brønsted acid 
usually indicates the nature of the catalyst.
77
 
 
 
 
Fig. 1.10 Simplified catalytic mechanisms of Brønsted acid catalysis with a Brønsted 
acid acting as (a) a proton donor (“specific Brønsted acid”) or (b) a hydrogen-bonding 
donor (“general Brønsted acid”). (A-H = Brønsted acid catalyst, S = Substrate, P = 
Product, H = hydrogen). 
 
 
 
Fig. 1.11 Types of chiral Brønsted acids.
78
 
 
1.3.3.5 Specific (strong) Brønsted acid catalysis 
The potential for using relatively strong chiral organic Brønsted acids as catalysts has 
been largely ignored over the last few decades. Since BINOL and its derivatives were 
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utilised as important chiral scaffolds in designing organocatalysts,
80
 BINOL-derived 
Brønsted acids have been well developed recently, such as chiral BINSA derivatives, 
axially chiral dicarboxylic acids. As the first chiral strong chiral Brønsted acid, 
BINOL-derived chiral phosphoric acids have been used as efficient catalysts for 
asymmetric reactions, and as useful building blocks for the synthesis of a novel class 
of organocatalysts.
77
 
 
The pioneering work in the field was conducted by Akiyama et al.
81
 and Terada et al.
82
. 
They reported relatively strong chiral cyclic phosphoric acid diesters as catalysts (16 
and 17), which are prepared from a 3,3’-disubstituted BINOL scaffold and are efficient 
and highly enantioselective catalysts for the Mannich reactions of aldimines (a and b 
in Scheme 1.17). Based on Akiyama’s work, Terada found that functionalization of the 
3,3’-position with bulky substituents can have a dramatic effect on both the yields and 
enantiomeric excess of the products. Thus, most chiral phosphoric acid-derived 
catalysts used contain some substitutions at the 3,3’-position and have been found in 
many asymmetric reactions.
83
 More recently, Terada et al. reported the first successful 
enantioselective Mannich reaction of enamide and thiazolone by chiral phosphoric acid 
containing a 9-anthryl group (18) at the 3.3’-positions, which proceeds with high 
diastereo- and enantioselectivity (c in Scheme 1.17).
84
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Scheme 1.17 Chiral phosphoric acids reported by Akiyama et al.
81
 and Terada et 
al..
82,84
 
 
However, due to the relatively low acidity of chiral phosphoric acids (pKa = 13.3 in 
MeCN),
83
 their function has been limited to more basic nitrogen-based electrophiles 
such as imines or aziridines.
85
 In order to activate the reaction of aldehydes and 
ketones by chiral phosphoric acids, Yamamoto et al. introduced the 
N-trifluoromethanesulfonyl group into the chiral phosphoric acid to synthesise a new 
chiral BINOL-derived, N-triflyl phosphoramide (19) and utilized the stronger Brønsted 
acid to obtain cyclohexene derivatives with high enantioselectivities from the 
Diels-Alder reaction of α,β-unsaturated ketones with electron-rich dienes (Scheme 
1.18).
86
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Scheme 1.18 Chiral N-triflyl phosphoramide catalyzed Diels-Alder reaction. 
 
N-phosphoramide catalyst (pKa = 6.4 in MeCN),
83
 are more acidic than the phosphoric 
acids and their derivatives have been used for the reaction in which the substrates are 
difficult to activate. However, the structural variety of N-phosphoramide is less 
prevalent of this type of catalyst as well as their limited use in many reactions, and 
most use bulky substituents to achieve high selectivity.
83
 Still, more novel 
N-phosphoramide-derived catalysts have been reported recently. For example, List et 
al. synthesised a novel Brønsted acid catalyst imino-imidodiphosphate (20), which was 
derived from the N-triflyl phosphoramide (19) by Staudinger coupling. The new highly 
acidic catalyst was successfully utilised for the asymmetric Prins cyclization of 
aliphatic and aromatic aldehydes, affording the product in high yield with excellent 
enantiomeric ratio of 95.5:4.5 in high yield (Scheme 1.19).
87
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Scheme 1.19 Asymmetric Prins cyclization of aliphatic and aromatic aldehydes by the 
imino-imidodiphosphate (20).
87
 
 
Catalysts prepared from the VANOL/VAPOL ligands have also been found to catalyse 
asymmetric aziridination of imines efficiently giving high yields and excellent 
enantioselectivities.
88
 Wulff et al. employed a similar synthetic method as used to 
make chiral phosphoric acid, which involved converting a chiral BINOL framework to 
a chiral phosphoric acid by treatment with POCl3, followed by hydrolysis.
89
 The group 
created new derivatives of VAPOL and VANOL using the biaryl diol ligands VAPOL 
and VANOL.
90
 Using the chiral VAPOL phosphoric acid catalyst (21), Liang et al. 
obtained high enantioselectivities and good yields for the addition of imides to 
imines.
91
 However, desymmetrization of meso-aziridines by Shawn et al. gave 
relatively low yields and enantioselectivities using the BINOL chiral phosphoric acid 
catalyst (22) (Scheme 1.20).
92
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Scheme 1.20 a) Comparison of enantioselectivity between BINOL phosphoric acid 
and VAPOL phosphoric acid for the addition of substituted phthalimides to N-Boc 
imines.
91
 b) Comparison of enantioselectivities between BINOL phosphoric acid and 
VAPOL phosphoric acid for desymmetrization of meso-aziridines.
92
 
 
1.3.3.6 General Brønsted acid catalysis 
The general Brønsted acid catalytic process is related to enzymatic catalysis where 
hydrogen-bonding within a transition state occurs. The majority of hydrogen-bonding 
catalysts are based on the (thio)urea motif and increasing use of thio(urea)-based 
catalysts in synthetic reactions has been found in the last decade, most part due to their 
hydrogen-bonding interactions with negatively charged atoms of the substrates in the 
transition states.
93
 
 
Use of hydrogen-bonding catalysts began with the promotion of racemic organic 
reactions. Using X-ray crystallography, Hine showed that donation of 
hydrogen-bonding by 1,8-biphenylenediol (23)
94
 to the oxygen atom of Lewis basic 
substrates, which could effectively active a substrate for a nucleophilic attack in 
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aminolysis reaction of phenyl glycidyl ether. The subsequent discovery by Etter et al. 
shows that an N,N’-diarylureas (24) co-crystallize with a variety of Lewis basic 
functional groups, such as nitroaromatics, ethers, ketones and sulfoxides, via 
hydrogen-bonding interactions.
95,96
 The donation of two hydrogen-bonds by a single 
urea molecule to the Lewis base was implicated. A similar dual-hydration model was 
proposed by computational studies conducted by Jørgensen et al. to explain the 
accelerating effect of water on the Diels-Alder reactions and Claisen rearrangement.
97
 
These studies provided the basis for the development of (thio)urea-based 
organocatalysts. Curran et al. reported that the outcome of allylation reactions and 
Claisen rearrangements can be affected by the presence of urea and thiourea, including 
Etter-type diarylurea (24A).
98,99
 Based on some of the key features of the thiourea 
scaffold, such as good solubility in a variety of solvents and the lower electronegativity 
of sulfur, Schreiner et al. carried out an investigation of thiourea derivatives as 
catalysts for the Diels-Alder reaction of cyclopentadiene and α,β-unsaturated carbonyl 
compounds in a similar approach used for Lewis acid catalysis. They proposed that the 
introduction of electron-withdrawing CF3 group substituents in the meta-position of the 
aryl ring (24B) would enhance the catalytic ability by generating a more rigid 
conformation due to H-bonding between the sulfur atom and the ortho-protons by 
computational modelling.
100
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Fig. 1.12 a) Hine’s biphenylenediol catalyst (23); b) rationale for the catalysis of the in 
aminolysis reaction by 23 through double hydrogen-bond donation; c) a representation 
of the binding between Etter’s urea catalyst (24) and acetone; d) Jørgensen's dual 
hydration model for explanation of rate enhancement for Diels-Alder reactions and 
Claisen rearrangement in the presence of water; e) Curran’s and Schreiner’s (thio)urea 
catalysts (24A and 24B, respectively). 
 
Based on the structure of bifunctional Schiff base-thiourea (25 in Fig. 1.13) by 
Jacobsen
101
 and tertiary amine-based thiourea (26 in Fig. 1.13) by Takemoto,
102
 the 
development of bifunctional amine-based (thio)urea derivatives have created new 
impulses to the field of organocatalysis. This type of catalysts possesses a thiourea or a 
urea moiety (hydrogen-donor site) and a basic group such as primary, secondary amine, 
which not only can activate both nucleophilic and electrophilic reactions 
simultaneously, but also can control the approach of the substrates stereoselectivity (b 
in Fig. 1.13).
103
 More recently, over 30 new primary amine-thiourea catalysts have 
been developed since 2006 and have emerged as new catalysts for a wide range of 
enantioselective transformations.
104
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Fig. 1.13 a) Pioneering bifunctional amine-thiourea organocatalysts and b) their 
general structures. 
 
Jacobsen et al. reported a new primary amino-thiourea catalyst (27) which enables the 
formal aza-Diels-Alder reaction of enones and cyclic imines for the 
enantiostereoselective synthesis of chiral indolo- and benzoquinolizidine compounds 
(Scheme 1.21).
105
 The hydrogen-bond donor and primary amine are essential 
functional components of the catalyst for simultaneous activation of both the enone 
and imine reaction components. 
 
Scheme 1.21 Catalysis of aza-Diels-Alder reaction of enone and 
3,4-dihydroisoquinolines by Jacobsen’s catalyst.105 
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Recently Wang et al. presented the first asymmetric formal thio [3+3] cycloaddition 
for the construction of optically active thiopyrano-indole annulated heterocyclic 
compounds in high yields with up to 96% ee, using a novel bifunctional tertiary 
amine-thiourea catalyst (28) derived from 1,2-diphenylethane-1,2-diamine (DPEN) 
(Scheme 1.22).
106
 According to density functional theory calculations, the authors 
confirmed that the high reactivity between indoline-2-thione (keto-S) and 
2-benzylidenemalononitrile as simultaneous activation of both reactants, leading to 
form a stable multiple hydrogen-bond complex with the bifunctional thiourea catalyst. 
Thus, carbon-carbon bond formation step occurs in a highly chiral environment. 
 
 
 
Scheme 1.22 Enantioselective formal thio [3+3] cycloaddition by the DPEN-derived 
bifunctional tertiary amine-thiourea catalyst (28) and the proposed transition-state 
model.
106
 
 
Regarding various organocatalysts based on the (thio)urea core are broadly utilised in 
the field of hydrogen-bond donor catalysis,
107
 bifunctional squaramide derivatives 
have emerged as an effective alternative to the urea and thiourea catalyst since they 
were reported by Rawal et al. for a highly enantioselective Michael addition of 
1,3-dicarbonyl compounds to nitroolefins.
108
 Several studies investigated the 
squaramide structural difference to the analogous thioureas and ureas. The two NH 
groups in thiourea, urea and squaramide can act effectively as two hydrogen-bond 
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donor sites. However, the presence of two carbonyl oxygen atoms in squaramide 
provides other two-fold hydrogen-bond acceptor sites, whereas there is only one in 
urea. Thus, the aromaticity of squaramide is enhanced in the presence of both 
hydrogen-bond accepting anions and hydrogen-bond donating cations (a in Fig. 
1.14).
109
 Therefore, squaramide could be considered as a better binding unit and anion 
hosts than thiourea and urea.
110,111
 Moreover, compared to the counterpart thiourea, the 
distance between the two NH groups of squaramide (ca. 2.72 Å) is about 0.6 Å longer 
than that of a thiourea (ca. 2.13 Å);
108
 Both (thio)urea and squaramide have the 
possibility of delocalizing the nitrogen lone pair, thereby restricting the rotation of C-N 
bond. However, only in squaramide can further delocalization occur through the 
cyclobutenedione system (b in Fig. 1.14).
112
 Thus, the pKa value of a squaramide
113
 is 
lower compared to their thiourea and urea analogous
114
 (c in Fig. 1.14), which leads to 
stronger hydrogen-bonding and increased catalytic activity.
113
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Fig. 1.14 a) and b) Structural difference between the squaramide and the (thio)urea; c) 
Comparison of pKa values of (thio)urea and squaramide derivatives in DMSO; d) 
General structure of squaramide organocatalyst. 
 
Regarding a variety of bifunctional thiourea catalysts incorporating amino 
functionalities, a squaramide catalyst also contains a chiral scaffold bearing a basic 
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group (d in Fig. 1.14) and most of the squaramide catalysts have been developed with 
a secondary amine or a tertiary amine as the basic site and been successfully employed 
in many transformations as bifunctional organocatalysts.
112
 For instance, bifunctional 
pyrrolidine-squaramide catalysts have been mostly reported recently as they were 
specifically designed for addressing remote reactivity through hydrogen-bond-direct 
dienamine-mediated catalysis.
115
 Jørgensen et al. developed the first 
hydrogen-bond-direct dienamine-mediated [2+2] cycloaddition of α,β-unsaturated 
aldehydes with nitroolefins using the secondary amine-squaramide catalyst (29) 
derived from 2-aminomethylpyrrolidine.
116
 The formation of dienamine between the 
secondary amine of the catalyst and α,β-unsaturated aldehyde, and simultaneous 
activation of the nitroolefin through hydrogen-bonding, towards the cyclobutane 
product bearing a quaternary stereocenter in high yield and excellent enantioselectivity 
(Scheme 1.23).
116
 Moreover, according to the theoretical mechanistic calculation, 
Jørgensen found that the reaction occurs in a stepwise manner. The first step involves a 
carbon-carbon bond formation between the γ-carbon of the dienamine and the 
β-carbon of the nitroolefin (intermediate A), followed by the second carbon-carbon 
formation between the β-carbon of iminium ion and the carbon of the nitro group 
(intermediate B) to form a catalyst-bound cyclobutane intermediate (intermediate C). 
 
 
Scheme 1.23 Enantioselective [2+2] cycloaddition reaction of α,β-unsaturated 
aldehyde with nitroolefin catalyzed by the pyrrolidine-squaramide catalyst (29).
116
 
 
Later on, using the same catalyst, Vicario et al. established a highly diastereo- and 
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enantioselective formal [5+2] cycloaddition of oxidopyrylium ylide and enal. The 
mechanistic study shows that a dienamine intermediate is formed after condensation of 
the enal with the catalyst (29), which raises the HOMO energy of the dipolarophile. 
Thus, creating an exclusive β,γ-reactivity provided direct access to the product contain 
an 8-oxabicyclo[3.2.1]octane moiety in high yield with excellent diastereo- and 
enantioselectivity (Scheme 1.24).
117
 
 
 
 
Scheme 1.24 Enantioselective [5+2] cycloaddition between oxidopyrylium ylides and 
enals via dienamine activation catalyzed by the pyrrolidine-squaramide catalyst (29).
117
 
 
More recently, Li et al. reported a highly enantioselective asymmetric addition reaction 
of thioglycolates and N-Boc aldimine was promoted by a tertiary amine-squaramide 
catalyst (30) to furnish N,S-acetal derivatives in high yield and excellent 
enantioselectivity (Scheme 1.25).
118
 According to the absolution configuration of 
product, the author proposed the N-Boc aldimine is activated and orientated by the 
hydrogen-bonds of the squaramide catalyst, simultaneously the tertiary amine of the 
catalyst provide suitable basicity to enhance the nucleophilicity of the thioglycolate. 
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Scheme 1.25 Asymmetric addition reaction of N-Boc aldimine and thioglycolate 
catalyzed by the bifunctional tertiary-amine squaramide catalyst (30).
118
 
 
 
1.4 Bifunctional chiral phosphoric acids 
1.4.1 Catalysis by acids 
Brønsted acids have been widely utilised as catalysts for numerous organic 
transformations. Although acting as catalysts, Brønsted acids still have some 
disadvantages in carbon-carbon bond formation reactions, such as high catalyst loading 
and undesired side reactions.
119
 Development of novel Brønsted acid catalysts has been 
continuously studied due to their broad synthetic applicability. The majority of the 
early research was to develop highly active Brønsted acids, known as superacids, 
which can generate unstable and highly reactive protonated intermediates.
119
 
 
As mentioned earlier it is expected that interactions with Brønsted acids, such as 
hydrogen-bonding, are suppressed between the conjugate base (A
−
) and the protonated 
substrate intermediate (S
+
H) (Fig. 1.15). 
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Fig. 1.15 Brønsted acid and chiral Brønsted acid catalysis in organic 
transformations.
120
 
 
Previously it was considered that Brønsted acids would only activate a substrate (S:) 
by protonation. Therefore, the conjugate base (A
−
) would be expected to only 
influence catalytic activity, rather than taking part in the selective formation of 
products. After focusing on studies of chiral Brønsted acid catalysis, in which 
enantiomeric products are obtained using a catalytic amount of a chiral organic 
molecule bearing an acidic functionality,
121
 the hydrogen-bonding between the 
conjugate base (A*
−
) and the protonated substrate intermediate (S
+
H) was determined 
to be the key to enantioselective catalysis.
120
 Therefore, the organic transformations 
proceed under a chiral environment created by the chiral conjugated base (A*
−
), which 
remains in the vicinity of the substrate through a hydrogen-bonding interaction.
120
 In 
other words, when the Brønsted acid has donated its proton to the substrate (S:), the 
conjugate base (A*
−
) remains to create the chiral environment for the subsequent 
bond-forming step (Fig. 1.15). 
 
Since the first example of chiral Brønsted acid catalysis was reported by Jacobsen et al. 
in the enantioselective Strecker reaction catalyzed by peptide-based thiourea 
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derivatives as hydrogen-bond-donor catalysts,
101,122
 enantioselective catalysis by chiral 
Brønsted acids has become of great interest. With development of chiral Brønsted acid 
catalysis, the binaphthol-derived chiral phosphoric acid class of molecules was 
discovered and has emerged as an attractive and applicable class of enantioselective 
organocatalysis for numerous organic transformations. 
 
1.4.2 Structural features of chiral phosphoric acids 
Many reactions using BINOL-derived phosphoric acids have been mention previously. 
Several features of this type of catalyst are essential for efficient asymmetric 
transformations:
120
 
 Phosphoric acids are expected to capture electrophilic components through 
hydrogen-bonding interactions without the formation of loose ion-pairs due to 
their relatively strong but appropriate acidity, for example, the pKa of (EtO)2 
P(O)OH is 1.39. 
 Besides the acidic proton on the Brønsted acidic site, the phosphoryl oxygen on 
the Brønsted basic site can act as a hydrogen-bonding acceptor, so that it would 
convey acid/base dual function even for monofunctional phosphoric acid catalysts. 
 When a ring structure is introduced to the phosphoric acid, an acidic functionality 
is still available. The ring system prevents the free rotation at the α-position of the 
phosphorus center.  
 A substituent group (STG) can be introduced into the ring system to provide a 
chiral environment for enantioselective transformations (Fig. 1.16). 
 
 
 
Fig. 1.16 Description of structure of (S)-chiral phosphoric acid catalyst.
120
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As mentioned above, it is anticipated that an efficient substrate recognition site could 
be constructed around the activation site of the phosphoric acid catalysts, namely the 
acidic proton, as a result of the acid/base dual function and the stereoelectronic 
influence of the substituents (STG). Binaphthol (BINOL) is well known as an axially 
chiral molecule having C2-symmetry, and derivatives have been extensively utilised as 
chiral ligands for metal-catalyzed reactions.
123
 Thus, BINOL derivatives were selected 
as chiral sources to assemble the catalyst with the advantage that both enantiomers are 
commercially available and numerous protocols for introducing substituents at 
3,3’-position of the binaphthyl scaffold are known. 
 
1.4.3 Catalysis of Mannich reaction by a chiral phosphoric acid 
The enantioselective Mannich reaction is one of carbon-carbon bond formation 
reactions for the synthesis of chiral compounds containing nitrogen, such as optically 
active β-amino carbonyl compounds, which are a versatile resource for preparation of 
biologically active natural products and drug candidates.
124
 ʟ-Proline and peptides 
were discovered to have the excellent catalytic ability for Mannich type reactions.
125
 
The mechanism of the Mannich reaction begins with the formation of an iminium ion, 
which is generated from the reaction between an amine and formaldehyde. A 
carbonyl-containing compound, such as a ketone, can tautomerize to the enol form and 
then attack the iminium ion to give the product. Scheme 1.26 shows the proposed 
mechanism of the Mannich reaction catalyzed by acid. 
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Scheme 1.26 Proposed mechanism of Mannich reaction catalyzed by acid.
126 
 
The exact mechanism of a chiral phosphoric acid catalyzed-Mannich reaction is not a 
straightforward procedure, because there are a large number of possible interactions 
that may take place between the catalyst and the substrates used in the reactions. Since 
BINOL derived phosphoric acids were developed by Akiyama et al. and Terada et al., 
they disclosed the stereochemical outcome of Mannich reaction using different 
reaction modes.
83
 
 
Akiyama et al. developed a chiral cyclic phosphoric acid diester catalyst (16) starting 
from (R)-BINOL and applied this catalyst to the Mannich reaction of ketene silyl 
acetal with aldimine to form β-amino esters (Scheme 1.27). Good syn 
diastereoselectivity and high enantioselectivity (up to 96% ee) were observed and they 
found that the introduction of 4-nitrophenyl groups on the 3,3’-position exhibited two 
enhancements: improvement of enantioselectivity and acceleration of the reaction rate. 
It was proposed that the reaction proceeded via an iminium salt generated from the 
aldimine and that the 3,3’-diaryl groups shielded the phosphate group, resulting in 
asymmetric induction. Akiyama also explained the reaction mechanism using density 
functional theory calculations. According to the results of the calculations, he disclosed 
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that the reaction occurs by a double hydrogen-bonding activation (dual activation 
mode), in which the acidic proton on the Brønsted acidic site of the catalyst activates 
the imine by protonation, and an additional hydrogen-bonding interaction between the 
phenol proton of the imine and the Lewis basic site of the catalyst. Thus, the resulting 
in the formation of the intermediate complex (A) between the catalyst and the imine, 
which provides a rigid and stronger chiral environment around the substrate.
83,127
 
 
 
 
Scheme 1.27 Mannich reaction of ketene silyl acetal with aldimine catalyzed by 16 via 
a dual activation mode.
83,127
 
 
In parallel, Terada et al. reported that the highly enantioselective direct Mannich 
reaction of N-Boc imine and acetyl acetone catalyzed by the chiral phosphoric acid 
catalyst (17) (Scheme 1.28). They considered that the reaction proceeds through 
bifunctional activation, which leads to generate two possible intermediates between the 
catalyst and reactant through hydrogen-bonding. One is from between the enol proton 
of the acetyl acetone tautomer and the phosphoryl oxygen of Brønsted basic site of the 
catalyst, the other is formed by the interaction of OH group on the Brønsted acidic site 
of the catalyst with the nitrogen atom of N-Boc imine having two possible 
orientations.
121
 Subsequently, N-Boc imine is activated by the catalyst through the 
acidic proton, meanwhile, the phosphoryl oxygen interacts with the OH group of the 
enol, resulting in the formation of two possible intermediate B and B’, respectively. 
Due to the close contacts of the Boc group of the imine with biphenyl substituents of 
the catalyst to prevent the free rotation around the hydrogen-bond, intermediate B is 
more likely to give the excepted configuration of product.
83,128
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Scheme 1.28 Mannich reaction of N-Boc imine and acetyl acetone catalyzed by 17 via 
a bifunctional activation mode.
83,121
 
 
In addition to the dual and bifuntional activation modes, the mono activation by single 
contact for the Mannich reaction has been also reported. For instance, Rueping et al. 
developed the first enantioselective domino Mannich–ketalization reaction of 
2-hydroxyphenyl imines with cyclic enol ethers. In the presence of 
N-triflylphosphoramide derivative (31), formation of an intermediate C by mono 
activation of the imine leads to stereoselective addition of the enol ether followed by 
cyclization of the hydroxyl group, resulting in 4-aminobenzopyran product in good 
yields with excellent enantioselectivities.
83,129
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Scheme 1.29 Enantioselective domino Mannich–ketalization of 2-hydroxyphenyl 
imines with cyclic enol ethers catalyzed by 31 via a mono activation mode.
83,129
 
 
 
1.5 Cinchona alkaloid-based thiourea and urea derivatives 
1.5.1 The cinchona alkaloids 
Alkaloids are a group of naturally occurring chemical substances and most originate 
from plants. Most alkaloids contain carbon, basic nitrogen substituents, and oxygen. 
They are usually used as drugs with pronounced effects on the nervous systems of 
humans and animals, for example, caffeine, cocaine and morphine.
130
 
 
Cinchona alkaloids are natural products found in the bark of several species of 
cinchona trees. In the early 17
th
 century, extracts from powdered bark of the cinchona 
species, such as quinine, were used for the treatment of malaria until it was replaced by 
synthetic analogues, for example, chloroquine and primaquine.
131
 Having over 300 
years of medicinal roles in human society, approximately 700 metric tons of cinchona 
alkaloids are extracted from cinchona bark annually, nearly half of which is used in the 
food and beverages industry as a bitter additive. The rest of the remaining quinine and 
quinidine is still used as an important antimalarial drug scaffold, muscle relaxant, and a 
cardiac depressant.
132
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Cinchona alkaloids contain five chiral centers (N1, C3, C4, C8 and C9), two basic 
molecular units, two rigid ring moieties (an aromatic quinoline ring and aliphatic 
quinuclidine ring as a tertiary amine), and a methylenic alcohol group linking the two. 
The studies on structural features of cinchona alkaloids have been summarized recently 
(Fig. 1.12): 
 
 
 
Fig. 1.17 Structure of cinchona alkaloids. 
 
1. The relative position adopted by the bulky ring systems of quinoline and 
quinuclidine possibly generates a rigid chiral pocket around the substrate, which 
enforces enantioselective induction during organic reactions.
133
 
2. Free rotation around the linker atoms C8-C9, which create a dynamic environment, 
provides many conformations with different stabilities and abilities to impart 
enantioselectivity in a given catalytic process.
134
 
3. The quinoline aromatic ring contains a potential secondary binding site and acts as 
a site for adsorption onto solid surfaces in heterogeneous catalysis. This flat 
aromatic ring could enable the formation of donor-acceptor complexes with 
electron-deficient molecules due to the electron-donating abilities.
133
 
4. The C9-stereogenic center makes diastereomers available, which provide access to 
both enantiomers of a product with almost identical selectivity. The free hydroxyl 
group on the C9 plays an important role for high catalytic reactivity and 
selectivity.
135
 
 
Over the past 30 years, the cinchona alkaloids have been studied mainly for being 
efficient chiral reagents, chiral auxiliaries and privileged catalysts. Various cinchona 
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alkaloids and their derivatives have been synthesised and utilised as catalysts in many 
asymmetric reactions to give a variety of enantiopure products.
136
 For instance, the 
application of cinchona alkaloid derivatives in phase-transfer catalyst and Brønsted 
base catalysis has been mentioned early. 
 
1.5.2 Cinchona alkaloid-based thiourea, urea and squaramide 
derivatives 
The developing concept of bifunctional catalysts using the natural cinchona alkaloids 
has resulted in the design and synthesis of the novel cinchona derivatives for 
asymmetric reactions. Urea- and thiourea-substituted cinchona alkaloid derivatives 
represent a large and dominant platform for the hydrogen-bonding promoted 
asymmetric catalysis, and recently followed by incredible growth in the form of 
squaramides.
137
 Since Takemoto reported the high enantioselective Michael addition of 
dimethyl malonate to nitroolefins using the first bifunctional amine-thiourea (26 in Fig. 
1.13), the significant progress of design and application of new bifunctional cinchona 
alkaloid based-thioureas/ureas have been made by the groups of Chen, Soós, Connon 
and Dixon, respectively (Scheme 1.30).
138
 Following the structure of Takemoto’s 
thiourea (26), they designed the first cinchona derived thiourea catalysts by 
modification of C9-hydroxyl group of the cinchona alkaloid starting materials for 
promoting different asymmetric conjugate and Michael additions. Soós et al. reported 
a highly enantioselective Michael addition of nitromethane to chalone using catalyst 
(32). Using the same catalyst, Connon et al. found high enantioselectivities and yields 
in the Michael addition of malonate into nitroalkenes. Dixon et al. reported high 
selectivities in the same reaction with comparable results, employing the catalyst (33) 
which shows high activity but moderate enantioselectivity in the Michael addition of 
thiophenol to α,β-unsaturated imide reported by Chen et al..138 Based on their 
pioneering work, C9 epimeric cinchona alkaloid catalysts show more effective (higher 
activity and selectivity) than analogues from natural stereochemistry cinchona 
alkaloids. 
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Scheme 1.30 The pioneering work of cinchona derived thiourea catalysts in conjugate 
addition reactions.
138
 
 
Due to the similar functional groups which cinchona derived thiourea derivative (32) 
and Takemoto’s thiourea (26) share, the catalytic activities of both thioureas are very 
similar. As shown in Fig. 1.18, the thiourea moieties in 32 and 26 provide double 
hydrogen-bonding interactions to coordinate and activate electrophile 
(hydrogen-bonding acceptor), while the tertiary amines in both compounds activate 
nucleophile by deprotonation. 
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Fig. 1.18 Comparison of cinchona alkaloid-based thiourea (32) and Takemoto’s 
thiourea (26). 
 
Based on these early examples of bifunctional cinchona derived thiourea catalysts, 
there has been a great advance in designing novel thioureas and ureas for synthetically 
useful organic transformations. Han et al. developed the first enantioselective 
nitro-Mannich reaction of 5H-oxazol-4-ones with various alkyl and aryl sulfonamides 
using cinchonine-derived urea (34). They found the different substituted groups on the 
aromatic rings of imines did not affect the reaction rate and enantioselectivity, but the 
substituents at the nitrogen atom of imines affected the diastereoselectivity. Hence, the 
N-TIPBs-alkylimines generated the product β-alkyl-substituted α-hydroxy-β-amino 
acids in the good yields with excellent diastereo- and enantioselectivities. Base on the 
successful initial work, the authors also scaled up the reaction to the gram scale 
without compromising the enantioselectivity (Scheme 1.31).
139
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Scheme 1.31 Asymmetric Mannich reaction of 5H-oxazol-4-ones with 
N-TIPBs-arylimines catalyzed by the cinchonine-derived urea (34).
139
 
 
Demir et al. have recently reported an asymmetric aldol reaction of α-azido ketones to 
ethyl pyruvate catalyzed by a cinchona-based bifunctional urea (35). With established 
the optimum reaction condition, the reaction led to furnish ethyl 
4-aryl-3-azido-2-hydroxy-2-methyl-4-oxobutanoates with high enantioselectivity and 
diastereoselectivity ratio, but in moderate yields (Scheme 1.32).
140
 
 
 
 
Scheme 1.32 Asymmetric aldol reaction of α-azido ketones to ethyl pyruvate catalyzed 
by the cinchona-based bifunctional urea (35).
140
 
 
Lu et al. developed the first asymmetric aldol reaction of isocyanoesters with 
β,γ-unsaturated α-ketoesters using C6’-thiourea cinchona alkaloid derivative (36). 
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After acidic hydrolysis, the reaction afforded the chiral β-hydroxy-α-amino acid esters 
were obtained in good yields and excellent enantioselectivities (up to 92% ee).
141
 
 
 
 
Scheme 1.33 Asymmetric aldol reaction of isocyanoesters with β,γ-unsaturated 
α-ketoesters catalyzed by the C6’-thiourea cinchona derivative (36).141 
 
He et al. reported that application of a novel C9-thiourea cinchona derivative (37) as 
the most efficient catalyst in the enantioselective oxaziridination of aldimines. With 
using meta-chloroperoxybenzoicacid (m-CPBA) as the oxidant, the reaction afforded 
several optically active oxzairdines in good yields with moderate to excellent 
enantioselectivities (up to 99% ee). Based on the experimental results, they found that 
the greater steric substrates generate a higher yields and ee values, such as isopropyl or 
tertiary butyl, and the electron-donating groups of substrates enhance the 
enantioselectivities (Scheme 1.34).
142
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Scheme 1.34 Asymmetric oxaziridination of aldimines catalyzed by the C9-thiourea 
cinchona derivative (37).
142
 
 
On the other hand, since Rawal et al. designed the first cinchona-derived squaramide 
as an efficient catalyst for the asymmetric Michael addition reaction,
108
 the squaramide 
bifunctional catalysts have attracted some attention in recent years. A series of chiral 
cinchona derived-squaramides have been developed and employed them successfully 
in various asymmetric reactions. As mentioned previously, due to the unique structural 
features, cinchona-derived squaramides have shown some advantages. For instance, 
Connon et al. presented that the quinine-derived squaramide catalyst (38) shows better 
catalytic performance than the corresponding thiourea catalyst (39) in the asymmetric 
coupling reaction of homophthalic anhydride with benzaldehyde (Scheme 1.35).
143
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Scheme 1.35 Comparison of the catalytic efficiency of the catalyst (38) and (39) in the 
addition of homophthalic anhydride to benzaldehyde.
143
 
 
More recently, Zhao et al. developed an asymmetric cascade Friedel-Crafts alkylation 
reaction of 1-naphthol with 3-trifluoroethylidene oxindole using a quinine-derived 
squaramide catalyst (40), to afford the corresponding α-aryl-β-trifluoromethyl 
dihydrocoumarin derivative in high yields with excellent enantioselectivities (up to 98% 
ee). They also found when using the other squaramide (41) as a catalyst for the 
reaction, a lower enantioselectivity was not observed (74% ee), although the reaction 
proceeded efficiently to furnish the desired product in good yield (90%).
144
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Scheme 1.36 Comparison of the catalytic efficiency of the catalyst (40) and (41) in the 
asymmetric Friedel-Crafts alkylation of 1-naphthol with 3-ylidene oxindole.
144
 
 
 
1.5.3 Catalysis of asymmetric Michael addition reactions by 
cinchona-derived urea and thiourea derivatives 
The Michael addition reaction is an addition reaction of a carbanion or another carbon 
nucleophile (reaction donor), such as dimethyl malonate, to an α,β-unsaturated 
carbonyl compound or electrophile (reaction acceptor) to form the corresponding 
addition product using a base catalyst. Michael addition reactions begin with 
deprotonation of the reaction donor with the base to form an enolate. This enolate then 
attacks the reaction acceptor to form the product with the formation of a new 
carbon-carbon bond. Scheme 1.37 shows the mechanism of the Michael addition 
reaction. 
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Scheme 1.37 Proposed mechanism of the Michael addition reaction.
145
 
 
The first asymmetric conjugate addition of 1,3-dicabonaly to nitroenynes was reported 
by Li et al.. They used The 1,4-addition product were obtained in good yields with ee 
values up to 93% using cinchona alkaloid-based thiourea (42). The authors claimed 
that the reaction method worked well with both aryl- and alkyl-substituted nitroenyne 
substrates, thus it provided a catalytic and transition-metal-free entry to the precursors 
of pharmaceutical important chiral β-alkynyl acid derivatives.146 
 
 
Scheme 1.38 Enantioselective Michael reactions of nitroenynes with malonates 
catalyzed the cinchona-derived thiourea (42).
146
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Matsubara et al. developed a novel enantioselective synthesis of 2-substituted 
chromans through an intermolecular oxy-Michael addition of phenol derivatives 
bearing (E)-α,β unsaturated ketones, using the quinidine-derived urea (43), the 
corresponding thiourea (44), and the quinine-derived urea (45) and as catalysts, 
respectively. High yields and good enantioselectivities were achieved using these three 
catalysts. The urea (43) appeared to be more efficient than the thiourea (44), while the 
urea catalyst (45) also revealed to be more efficient catalyst for affording the opposite 
enantiomer of product with good enantioselectivities.
147
 
 
 
Scheme 1.39 Application of the cinchona alkaloid-based ureas (43 and 45) and the 
thiourea (44) in oxy-Michael addition of phenol derivatives.
147
 
 
 
1.6 Opium alkaloid-based organocatalysts 
1.6.1 The morphine alkaloids 
The opiates are isolated from the sap of the poppy plant. The opium alkaloids which 
occur naturally in the largest amounts are morphine, codeine, noscapine, thebaine and 
papaverine.
148
 Fig. 1.15 shows some examples of natural morphine alkaloids and the 
synthetic derivative naltrexone. Morphine has been widely used as a powerful 
analgesic since it was isolated in its pure form in 1803.
149
 The commercial 
manufacturing of codeine is performed (from morphine) due to the high abundance of 
morphine in nature from poppy extracts, coupled with the low annual demand for this 
painkiller. Medically important derivatives of thebaine can also be synthesised from 
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codeine via codeine methyl ether.
150
 These opiates have been investigated as drugs 
with analgesic or pain-relieving effects. 
 
 
 
Fig. 1.19 Examples of morphine alkaloids. 
 
1.6.2 The structure of morphine alkaloids 
As natural compounds with unique chiral structures, opiate alkaloids, in particular 
morphine and codeine, possess a wide range of structural features. Thus, an 
examination of the structural features common to the phenanthrene opiate subfamily is 
important for further modification and study of their chemical and pharmacological 
profiles. For example, morphine has a rigid pentacyclic structure consisting of a 
benzene ring (A), two partially unsaturated cyclohexane rings (B and C), a piperidine 
ring (D) and a tetrahydrofuran ring (E).
151
 The morphine molecule adopts a 
three-dimensional “T” shape with rings A, B and E forming a near perfect vertical 
plane and rings C and D forming a more distorted horizontal plane.
152
 There are two 
hydroxyl functional groups located at C3 (pKa= 9.9) and C6 (allylic OH) respectively; 
an ether linkage between C4 and C5 and unsaturation between C7 and C8; a basic 
tertiary amine function at position C17; five chiral centers: C5(R), C6(S), C9(R), 
C13(S) and C14(R) in the unique chiral scaffold exhibit a high degree of 
stereochemical diversity
151
 and it is hypothesized that the possibility for 
enantioselective catalysis exists. Fig. 1.20 shows the three-dimensional structure and 
structural features of morphine. 
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Fig. 1.20 The three-dimensional structure (a) and structural features (b) of morphine. 
 
Although both quinine (pKa = 4.29) and codeine (pKa = 8.15)
153
 have different pKa 
values, these two weak bases share some common structural features: an aromatic ring, 
a double bond, a secondary alcohol, tertiary nitrogen and aromatic methyl ether (Fig. 
1.21). With a prolific history and successful application in organocatalysis of the 
cinchona alkaloids, the investigation of morphine alkaloids and their derivatives as a 
novel class of organocatalysts is the main purpose of this research work. 
 
 
 
Fig. 1.21 Common features in quinine and codeine. 
 
1.6.3 Catalysis of reactions by morphine alkaloids 
High enantioselectivity has been successfully achieved by using chiral alkaloids such 
as quinine and quinidine. Morphine-derived alkaloids have rarely been investigated as 
chiral ligands in asymmetric reactions. The first asymmetric reaction carried out using 
such related alkaloids was published by Wells et al..
154
 They investigated the use of 
codeine, dihydrocodeine and oxycodone to modify a platinum surface in the 
asymmetric hydrogenation of methyl pyruvate and butane-2,3-dione, but very low 
enantioselectivities were obtained. 
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Dabiri et al. demonstrated the asymmetric addition reaction of diethylzinc to 
benzaldehyde with a catalytic amount of 14-hydroxyl substituted 6-ketomorphinans.
155
 
They optimised the conditions by lowering the temperature and increasing the catalyst 
loading to give high yield and good enantioselectivities: At the lower temperature of 
−30 ºC, the alcohol product, with 80% ee (S) and 89% ee (S) were obtained by using 
20 mol% of 46 and 20 mol% of 48, respectively. The alcohol product with only 53% 
ee (R) was isolated when using 10 mol% of 47. When the temperature was increased to 
10 ºC, 46 and 48 still afforded better enantioselectivities than 47, using 10 mol% of 
catalyst loading (Scheme 1.40). Based on the results they obtained, Dabiri et al. 
recommended morphine alkaloids certainly deserved further study in asymmetric 
catalysis applications. 
 
 
 
Scheme 1.40 Enantioselective addition reaction of diethylzinc to benzaldehyde 
catalyzed by opioid derivatives.
155
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1.7 Conclusion 
Enantioselective organocatalysis has emerged as a powerful and efficient synthetic tool 
being a complementary mode of catalysis in the field of asymmetric synthesis, due to 
having the potential for saving in cost, time and energy, conducting easy experimental 
procedure with a less chemical waste output. With respect to industrial applications, 
especially in medicinal industries, the requirement of catalysts is considerate extremely 
important for the construction of new candidate drugs, such as its generality, 
convenience and robustness. Organocatalysts meet all these standards and have already 
been used in search of pure enantiomeric drugs for leading to 100% yield and 100% 
ee.
156
 
 
Among the available methods for synthesis of enantiopure chiral compounds, 
asymmetric catalysis has been demonstrated to be an important alternative to access 
chiral molecules as one molecule of the chiral catalyst can transfer its chiral 
information to many new chiral molecules. Therefore, since the successful 
demonstration of ʟ-proline in many asymmetric syntheses, the design and synthesis of 
the structural versatility of chiral organocatalysts have appeared as a viable strategy for 
preparation of enantiomeric compounds or building blocks.
157
 The most notable 
advance is certainly the development and application of a range of chiral molecules for 
the synthesis of new catalysts. Undertaking organic transformations in an 
environmentally benign manner is increasingly important. Therefore, the catalytic 
properties of optically active small organic molecules have attracted a great deal of 
attention.
158
 
 
On the other hand, due to the ability of the simultaneous donation of two 
hydrogen-bonds for electrophile activation and transition-state organization, both ureas 
thioureas and even squaramides have been employed in asymmetric reactions. Thus, 
the design and application of bifunctional chiral (thio)ureas have been continuously 
developed with the discovery of several structural factors that influence the behaviour 
of new catalysts in asymmetric reactions. In general, a bifunctional catalyst 
incorporates an electron-poor aryl group (3,5-CF3 disubstituted) on one of the attached 
substitutes, which leads to decrease the pKa for increasing the hydrogen-bond donating. 
Furthermore, to ensure the asymmetric character of the catalysis, the skeleton of the 
ligand must be chiral,
159
 such as the cinchona alkaloid scaffold in their (thio)urea 
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derivatives, which has been discussed in the chapter. The combination of (thio)urea 
moiety with amines, for example, tertiary amines, has also been utilized for design of 
bifunctional catalysts with the capability of simultaneously activating both the 
electrophile and the nucleophile. This allows not only to improve catalytic activity, but 
more importantly to contribute a greater degree of stereocontrol.
159
 Researchers have 
also discovered that various types of chiral, highly pre-organized and available 
scaffolds in natural products that can be easily combined into the (thio)urea 
architectures for the fine-tuning of the catalyst system. For example, application of the 
novel class of thiourea catalysts bearing a bulky, rigid and chiral terpene skeleton in 
many asymmetric reactions has been reviewed more recently.
159
 
 
Opiates and their semi-synthetic derivatives have long been investigated as potent 
analgesic compounds for medicinal purposes. However, the development of a class of 
chiral bifunctional (thio)urea derivatives that are based on the morphine alkaloids has 
remained uncovered in many literatures, due to its novelty. Thus, gaining inspiration 
from those successful example of cinchona-derived thioureas and ureas, and also from 
the presence of the common structural features between cinchona and morphine 
alkaloids, alongside utilization of the literature data to develop novel alkaloid 
structures, one can propose that the use of sustainable chiral building blocks or chiral 
ligands, such as codeine as a starting material, could allow for the future development 
of novel families of morphine alkaloid-based organocatalysts. 
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Chapter 2 
Synthesis and Structural 
Characterisation of Thiourea and Urea 
Opioid Derivatives 
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2.1 Synthesis of opioid derivatives 
An introduction to the morphine alkaloid structure has been discussed in Chapter 1. In 
order to synthesise the target compounds, some of the key desired manipulations of the 
opiate scaffold for organocatalyst development, which includes (Scheme 2.1), are 
listed below: 
 
 
 
Scheme 2.1 Modification of codeine and morphine for synthesis of catalysts.  
 
 Modification of the phenolic hydroxyl at the C3 and of the secondary C6-hydroxyl 
of codeine and morphine.
1
 
 Manipulation of the double bond between C7 and C8.2 
 Functionalization of the C8-position.3  
 Opening of the tetrahydrofuran ring.4  
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 C-C bond formation using transition metal catalysis to couple at the A ring.5 
 
Codeine and morphine differ by the extra C18-methyl group present in codeine. We 
consider this a protecting group for morphine, albeit a robust one. On the other hand, 
the two reactive hydroxyl groups located on the C3- and C6-position of morphine can 
be easily substituted.  
 
To facilitate the synthetic process scale-up, the goal of the synthetic route was set up to 
meet the following criteria: 1. convergent, 2. through same intermediates for 
convenience, 3. safe and green, 4. commercial availability of starting material. The 
retrosynthetic analysis (Scheme 2.2) revealed that the skeletal framework of the target 
molecules can be assembled at the thiourea and urea functionalities. The 
N,N’-disubstituted thiourea (5) can be accomplished readily by the facile coupling of 
C8-substituted opioid isothiocyanate precursor (2) with C8-substituted opioid amino 
precursor (4).
6
 The synthesis of C8-substituted opioid amino precursor (4) would also 
allow the preparation of the corresponding the N,N’-disubstituted urea (6) by reacting 
with C8-substituted opioid isocyanate precursor (2’).7 All opioid precursors can be 
synthesised from the starting material codeine, which is commercially available in bulk 
quantities through series of substitution reactions at C6- and C8-positions. The yield 
and purity of two intermediates (1) and (4) were also crucial for synthesis of the target 
molecules. 
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Scheme 2.2 Retrosynthetic analysis of thiourea (5) and urea (6) derivatives (FGI: 
Functional Group Interconversion). 
 
2.1.1 Synthesis of 6-O-tosylcodeine (1) 
Alcohols are poor substrates for nucleophilic substitution reactions due to being a 
strong base. Mesylates and tosylates are sulfonate compounds that make alcohols into 
good leaving groups, by turning them into organosulfonates: tosylate and mesylates. 
Bases such as triethylamine and pyridine can catalyse the reaction and also neutralize 
the by-product, HCl, preventing acid-catalyzed rearrangement reactions. In the 
reaction, a nucleophile such as a hydroxyl group can attack the electrophilic center of 
the sulfonyl chloride and substitute the chloride. The base then removes a proton from 
the intermediate to give the sulfonate product. The alcohol is converted into a good 
leaving group.
8
 Thus, it would be relatively easy to synthesise other derivatives by 
starting with the sulfonate product. Tosylation of the codeine was carried out under 
low-temperature conditions and with an excess of pyridine, which allows the reaction 
was complete within 24 hours (Scheme 2.3). The mechanism for the formation of 
6-O-tosylcodeine is shown in Scheme 2.4. 
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Scheme 2.3 Synthesis of 6-O-tosylcodeine (1).
9 
 
 
Scheme 2.4 Mechanism for the formation of 6-O-tosylcodeine (1).
10
 
 
As shown in Scheme 2.4, the nucleophilic oxygen of hydroxyl group on the C6 attacks 
electrophilic sulfur from the front side, which leads to the formation of O-S bond with 
losing chloride. Generation of the tosylate product proceeds with retention of 
configuration at chiral C6 via SN2 nucleophilic substitution reaction. This means the 
stereochemistry of the product remains the same as of the starting material codeine. 
This configuration of the product was confirmed by NMR analysis (see Section 2.2). 
The procedure of synthesis of 6-O-tosylcodeine (1) was arrived at after multiple 
experiments examining the temperature, time and the dry pyridine/DCM ratio. The 
optimized reaction conditions allowed for the purification of the compound via 
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trituration in diethyl ether. This is the first intermediate compound for the synthesis of 
the other opioid derivatives of this part of the project. All opioid derivatives shown in 
Scheme 2.5 were synthesised with optimised reagents ratio and conditions in order to 
obtain the maximised yield and were from the procedure were identified by 
1
H and 
13
C 
NMR spectroscopy (Appendix A). 
 
 
 
Scheme 2.5 General synthetic procedure of N,N’-disubstituted thiourea (5) and urea 
(6) derivatives. 
 
2.1.2 Synthesis of 8-isothiocyanocodide (2) and 8-azidocodide (3) 
6-O-tosylcodeine (1) was the first intermediate for both the synthesis of 
8-isothiocyanocodide (2)
11
 and 8-azidocodide (3) (Scheme 2.6).
12
 In both reactions, 
substitution of the tosyl group with the isothiocyanate ion (NCS
–
) or an azide anion 
(N3
–
) can occur via two different mechanisms (Scheme 2.7). The first mechanism is an 
SN2' reaction where the nucleophile attacks the alkene at C8 to give the isothiocyanate 
or azide in the C8-position directly. The second mechanism is an SN2 reaction where 
the nucleophile attacks the saturated C6, followed by a [3,3] sigmatropic 
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rearrangement which shifts the thiocyanate or azide group from the C6- to the 
C8-position.
11
 Use of dry solvents led two reactions being completed within 4 hours. 
Purification of 8-isothiocyanocodide (2) was by flash chromatography after filtration, 
whereas 8-azidocodide (3) which is the important precursor to the amine (4), was 
easily obtained in high purity by extraction and crystallization with diethyl ether and 
acetone
12
 or by flash chromatography. It is interesting that at low temperatures, it is 
postulated that the SN2 reaction occurs with formation of the kinetically favoured 
product to form 6-substituted opiates such as in the case of 6-O-tosylcodeine (1) as the 
main product. At high temperature, however, the possible reaction pathway of SN2' and 
subsequent allylic rearrangement of any formed 6-substituted opiates to the 
corresponding 8-substituted opiates can occur.
11
 
 
 
 
Scheme 2.6 Synthesis of 8-isothiocyanocodide (2)
11
 and 8-azidocodide (3).
12 
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Scheme 2.7 Proposed mechanism of synthesis of 8-isothiocyanocodide (2) and 
8-azidocodide (3) (SN2' and SN2 reactions).
11
 
 
2.1.3 Synthesis of 8-aminocodide (4) 
8-Aminocodide (4) is the key compound for the synthesis of both N,N’-disubstituted 
thiourea (5) and N,N’-disubstituted urea (6). Using 4 equivalent of 1.0 M LiAlH4 in 
THF,
11
 the reduction of 8-azidocodide was completed within 3 hours and accompanied 
by unreacted starting material 8-azidocodide by TLC monitoring (3) and no evidence 
of any SN2' products were observed, but non-opioid impurities by NMR analysis 
(Scheme 2.8). Purification of the crude product was achieved by column 
chromatography. Trituration of 8-aminocodide with diethyl ether occurs slowly and the 
product was isolated as 0.42 g of waxy crystals in 46% yield. This result was slightly 
better than 20% yield from the previous work using 3 equivalent of LiAlH4.
11
 It should 
be noticed that the excess of LiAlH4 would not be recommended to use for the 
synthesis, due to time-consuming on filtration work. The reduction of 8-azidocodide 
(3) using PPh3 was also examined, however, we found that the crude product was 
difficult to purify by flash chromatography. 
 
Scheme 2.8 Synthesis of 8-aminocodide (4).
11 
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2.1.4 Synthesis of N,N’-disubstituted thiourea (5) and urea (6)  
derivatives 
N,N’-disubstituted thiourea derivative (5) was synthesised by a nucleophilic addition 
of 8-aminocodide (4) to 8-isothiocyanocodide (2).
11
 In the reaction, the 8-aminocodide 
(4) acts as a nucleophile to attack the electrophilic carbon of 8-isothiocyanocodide (2), 
then the N atom from the 8-isothiocyanocodide abstracts a proton from 8-aminocodide 
to form urea. The proposed mechanism is shown in Scheme 2.9b. The reaction was 
heated under reflux conditions in dry THF for 24 hours and purification of the crude 
product was achieved by column chromatography to give the target compound (7) in 
44% yield and unreacted materials (2) and (4) were observed by TLC monitoring. 
 
 
 
Scheme 2.9 a) Synthesis of N,N’-disubstituted thiourea derivative (5).11 b) Proposed 
mechanism for the synthesis of N,N’-disubstituted thiourea derivatives by nucleophilic 
addition of a secondary amine to isothiocyanate. 
 
Phosgenation of amines is an important reaction in the manufacturing of N-containing 
compounds such as isocyanates, carbamates and N,N’-disubstituted urea derivatives.13 
Therefore, the urea derivative (6) was synthesised by a phosgenation of 8-aminocodide 
(4) with triphosgene (Scheme 2.10). With triphosgene as a reactant for the reaction, it 
is considered to have three advantages:  
1. A one-pot synthesis of the urea derivative with an amine, without the use of 
another opioid derivative, shortens the total synthesis process. 
 92 
2. Compared to diphosgene and phosgene, triphosgene is safer to handle as a 
reagent due to its solid nature. It is also soluble in most organic solvents, which 
makes it easy to carry out an aqueous workup after the reaction is complete.
14,15
 
3. The reaction conditions can be carried out at low temperature or even room 
temperature (under anhydrous conditions) unlike the conditions required for 
diphosgene or phosgene that require lower temperatures and potentially 
hazardous setups. The elevated temperatures available would speed up the rate 
of reaction. 
 
Theoretically, when using 0.35 equivalents of triphosgene and an excess of 
triethylamine (3 eq.), the 8-isocyanocodide (2’) (Scheme 2.10) would be expected to 
form as an intermediate and then reacted with the second portion of 8-aminocodide to 
generate the target urea compound. Therefore, the novel compound 8-isocyanocodide 
(2’) could be detected with urea product by TLC, due to having a similar Rf value of 
8-isothiocyanocodide (2). However, isolation of isocyanates was not able to reach by 
the method from the literature.
15,16
After monitoring the reaction by TLC after 24 and 
72 hours respectively, only the desired urea product and the unreacted 8-aminocodide 
(4) were detected, rather than the expected 8-isocyanocodide (2’). The purification of 
urea derivative was achieved by chromatography to give the urea in a moderate 28% 
yield. 
 
 
 
Scheme 2.10 Synthesis of N,N’-disubstituted urea derivative (6) by triphosgene: a) 3 
eq. TEA, 0.3 eq. triphosgene, dry DCM, N2 gas, 0 ºC, 1 h. b) 1 eq. 8-aminocodide (4), 
rt, 72 h.
15,16
 
 
A second method of forming the urea using diethyl carbonate was examined. The 
literature procedure utilised a solvent-free process and the use of nontoxic reagents and 
recoverable catalysts, making it an environmentally friendly chemical procedure. The 
method of synthesis of a urea using volatile diethyl carbonate and 
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1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free condition was thus 
examined.
17
 With knowing the Rf value of the N,N’-disubstituted urea derivative (6), 
the formation of product was observed by TLC monitoring. However, the desired 
product could not be isolated from impurities by column chromatography. 
 
The isolated yield obtained was poor for both target compounds. There are two issues 
need to be concerned: reaction condition and long-time purification. For both 
reactions, starting materials were observed by TLC, which indicates the reactions were 
not fully completed. Thus, it is necessary to optimise the reaction conditions such as 
solvents used, temperature and reagents ratio in the future work. Due to the existence 
of impurities in the crude mixture, the excess of silica was used in order to reach 
separation quality. However, overloading of silica not only extended time to isolate 
products from impurities, but the loss was also prominent when more silica is around, 
especially when compound slowly decompose or reacts with the silica surface. 
Therefore, calculating the amount of silica to be used is crucial for purification of 
compounds. 
 
2.1.5 Attempted synthesis of chiral phosphoric acid based opioid 
derivative 
As mentioned in chapter 1, chiral phosphoric acids can also be synthesised from 
VAPOL and POCl3.
18
 The study of the VAPOL structure led to a synthesis of a novel 
chiral phosphoric acid, which is based on the opiate scaffold. The structures of 
codeine and (R)-VAPOL are shown in Fig. 2.1, both contain a similar polycyclic ring 
structure. The structure of the VAPOL molecule is very close to the combination of 
two codeine molecules. Thus, it may be possible to synthesize a novel chiral 
phosphoric acid by the reaction of codeine and POCl3. 
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Fig. 2.1 Comparison of codeine and VAPOL structures. 
 
By following the same synthetic procedure for preparation of the chiral phosphoric 
acids derived from VAPOL, but using codeine instead of VAPOL, codeine was 
reacted with 0.5 equivalents of POCl3 and the reaction was completed within 6 hours 
(Scheme 2.11).
18
 After workup the main product, however, was identified as 
α-chlorocodide (7), rather than a desired chiral phosphoric acid derivative. The 
original synthesis of α-chlorocodide (7) by SOCl2 at low temperature
19,20 
was also 
carried out in order to confirm the product from the reaction of POCl3.
 
With the 
1
H 
NMR and 
13
C spectra being identical, the alternative synthetic method of 
α-chlorocodide was confirmed. 
 
According to the proposed mechanism (Scheme 2.12), the hydroxyl group on the 
C6-position of codeine was converted into a better leaving group by nucleophilic 
attack on the electrophilic phosphorus of POCl3 with the generation of Cl
–
 at the same 
time. The OPOCl2 group was then SN2 attacked by Cl
– 
on the C6-position to leading of 
inversion configuration of the kinetic product α-chlorocodide (7), generating PO2Cl 
and Cl
–
. The function of SOCl2 is virtually identical to the POCl3 in this context. 
Formation of an epimer of α-chlorocodide (5) would possibly occur in this reaction. 
However, the configuration of the product from the reaction was proved by 
1
H NMR 
analysis and further details are given in the following section. 
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Scheme 2.11 a) Synthesis of (R)-VAPOL hydrogenphosphate.
18
 b) Attempted 
synthesis of chiral phosphoric acid derivative and of α-chlorocodide (7).19,20 
 
 
 
Scheme 2.12 Proposed mechanism of reaction of codeine with POCl3. 
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2.2 Characterization of opioid precursors 
2.2.1 1H NMR of opioid precursors 
Previously study on the 
1
H and 
13
C NMR spectra of codeine were performed by 
Batterham et al.
21
 and Carroll el at.
22
, respectively. The 
1
H and 
13
C spectra of opioid 
derivatives were assigned according to their study on codeine spectra and are in 
agreement with previous work
11
 and literature.
3,20,21
 
 
6-O-tosylcodeine (1), 8-isothiocyanocodide (2), 8-azidocodide (3), 8-aminocodide (4) 
and α-chlorocodide (7) are isolated from the substitution reaction of codeine. 
Therefore, these compounds have common structural features of codeine (Fig. 2.2), 
which can be illustrated by their 
1
H NMR spectra. 
 
 
 
Fig. 2.2 Structures and numbering systems for opioid derivatives synthesised. 
 
As shown in comparison 
1
H spectra (Fig. 2.3), in codeine and its derivatives, the 
doublets of aromatic protons H2 and H1(J = 8.2 Hz) were shifted downfield and the 
ortho effect of the C3 methoxyl group caused the upfield resonance of H2. The protons 
of methyl group H17and H18 were easily assigned as they present singlets with the 
similar chemical shift. The protons H9 and diastereotopic protons (H10, H16 and H15) 
in codeine derivatives also have similar chemical shifts with those in codeine. The 
occurrence of substitution reaction at the C6-position in the C-ring, contributing to the 
differences of the chemical shift of H5, H6, H7, H8 and even H14, due to the 
flexibility of the C-ring. 
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Fig. 2.3 Comparative 
1
H spectra of codeine and its C6-substituted derivatives (400 
MHz, in CDCl3), difference highlighted in red. 
 
Codeine and isocodeine are epimeric alcohols.
23
 Jacobson et al. confirmed the 
configuration about C6 in the ring C of both codeine and isocodeine with comparing of 
their 
1
H NMR spectra and noted the variation in the chemical shift of H14.
24
 They 
reported that the C6-hydroxyl group in codeine is equatorially oriented and is suited far 
from the H14. Thus, As showed in Fig. 2.3, H14 appeared relatively shielded with its 
chemical shift at δ = 2.66 (Table 2.1) in the upfield region, whereas as compared with 
the chemical shift of H14 (δ = 3.08) in isocodeine,24 as C6-hydroxyl group is fairly 
close to the H14 to form a cis-diaxial relationship (Fig. 2.4). In contrast, the resonance 
of H6 proton in the 6-O-tosylcodeine (1) shifted to the downfield due to electron 
withdrawing from the tosylate group, but remained the unaffected H14. It suggests that 
the C6 configuration of 6-O-tosylcodeine (1) and codeine are identical (Fig. 2.4). 
Furthermore, the absence of the hydroxyl group (δ= 2.99 ppm) and the presence of 
proton signals for tosylate group protons: H20, H20’, H21, H21’ in the aromatic 
region, and of methyl group H23 in the upfield region, the other proton signals 
remained as same as those in the codeine. This tells that the tosylation of codeine to 
afford 6-O-tosylcodeine (1) with having the identical configuration of the scaffold. 
Likewise, H14 in the α-chlorocodide (7) located at downfield region δ = 3.17 (Table 
2.1) and could expect to be deshielded by C6-hydroxyl group in the cis-diaxial 
relationship, which is exactly similar to the one the isocodeine. Therefore, the chlorine 
in α-chlorocodide (7) is axially oriented in the C6-iso series of the C-ring, which is in 
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the isocodeine series (Fig. 2.4).
25
 On the other hand, the H7 proton in the 
α-chlorocodide (7) shifted to the further downfield region, which was more deshielded 
than the H8 proton as expected due to its proximity to the chlorine atom. Accompanied 
by the chemical shift of H7, H5 correspondingly shifted to the downfield, which 
revealed the presence of their correlation relationship. 
 
 
 
Fig. 2.4 Comparison of configurations of codeine and its C6-substituted derivatives. 
 
Table 2.1 Collated common 
1
H NMR for codeine and its substituted derivatives 1, 2, 
3, 4, 7 (CDCl3 used as NMR solvent, 
1
H NMR data recorded in δ values ppm at 400 
MHz). 
 H1 H2 H5 H6 H7 H8 H9 H10β H10α 
Codeine 6.59 6.68 4.90 4.20 5.70 5.30 3.35 3.05 2.30 
1 6.44 6.56 4.79 4.88- 
4.84 
5.50 5.30 3.27 2.95 2.20 
2 6.58 6.64 4.93- 
4.88 
5.80- 
5.71 
5.80- 
5.71 
3.72 3.42 3.04 2.42- 
2.34 
3 6.57 6.64 4.95- 
4.85 
5.87- 
5.74 
5.87- 
5.74 
3.21 3.42 3.02 2.42- 
2.32 
4 6.55 6.63 4.90 5.60 5.67 3.21 3.51 3.00 2.42- 
2.33 
7 6.59 6.69 5.05 4.55 6.00 5.69 3.39 3.09 2.35 
 H14 H15a H15b H16a H16b H17 H18  
Codeine 2.66 2.06 1.89 2.60 2.40 2.44 3.85 2.99 
(OH) 
1 2.58 1.92 1.77 2.49 2.30 2.38 3.76  
2 2.51- 
2.44 
1.87 1.75 2.51- 
2.44 
2.20 2.42- 
2.34 
3.77  
3 2.28 1.87 1.74 2.51- 
2.44 
2.18 2.42- 
2.32 
3.77 
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4 1.96 1.84 1.75 2.43 2.22 2.42- 
2.33 
3.78 
1.18 
(NH
2
) 
7 3.17 2.19 1.88 2.62 2.40 2.45 3.85  
 
The 
1
H NMR spectra of the C8-substituted derivatives show a considerable shift of 
several protons by comparing with their positions in codeine (Fig. 2.5). As shown in 
the 
1
H NMR spectra of the compounds 2, 3 and 4, the successful substitution reaction 
at the C8-position was indicated by the disappearance of multiplets signals from 
olefinic proton H7 and H8, and formation of another multiplets which represents H6 
and H7 in the downfield region. Thus, H8 resonance was upfield as expected. The 
electronegativity from the substituents also affect the chemical shifts of H8s in the C8 
derivatives. H8 of 8-isothiocyanocodide appears relatively deshielded due to the strong 
electrophilic character of the isothiocyanate group, whereas the H8 of 8-aminocodide 
(4) is more shielded by the strongly electron donating group primary amine NH2 as the 
presence of a broad and weak signal in the upfield region (δ = 1.18). Due to correlation 
with H8, change of chemical shift of H14 in all C8-substituted derivatives was also 
observed. 
 
 
 
Fig. 2.5 Comparative 
1
H spectra of codeine and its C8-substituted derivatives (400 
MHz, in CDCl3), difference highlighted in red. 
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2.2.2 13C NMR of opioid precursors 
Exception of the carbon signals from substituents, there are 18 carbon signals in total, 
including five quaternary carbons C3, C4, C11, C12, C13 in the codeine scaffold and 
assignment of codeine derivatives’ 13C spectra was aided by reference to the published 
spectrum of codeine, which was report by Carroll et al..
22
 All chemical shift data from 
codeine and its derivatives were list in Table 2.2. 
 
As shown in Fig. 2.6, the majority of the peaks for the C6-substituted derivatives can 
be easily assigned according to their δ values (ppm) in the 13C spectrum with most 
similar peaks to the starting material codeine. The two aromatic carbons C1 and C2 
can be easily differentiated from the olefinic C7 and C8 by the upfield shift of the 
latter resonances on the reduction of the double bond. C2 was even further upfield than 
C1 as a consequence of neighbouring C3 methoxyl substituent. Both the quaternary 
carbons C4 and C12 are deshielded by oxygen atom on the tetrahydrofuran E-ring, but 
C12 appeared more shielded than C4 to shift upfield, as it neighbours to the methylene 
protons of C15. The peaks of C9 and C16 were located upfield as they are close to the 
NCH3 on the piperidine D-ring. The C9 resonance was further downfield than C16 as 
it possessed more β effect from C8 and the NCH3 group.
22
 Carroll et al. reported that 
C15 appeared in the downfield region, because it has more α- and β-substituents and 
fewer γ-substituents than C10. While C10 resonance was upfield with the combination 
γ effects from C8, C16 and the NCH3 group.
22
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Fig. 2.6 Comparative 
13
C spectra of codeine and its C6-substituted derivatives (100 
MHz, in CDCl3), difference highlighted in red. 
 
Same as their 
1
H spectra, the distinction between codeine and its C6-derivatives can be 
also observed from their 
13
C chemical shifts of C6, C7 and C8, due to the substituent 
reactions of C6-allylic alcohol in the C-ring (Fig. 2.6). Compared to the 
13
C spectrum 
of codeine, as bonding with the tosylate group, C6 in the 6-O-tosylcodeine (1) is 
deshielded by the adjacent oxygen and leads to the downfield region. Whereas, since 
chlorine is less electronegative than oxygen, C6 in the α-chlorocodide (7) appears 
more shielded and resonate upfield. The result reflects the 
13
C chemical shifts can be 
influenced by α effect, which strongly dependent on electronegativity of the 
substituents. It should note that in all C6-substituted derivatives, the substitution 
reaction of C6-allylic alcohol also induces strong carbon shift, which caused the 
upfield shift of C7 and downfield shift of C8 resonances ongoing from codeine to 
either compared to 6-O-tosylcodeine (1) or α-chlorocodide (7) (Table 2.2), owing to 
the long range effect of the C6-substituents.
22,26
 On the other hand, C6-substituents 
also affected the C5 resonance to the downfield region by the β effect from the 
chlorine in α-chlorocodide (7).22 Whereas, C5 resonance in the 6-O-tosylcodeine (1) 
was upfield, due to neighbouring the tosylate group in the equatorially oriented 
configuration, which was mentioned previously. The extract aromatic signals C20, 
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C20’, C21, C21’ and the methyl signal C23 indicates the tosylate group presents in the 
6-O-tosylcodeine (1). 
 
Table 2.2 Collated common 
13
C NMR for codeine and its substituted derivatives 1, 2, 
3, 4, 7 (CDCl3 used as NMR solvent, 
1
H NMR data recorded in δ ppm at 100 MHz). 
 C1 C2 C3 C4 C5 C6 C7 C8 
Codeine 119.6 112.9 142.2 146.3 91.3 66.4 133.4 128.2 
1 119.4 114.6 142.1 147.0 89.1 74.4 127.5 130.9 
2 119.3 113.6 143.3 144.4 86.2 131.5/
126.3 
131.5/
126.3 
53.1 
3 118.1 112.3 142.3 143.1 85.4 130.5/
126.2 
130.5/
126.2 
55.1 
4 118.8 112.9 143.2 144.3 87.5 123.7 139.5 46.3 
7 119.3 112.9 141.9 145.8 93.9 53.9 128.7 135.3 
 
 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 
Codeine 58.9 20.5 127.1 131.1 43.0 40.0 35.8 46.5 43.1 56.4 
1 58.8 20.4 126.9 130.4 43.3 40.9 35.5 46.3 43.1 57.0 
2 56.2 19.7 128.2 133.3 40.9 46.8/ 
46.5 
35.3 46.8/
46.5 
43.2 56.3 
3 55.3 18.8 125.8 127.8 39.8 44.4 34.2 45.6 42.2 55.5 
4 56.2 19.8 127.3 129.8 41.1 49.4 35.6 46.9 43.2 56.3 
7 58.7 20.3 127.4 130.1 44.5 40.0 36.3 46.7 43.2 56.3 
 
Substitution reactions at the C8-position cause the upfield C4 by ca. 2─3 ppm (Table 
2.2). The downfield shift of C6 and the upfield shift of C8, which indicates the 
presence the double bond between C6 and C7. Poor resolution of peaks of C6 and C7 
from 8-isothiocyanocodide (2) and 8-azidocodide (3) correspond to their multiplets 
were observed in the 
1
H NMR spectrum, but not in the 8-aminocodide (4). Compared 
to the spectrum of codeine, the C5 signal appeared as upfield resonance due to the δ 
substituent effect at the C8-position. The downfield thiocarbonyl signal (δ = 135 ppm) 
in the spectrum of 8-isothiocyanocodide (2) proved the presence of isothiocyanate 
group. Furthermore, C8-substituent also caused the downfield shift of C14 with the β 
effect; and the upfield shifts of C9 and C13 by the γ effect. The rest of peak signals in 
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three C8 derivatives are nearly same as those in codeine, which implied the codeine 
scaffold did not alter in the reaction process. 
 
 
 
Fig. 2.7 Comparative 
13
C spectra of codeine and its C8-substituted derivatives (100 
MHz, in CDCl3). 
 
 
2.3 Characterization of N,N’-disubstituted thiourea and urea 
derivatives 
The identification and characterization of N,N’-disubstituted thiourea and urea 
derivatives were carried out by NMR, mass spectrometry and X-ray analysis. The 
NMR data which includes 
1
H, 
13
C, DEPT-135, COSY and HMQC data were recorded 
at room temperature in DMSO-d6. The mass spectrometry data of the thiourea and 
urea novel compounds was provided by Dr. Florence McCarthy in University College 
Cork and Dr. Kevin Conboy in University College Dublin, respectively. The X-ray 
crystallography of thiourea and urea derivatives was analyzed by Dr. Vickie McKee in 
Loughborough University and Dr. Brendan Twamley in Trinity College Dublin, 
respectively. The structure of the thiourea and urea derivatives, their molecular 
formulae and numbering system (based on the conventional numbering system for 
opiates) are shown in Fig. 2.8. 
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Fig. 2.8 Structures and numbering systems for the N,N’-disubstituted thiourea (5) and  
urea (6) derivatives. 
 
2.3.1 1H NMR study of N,N’-disubstituted thiourea and urea 
derivatives 
The assignment of the proton peaks is based on the multiplicity and chemical shift. As 
shown in Fig. 2.8, both the structures of the thiourea and urea compounds are 
C2-symmetric, which makes each side of the opioid moiety on the whole molecule 
(thiourea/urea) equivalent by an axis of symmetry in NMR analysis. For the most part, 
the 
1
H NMR spectrum of two novel compounds is similar to parent opioid derivatives, 
such as 8-aminocodide (4). 
 
Some common features were observed from the thiourea and urea NMR due to the 
similar C2-symmetric structure. From the 
1
H spectra Fig. 2.9 and Fig. 2.10, the 
aromatic protons H1and H2 appear as a pair of doublets with the coupling constant of 
8.2 Hz at the range of δ = 6.75 ─ 6.60 ppm, which is within the expected range of 
vicinal aromatic protons. H6 and H7 on the thiourea compound (5) appeared as a 
singlet, whereas the presence of a doublet of doublets was observed from the starting 
compound 8-aminocodide (4) (Fig. 2.11). It is highly unusual that the two 
magnetically non-equivalent signals from H6 and H7 have nearly identical resonance 
frequencies leading them to be close to one another, which creates two overlapping 
non-equivalent signals on the spectrum, i.e. accidental degeneracy.
27
 This exception 
did not occur for the urea compound (6) as the formation of a multiplet by overlapping 
of H6 and H7, rather than of a singlet. A multiplet by overlapping of H6 and H7 
signals was also observed from the 8-isothiocyanocodide (2) and 8-azidocodide (3) 
compounds (Fig. A3 and Fig. A5 in appendix A). 
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Fig. 2.9 Peak assignments of N,N’-disubstituted thiourea derivative (5) 1H NMR 
spectrum (600 MHz) in DMSO-d6. 
 
 
 
Fig. 2.10 Peak assignments of N,N’-disubstituted urea derivative (6) 1H NMR 
spectrum (600 MHz) in DMSO-d6. 
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Fig. 2.11 Peak assignments of 8-aminocodide (4) 
1
H NMR spectrum (400 MHz) in 
CDCl3. 
 
H5 on both novel compounds appears as a doublet with a small coupling constant of 
1.9 Hz, which couples to H6 and H7. H8 on the thiourea compound (5) located at δ = 
4.48 ppm as a broad singlet, while one on the urea compound (6) slightly shifted 
upfield (δ = 3.62 ppm) as an unresolved doublet of triplets. The methyl signals H18 
and H17 correspond to a singlet on both novel compounds, having a similar chemical 
shift, located at δ = 3.74 ppm and δ = 2.28 ppm for thiourea compound (5) and δ = 
3.73 ppm and δ = 2.25 ppm for urea compound (6). Locations of the H9 protons on 
both of the novel compounds are at δ = 3.10 ppm with the same coupling constants of 
3.2 Hz and 2.7 Hz and this proton couples to H10α with the coupling constant of 3.2 
Hz and to H14 with the coupling constant of 2.7 Hz. Protons attached to C10, C15 and 
C16 are diastereotopic due to their being in different chiral chemical environments. 
Two protons on the C10 have the geminal coupling (
2
JHH), they are not chemically 
equivalent: a doublet of H10β with the coupling constant 18.0 Hz does not couple to 
H9. According to the Karplus curve, vicinal coupling constant (
3
J) from H10β and H9 
equals 0, which means H10β is perpendicular to H9.28 In the thiourea compound (5), 
H10α is located at δ = 2.64 ppm as a doublet of doublets with coupling to H9 (3J = 5.4 
Hz) and H10β (2J = 12.8 Hz), while H10α in the urea compound (6) is located at δ = 
2.46 ppm as a doublet of doublets with coupling to H9 (
3
J = 6.1 Hz) and H10β (2J = 
12.5 Hz). 
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H16 protons on the thiourea compound (5) appear as a doublet of doublets and a triplet 
of doublets at δ = 2.43 ppm and δ = 2.09 ppm, respectively. Only a doublet of doublets 
for H16a was observed at δ = 2.40 from the urea compound (6) and the triplet of 
doublets for H16b overlapped with the doublet of doublets for H14 to form a multiplet. 
 
A doublet of doublets at δ = 2.18 ppm from the thiourea compound (5) corresponds to 
H14, which couples to H9 with the coupling constant 2.5 Hz while coupling to H8 
with the coupling constant 9.8 Hz. However, the corresponding proton in the urea 
compound could not be determined because of overlapping with H16b proton. 
 
One of the H15 protons of both thiourea and urea compounds resonate at high field in 
presence of a triplet of doublets and a doublet. The chemical shifts of the triplet of 
doublets of the thiourea compound (5) and the urea compound (6) are at δ = 1.86 ppm 
and δ = 1.82 ppm, respectively, and with similar coupling constants: J = 7.6, 4.8 Hz 
for the thiourea, J = 7.5, 5.0 Hz for the urea. Presumably the doublet at δ = 1.60 ppm 
(thiourea) and δ = 1.57 ppm (urea) appear as a doublet of doublets and it could be 
another consequence of the poorly resolved signal. 
 
The downfield signal of NH proton on the thiourea moiety appears as a broad singlet 
at δ = 7.50 ppm, while the one on the urea moiety appeared to be a sharp doublet and 
shift slightly upfield (at δ = 6.03 ppm). Oxygen is more electronegative than sulfur, 
which will cause the NH proton in the urea compound might be expected to present 
more downfield than one in the thiourea compound, due to deshielding from the C=O 
group, but the observation from their NMR spectra is actually reversed. Jirman et al. 
explained the result with comparing the ∆δ (15N) from acylureas and acylthioureas.29 
They found that the C=S group of thioureas is better than C=O group of the ureas in 
the transmission of the electron-acceptor effect of the acyl group. Furthermore, they 
also observed the higher electron density at both nitrogens in the benzoylurea in regard 
to the benzoylthiourea. According to the results, they concluded the C=S group of 
acylthioureas is more efficient than the C=O group of acylureas in lowering the 
electron density at both the nitrogen atoms.
29,30
 In other words, the protons of thiourea 
are more acidic than those of urea, as they are hydrogen-bond donors.
31
 Therefore, 
based on the information above, it was concluded that the chemical shift of NH proton 
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in the thiourea (5) and urea (6) compounds are not affected by the electronegativity of 
sulfur or oxygen atom, rather by the C=S and C=O as a whole. 
 
2.3.2 1H-1H COSY of N,N’-substituted thiourea and urea derivatives 
1
H-
1
H Correlation Spectroscopy (COSY) is a 2D experiment, which is a useful method 
to indicates which protons are coupling with each other. Two axes of the 
1
H spectrum 
are plotted orthogonally and spin-spin coupling is indicated in the form of a contour 
plot. Correlations only appear when there is spin-spin coupling between protons. In 
both the COSY spectra of thiourea (5) and urea (6) (Fig. 2.12 and Fig. 2.13), a weak 
coupling between the NH and H8 is observed, which confirms the assignment of the 
proton bonded to the nitrogen of the thiourea and urea moiety. Coupling between H1 
and H2 on the aromatic ring of the opiate scaffold shows strong signals; H5 couples to 
the singlet representing the protons H6 and H7. It is interesting to note that the 
coupling between H8 and H14 is observed, but not between H8 and H7. H9 couples 
weakly to H14, but strongly to H10α, the Geminal coupling is observed between the 
diastereotopic protons H10, H15 and H16 protons. In the thiourea COSY spectrum 
(Fig. 2.12), the vicinal coupling between H16a (δ = 2.43 ppm) couples to H15a (δ = 
1.86 ppm), but not to H15b (δ = 1.60 ppm) whilst H16b (δ = 2.09 ppm) couples to 
both H15a (δ = 1.86 ppm) and H15b (δ = 1.60 ppm). The same can be observed in the 
urea COSY spectrum (Fig. 2.13), the vicinal coupling between H16a (δ = 2.40 ppm) 
only couples to H15a (δ = 1.82 ppm), and H16b which overlaps with H14 (δ = 2.06 
ppm) couples to both H15a (δ = 1.82 ppm) and H15b (δ = 1.57 ppm). Analysis of the 
COSY spectra for both thiourea and urea compounds shows the peaks assignments 
agree with the 
1
H NMR spectrum. The coupling data of thiourea and urea are 
summarized in Table 2.3 and Table 2.4 respectively with COSY spectra. 
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Fig. 2.12 1H-
1
H COSY spectrum (600 MHz) in DMSO-d6 of N,N’-disubstituted 
thiourea derivative (5) with coupling highlighted in red. 
 
Table 2.3 Observed coupling in COSY spectrum of N,N’-disubstituted thiourea 
derivative (5) (* denotes weak coupling). 
Proton Coupling 
NH H8 
H1 H2 
H2 H1 
H6/H7 H5 
H5 H6/H7 
H8 NH*, H14  
H9 H10α, H14* 
H10β H10α 
H10α H9, H10β 
H16a (δ = 2.43 ppm) H16b (δ = 2.09 ppm), H15a (δ = 1.86 ppm) 
H14 H8, H9* 
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H16b (δ = 2.09 ppm) H16a (δ = 2.43 ppm), H15a (δ = 1.86 ppm), 
H15b (δ = 1.60 ppm) 
H15a (δ = 1.86 ppm) H15b (δ = 1.60 ppm), H16a (δ = 2.43 ppm), 
H16b (δ = 2.09 ppm) 
H15b (δ = 1.60 ppm) H16b (δ = 2.09 ppm), H15a (δ = 1.86 ppm) 
 
 
 
Fig. 2.13 
1
H-
1
H COSY spectrum (600 MHz) of N,N’-disubstituted urea derivative (6) 
with coupling highlighted in red. 
 
Table 2.4 Observed coupling in COSY spectrum of N,N’-disubstituted urea derivative 
(6) (* denotes weak coupling). 
Proton Coupling 
H2 H1 
H1 H2 
NH H8 
H6/H7 H5 
H5 H6/H7 
H8 NH*, H14  
H9 H10α, H14* 
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H10β H10α 
H10α H9, H10β 
H16a (δ = 2.40 ppm) H16b (δ = 2.06 ppm), H15a (δ =1.82 ppm) 
H14 H8, H9* 
H16b (δ = 2.06 ppm) H16a (δ = 2.40 ppm), H15a (δ = 1.82 ppm), 
H15b (δ = 1.57 ppm) 
H15a (δ = 1.82 ppm) H15b (δ = 1.57 ppm), H16a (δ = 2.40 ppm), 
H16b (δ = 2.06 ppm) 
H15b (δ = 1.57 ppm) H16b (δ = 2.06 ppm), H15a (δ = 1.82 ppm) 
 
2.3.3 13C and DEPT-135 of N,N’-disubstituted thiourea and urea 
derivatives 
Nuclear Magnetic Resonance (NMR) spectroscopy is not limited to the study of 
protons. Any elements with a nuclear spin such as 
1
H, 
13
C, 
19
F will generate signals in 
NMR spectroscopy. Carbon-13 has a nuclear spin I = 1/2 and makes up 1.1% of all 
naturally occurring carbon. As a result, the sensitivity of 
13
C NMR is lower than of 
1
H 
NMR (with a relative abundance of 99.98%). The 
13
C NMR spectrum is generally 
proton decoupled in routine use, which causes spin-spin coupling patterns and 
overlapping multiplets to be seldom observed and displays the number of 
non-equivalent carbon signals in a molecule within a wide chemical shift range. The 
distortionless Enhancement by Polarization Transfer (DEPT) is useful to determine the 
number of protons attached to a carbon. The signals of CH and CH3 carbons are 
displayed as positive signals while the negative signal for CH2 carbons. The signals of 
quaternary carbons cannot be observed from DEPT spectra. The combination of 
13
C 
and DEPT-135 usually are used for the peak assignments. 
 
In the 
13
C spectra of thiourea and urea derivatives (Fig. 2.14 and Fig. 2.16), there are 
19 carbon signals corresponding to non-equivalent carbons. C19 from both compounds 
fall within the expected range and disappear in the DEPT spectrum. It is interesting 
that the thiocarbonyl carbon signal (δ = 183.2 ppm) appears much weaker than the 
carbonyl carbon signal (δ = 158.4 ppm). The signals of the aromatic and vinylic 
carbons are in the region 145 ─ 110 ppm of the 13C spectra and C6, C7, C1 and C2 are 
present in the DEPT. The absent signals are considered to be the quaternary carbons. 
C5 is identified at the range δ = 85 ─ 87 ppm which is at an analogous chemical shift 
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relative to the 
13
C spectrum of codeine. Methylene group carbons C16, C15 and C10 
are easy to identify as they appear as negative signals in the DEPT (Fig. 2.15 and Fig. 
2.17). These assignments can be confirmed by further HMQC analysis. 
 
 
 
Fig. 2.14 
13
C spectrum of N,N’-disubstituted thiourea derivative (5) (150 MHz) in 
DMSO-d6. 
 
 
Fig. 2.15 DEPT-135 spectrum of N,N’-disubstituted thiourea derivative (5) (150 MHz) 
in DMSO-d6. 
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Fig. 2.16 
13
C spectrum of N,N’-disubstituted urea derivative (6) (150 MHz) in 
DMSO-d6. 
 
 
 
Fig. 2.17 DEPT-135 spectrum of N,N’-disubstituted urea derivative (6) (150 MHz) in 
DMSO-d6. 
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2.3.4 HMQC of N,N’-disubstituted thiourea and urea derivatives 
Heteronuclear Multiple Quantum Correlation (HMQC) is a two-dimensional 
correlation spectroscopy technique, which shows 
13
C-
1
H shift correlations and reveals 
the coupling between protons and the carbons to which they are attached. In the 
HQMC spectrum, a compound’s 13C NMR spectrum is displayed on the y-axis and its 
respective 
1
H NMR spectrum is shown on the x-axis. Only directly bonded hydrogens 
and carbons will give cross peaks. 
 
Fig. 2.18 and Fig. 2.19 are the HMQC spectra of the thiourea and urea derivatives, 
respectively, and both are almost the same due to having identical structural features. 
On the spectra of both novel compounds, the diastereotopic protons correlate to the 
carbon signal for C10, C15 and C16. Carbons C1, C2, C9, C14 C17 and C18 are also 
assigned by correlation with their corresponding protons. C6 and C7 of both 
compounds cannot be distinguished because their carbon signals in the 
13
C NMR 
spectrum correspond to a singlet in the 
1
H NMR spectrum. A summary of the HMQC 
correlations of thiourea and urea derivatives are shown in Table 2.5 and Table 2.6, 
respectively. 
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Fig. 2.18 HMQC spectrum (600 MHz) of N,N’-disubstituted thiourea derivative (5) 
with observed correlations. 
 
Table 2.5 Observed coupling in HMQC spectrum of N,N’-disubstituted thiourea 
derivative (5). 
Assigned Peak Number Carbon δ (ppm) Proton δ (ppm) 
10 C10 (20.0) H10β (2.91), H10α (2.64) 
15 C15 (34.8) H15a (1.86), H15b (1.60) 
17 C17 (42.8) H17 (2.28) 
14 C14 (45.4) H14 (2.18) 
16 C16 (46.2) H16a (2.43), H16b (2.09) 
8 C8 (48.8) H8 (4.48) 
9 C9 (55.5) H9 (3.10) 
18 C18 (55.9) H18 (3.74) 
5 C5 (85.9) H5 (4.98) 
2 C2 (113.6) H2 (6.74) 
1 C1 (118.8) H1 (6.63) 
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6/7 C6/C7 (124.8) 
C6/C7 (135.3) 
H6/H7 (5.66) 
 
 
 
Fig. 2.19 HMQC spectrum (600 MHz) of N,N’-disubstituted urea derivative (6) with 
observed correlations. 
 
Table 2.6 Observed coupling in HMQC spectrum of N,N’-disubstituted urea derivative 
(6). 
Assigned Peak Number Carbon δ (ppm) Proton δ (ppm) 
10 C10 (19.9) H10β (2.85), H10α (2.46) 
15 C15 (35.4) H15a (1.82), H15b (1.57) 
17 C17 (43.3) H17 (2.25) 
8 C8 (44.8) H8 (3.62) 
16 C16 (46.7) H16a (2.40), H16b (2.06) 
14 C14 (46.9) H14 (2.06) 
9 C9 (56.0) H9 (3.06) 
18 C18 (56.5) H18 (3.73) 
5 C5 (86.7) H5 (4.96) 
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2 C2 (114.2) H2 (6.72) 
1 C1 (119.2) H1 (6.61) 
6/7 C6/C7 (125.2) 
C6/C7 (137.2) 
H6/H7 (5.63) 
 
2.3.5 IR spectroscopy of N,N’-disubstituted thiourea and urea 
derivatives 
Chemical compounds exhibit different chemical properties due to the presence of 
different functional groups. Infrared Spectroscopy (IR) can be very sensitive towards 
different functional groups within a sample since different functional groups absorb 
different particular frequency ranges of IR radiation. Each functional group has 
characteristic spectral properties which are referred to as its respective “fingerprint”. 
Therefore, IR spectroscopy is another useful method for the identification and 
structure analysis of a variety of chemical compounds. 
 
Due to having a similar structure, the presence of NH in both the thiourea and urea 
derivatives are clearly indicated by the broad signals, which are in the region 3500 ─ 
3100 cm
-1
. The CH3 alkane groups in both compounds appear as sharp bands in the 
region 3000 ─ 2800 cm-1; the weak band appears at 1636 cm-1 and the strong band at 
1502 cm
-1
 for thiourea compounds, and the weak band at 1635 cm
-1
 and the strong 
band at 1501 cm
-1
 for urea compounds, represent the C=C in the benzene ring. Two 
bands of C-N for both compounds appear in a similar region (1247 cm
-1 
for
 
thiourea; 
1275 cm
-1
 for
 
urea). Assignment of C=S stretching is often uncertain with thiocarbonyl 
compounds and especially complicated in the case of thiourea. According to the 
correlated data on the IR spectra of thiocarbonyl derivatives from Rae and 
Venkataraghavan, the bands of thiocarbonyl group appear in the region 1570 ─ 1397 
cm
-1
, 1420 ─ 1260 cm-1 and 1140 ─ 940 cm-1.32 Thus, a strong band at 1096 cm-1, 
which is likely to represent C=S stretching for the thiocarbonyl group on the thiourea 
derivative, can be observed. The carbonyl C=O group stretching band on the urea 
appears as a weak and broad band in the region 1700 cm
-1
. The IR spectra of thiourea 
and urea derivative are shown in Fig. 2.20 and Fig. 2.21, respectively. 
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Fig. 2.20 IR spectrum of N,N’-disubstituted thiourea derivative (5). 
 
 
 
Fig. 2.21 IR spectrum of N,N’-disubstituted urea derivative (6). 
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2.3.6 MS of N,N’-disubstituted thiourea and urea derivatives 
The electrospray ionisation (ESI) technique (in positive mode) was used to analyse the 
opiate urea and thiourea compounds. A typical mass spectrum of the 
N,N’-disubstituted thiourea (5) and urea (6) is shown in Fig. 2.22 and Fig. 2.23, 
respectively. An exact mass of the thiourea (5) was observed as m/z = 639.2977 
[M+H]
 +
, which matches the expected exact mass value of 639.2900 [M+H]
 +
, while 
the molecular mass of the urea (6) was observed as m/z = 623.3202 [M+H]
+ 
 which 
matches the exact mass value (623.3200) [M+H]
 +
. 
 
The mass spectrum for N,N’-disubstituted thiourea (5) provided detailed information 
with respect to the structures of fragment ions, which is also illustrated in Fig. 2.22. 
The molecular ion of the starting compound 8-isothiocyanocodide (2) was observed at 
m/z = 340.6648 [M]
+
 with relatively intensity (RI) 100%, which may be due to 
presence of charge localisation over the whole molecule
33
 and the peak at m/z = 
341.160 [M+H]
+
 is formed directly from the molecular ion of 8-isothiocyanocodide 
(2). The protonated molecule of the other starting compound 8-aminoocodide (4) was 
also detected at m/z = 299.1739 [M+H]
+
, but having relatively low intensity. The peak 
at m/z = 320.1501 represents the half mass of protonated N,N’-disubstituted thiourea 
(5) ion [(M+H))/2]
+
. Likewise, the peak at m/z = 1277.5830 corresponds to a double 
mass of N,N’-disubstituted thiourea (5) ion [2M]+. Because of using formic acid and 
H2O as the mobile phase in LC-MS system, the total mass of N,N’-disubstituted 
thiourea (5) molecular ion and formic acid gives the value of m/z 685.3037, while m/z 
= 1341.5137 is the sum mass of the two N,N’-disubstituted thiourea (5) ions, formic 
acid and H2O. 
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Fig. 2.22 Mass spectrum of N,N’-disubstituted thiourea derivative (5) and assignment 
of fragment ions. [M5: exact mass of the thiourea compound (5), M2: exact mass of 
the 8-isothiocyanocodide (2), M4: exact mass of the 8-aminocodide (4)] 
 
 
 
 
Fig. 2.23 Mass spectrum of N,N’-disubstituted urea derivative (6). 
 
On the other hand, the fragmentation pathway of opioids alkaloids was also revealed 
in Scheme 2.13. The A-type fragment ions of 8-thiocyanocodide (2) (A1) and 
8-aminocodide (4) (A2) are formed by loss of an amine group (CH2CHNHCH3) on the 
piperidiene D-ring, due to partial cleavage of the C13-C15 and C9-N covalent 
bonds.
34,35
 Further expulsion of the methyl radical from methoxy group (CH3O) on the 
8-aminocodide (4) leads to give a product ion C at m/z = 228. Loss of functional 
groups NCS
−
 and NH2 at C8-position (converting C8 to a CH2 group) from type A 
ions of both of 8-isothiocyanocodide (2) (A1) and 8-aminocodide (4) (A2), affords the 
B-type fragment at m/z = 227, which was in good agreement with previous reports.
34,36
 
It is noteworthy that the product ion D at m/z = 225 which was proposed by Zhang et 
al.,
34
 was not detected, although it can be explained by loss of 2 Hs from the B-type 
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fragment ion (m/z = 227) theoretically, instead it gives the appearance at m/z = 224. It 
is suggested that the presence of isotopes of 
13
C are present in the thiourea 
compound.
36
 Furthermore, the E1-type ion at m/z 197 formed by loss of epoxy ring 
and the methyl radical from a D-type fragment, was also not detected. However, with 
further loss of hydrogens, the F2 and F3 ions were given at m/z = 153 and m/z = 151, 
respectively. 
 
 
Scheme 2.13 Proposed fragmentation routes of protonated N,N’-disubstituted thiourea 
(5).
34-36
 
 122 
2.3.7 XRD of N,N’-disubstituted thiourea and urea derivatives 
The structure of crystals and molecules are usually identified using X-ray diffraction 
studies. The angle and intensities of the diffraction of X-ray beams are recorded with 
diffraction patterns of spots/reflections. Analysis of the diffraction pattern by Fourier 
mathematical methods gives information on the distribution of electron density within 
the unit cell. A 3D picture of the structure is built from the atomic positional 
coordinates and displacements parameters. Within the unit cell, bond lengths and 
angles measurements can be determined. The dimensions of the unit cell, 
intermolecular interaction and hence the crystal packing is determined.
11
 
 
The thiourea derivative was crystallized by evaporation of an ethyl acetate/hexane 
solution in the orthorhombic P212121 group, while the crystal of urea derivatives was 
grown from methanol in the orthorhombic C2221 crystal system. The absolute 
configuration of thiourea and urea compounds were determined from the diffraction 
data (absolute structure parameter, -0.02(3) for thiourea and 0.06(5) for urea). The 
summary of the experimental details of thiourea and urea compounds are given in 
Appendix C. 
 
According to the crystal structures of the two molecules in Fig. 2.24 and Fig. 2.25, it is 
generally thought that two rotamers trans/trans and trans/cis would form as thiourea 
and urea products (Fig. 2.26) due to rotation about the C-N bond.
37
 However, 
according to the crystal structure of both molecules, existence of trans/trans isomers 
can be confirmed. 
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Fig. 2.24 The molecular structure of N,N’-disubstituted thiourea derivative (5) showing 
the atom numbering scheme. Displacement ellipsoids are drawn at the at 50% 
probability. Only symmetry unique atoms labelled. 
 
 
 
 
Fig. 2.25 The molecular structure of N,N’-disubstituted urea derivative (6) showing the 
atom numbering scheme. Displacement ellipsoids are drawn at the at 50% probability. 
Only symmetry unique atoms labelled. 
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Fig. 2.26 Structure of N,N’-disubstituted thiourea/urea with labelled opioid rings and 
their rotamers. 
 
Selected bond lengths and bonds angles are listed in Table 2.7 and Table 2.8, 
respectively. Both thiourea and urea molecules have an approximate 
(non-crystallographic) two-fold axis along the S1=C19 and O1=C2. The sulfur of the 
thiocarbonyl group and the oxygen atom of the carbonyl group are highlighted in 
yellow and red, respectively. The bond length of S1=C19 thiocarbonyl is 1.697(2) Å 
and O1=C2 carbonyl is 1.249(3) Å, which agrees with the observation that the S=C 
bond length is considerably longer than O=C bond due to dissociation energy of the 
O=C bond being stronger than that of S=C. Both lengths of the thiocarbonyl and 
carbonyl groups are within the expected range.
38
 For the C-N bond, the bond length of 
N2-C19 (1.339(3) Å) in the thiourea compound is close to that of N3-C2 (1.346(3) Å) 
in the urea compound, but both compounds’ C-N bond lengths are shorter than the 
normal one of 1.47 Å. This can be explained on a delocalization of the two lone pairs 
of electrons on the nitrogen atoms.
39
 Both thiourea and urea compounds have the 
similar value of the N-C-N’s bond angle. (N2-C19-N3 is 114.3(2)° in the thiourea 
compound, N3-C2-N3a is 114.0(2)° in the urea compound), while the bond angle of 
the thiourea moiety S1=C19-N2 (122.19(18)°) is nearly identical with of the urea 
moiety O1=C2-N3 (122.98(11)°). The angles of link section in the thiourea compound 
(C8-N2-C19) and in the urea compound (C4-N3-C2) are similar at the 126.28(19)° 
and 124.27(16)°, respectively. The distances between thiourea (urea) moiety and the 
C8-position of the C-ring are nearly identical, which is about 1.456(3) Å.  
 
Each codeine structural unit in the thiourea and urea compounds are similar to 
previously reported opioid derivatives.
40,41
 Kartha et al. reported that the different 
bond lengths for C9-N and C16-N in the D-ring of the codeine hydrobromide 
dihydrate.
42
 However, the difference were not found in both thiourea and urea 
compounds, where the bond lengths for C9-N1 and C16-N1 in the thiourea are is 
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1.477(3) Å and 1.473(3) Å, respectively, while the urea has these bond lengths equal 
to 1.476(3) Å (C13-N11) and 1.472(3) Å (C10-N1), respectively. The presence of the 
double bonds of C6=C7 in the thiourea and C5=C6 in the urea are clearly indicated, as 
distance of 1.326(4) Å and 1.330(3) Å in the C-ring, respectively. 
 
The five ring conformations of codeine scaffold in the thiourea and urea compounds 
can be also explained using the torsion angles data from Tables 2.9. The A-ring 
appears some derivation from planarity, which was expected with the feature of a 
benzene ring such as this. The O2 (thiourea) linked to C3 (thiourea), and O20 linked to 
C19 (urea) to the plane of the benzene ring with the distance of 1.366(3) Å and 
1.364(2) Å, respectively. These bond lengths are same as the one in codeine (1.367(6) 
Å).
41
 The torsion angles of −4.6(3)° (C12-C4-O1-C5) and 23.5(16)° (C13-C5-O1-C4) 
from the thiourea compound, and the one of −4.9(2)° (C24-C22-O23-C7) and 24.6(18)° 
(C8-C7-O23-C22) from the urea compound give the E-ring in an envelope 
conformation. The angles of ring E in both compounds are also similar: C4-O1-C5 
equals to 104.57(17)° in the thiourea, while C22-O23-C7 in the urea is 105.36(13)°, 
respectively. The D-ring is in a chair conformation with the methyl group of the 
nitrogen in the equatorial position, and it joined to the B-ring through bonds, which are 
C13-C15 and C9-N1 in the thiourea compound, and C8-C9 and C13-N11 in the urea 
compound, respectively. Both sides of the D-ring facing the opposite direction: one 
faces forwards and the other faces backwards. C13-C5-C6=C7 of the C-ring in the 
thiourea and C5=C6-C7-C8 of the C-ring in the urea are relatively planar with a 
torsion angle of −3.8(3)° (thiourea) and −3.6(3)° (urea), and formed a more distorted 
horizontal plane with the D-ring. This is unlike that the boat conformation with the C6 
and C14 fore and aft in the codeine molecule. Distortion of the C-ring boat 
confirmation could be explained by the effect of C8-position of the thiourea (urea) 
functionality.
43
 In both the thiourea and urea molecules, the A-B-E rings are almost 
perpendicular to the C- and D-rings, which titles each codeine scaffold unit has the 
classic T-shape configuration as it was expected. 
 
The tertiary amine and NH groups in the thiourea and urea molecules are 
hydrogen-bonding to water molecules. The only difference between each is that the 
ether oxygen (O1 and O3) from the thiourea molecule also acts as a hydrogen-bond 
acceptor, but hydrogen-bonds did not exist among those ether oxygen atoms in the 
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urea molecules. All water molecules are involved in hydrogen-bonding, with each 
other and with the two organic molecules. The hydrogen-bonding links the molecules 
to form double-layer sheets parallel to the ab plane, but there are only weak 
interactions linking the sheets along the c direction (Fig. 2.27 and Fig. 2.28).  
 
Table 2.7 Selected bond lengths for N,N’-disubstituted thiourea (5) and urea (6) 
derivatives. 
Bond lengths 
[Å] 
Thiourea derivative Bond lengths 
[Å] 
Urea derivative 
S1=C19 1.697(2) O1=C2 1.249(3) 
N2-C19 1.339(3) N3-C2 1.346(3) 
N2-C8 1.456(3) N3-C4 1.455(2) 
C9-N1 1.477 (3) C13-N11 1.472(3) 
C16-N1 1.473 (3) C10-N11 1.472(3) 
 O2—C3  1.366 (3) C19-O20 1.364(2) 
C6=C7 1.326(4) C5=C6 1.330(3) 
 
Table 2.8 Selected bond angles for N,N’-disubstituted thiourea (5) and urea (6) 
derivatives. 
Bond Angles  Thiourea derivative[º] Bond Angles  Urea derivative[º] 
N2-C19-N3 114.3(2) N3-C2-N3a 114.0(2) 
S1=C19-N2 122.19 (18) O1=C2-N3 122.98(11) 
C8-C7=C6 124.7(2) C4-C5=C6 124.58(18) 
C8-N2-C19 126.28 (19) C4-N3-C2 124.27(16) 
C4-O1-C5 104.57 (17) C22-O23-C7 105.36(13) 
 
Table 2.9 Selected torsion angles for N,N’-disubstituted thiourea (5) and urea (6) 
derivatives. 
Torsion Angles  
 
Thiourea 
derivative[º] 
Torsion Angles  
 
Urea 
derivative[º] 
A-ring: C1=C2-C3=C4  2.9(2) C17=C18-C19=C22 2.9(3) 
A-ring: C1-C11=C12-C4 6.5(3) C17-C16=C24-C22 5.3(3) 
B-ring: C14-C9-C10-C11 31.6(2) C14-C13-C15-C16 31.0(2) 
B-ring: C12-C13-C14-C9 61.8(15) C24-C8-C14-C13 60.1(18) 
 127 
C-ring: C13-C5-C6=C7 −3.8(3) C5=C6-C7-C8 −3.6(3) 
C-ring: C14-C8-C7=C6 17.5(2) C14-C4-C5=C6 18.5(2) 
D-ring: C15-C16-N1-C9 57.5(3) C9-C10-N11-C13 56.9(2) 
D-ring: C14-C9-N1-C16 -63.1(15) C14-C13-N11-C10 −64.54(17) 
E-ring: C12-C4-O1-C5 −15.6(3) C24-C22-O23-C7 −14.9(2) 
E-ring: C13-C5-O1-C4 23.5(16) C8-C7-O23-C22 24.6(18) 
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Fig. 2.27 Packing diagram of N,N’-disubstituted thiourea derivative (5) viewed along 
the a-axis. Hydrogen atoms omitted for clarity. Dashed lines indicate strong 
hydrogen-bonding (Packing diagram viewed perpendicular to the b axis). 
 
 
 
Fig. 2.28 Packing diagram of N,N’-disubstituted urea derivative (6) viewed along the 
a-axis. Hydrogen atoms omitted for clarity. Dashed lines indicate strong 
hydrogen-bonding (Packing diagram viewed perpendicular to the b axis). 
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2.4 Future work 
The synthesis of a number of N,N’-disubstituted thiourea and urea derivatives has been 
achieved. Both N,N’-disubstituted thiourea and urea derivatives were synthesised in 
five steps from codeine and the synthetic routes are described within. Some methods 
for the synthesis of opioid derivatives have been improved to obtain better yields. 
However, the yields of N,N’-disubstituted thiourea and urea derivatives are relatively 
low, so the reaction conditions for the synthesis of thiourea and urea compounds need 
to be further optimized. Characterization of the N,N’-disubstituted thiourea and urea 
derivatives were successfully completed by melting point, NMR, IR, [α]d and MS. 
Using X-ray analysis the structures of both the thiourea and the urea compound were 
confirmed.  
 
The failure of synthesis of chiral phosphoric acid based opioid derivative revealed the 
C6-hydroxyl group in the codeine molecule could be easily substituted by a variety of 
reagents. Regarding the synthesis of VAPOL-like chiral phosphoric acids, 
modification of functional groups in the C-ring needs to be prioritized before coupling 
of opioid scaffolds. With gaining inspiration from the success associated with the 
8,8’-diaryl VAPOL derivatives in the asymmetric catalysis, which was reported by 
Wulff et al.,
44
 there are two proposed synthetic routes can be designed for the future 
synthesis of a proposed chiral phosphoric acid based opioid derivative. As the 
retrosynthetic analysis shown in Scheme 2.14, in the route 1, deoxycodeine could be 
synthesised from 6-O-tosylcodeine (1).
45
 After the demethylation of deoxycodeine, for 
example using BBr3,
45
 dimerization of the two codeine-derived scaffolds 
(desomorphine derivative) at the 2 and 2’ position, which can be achieved with 
K3[Fe(CN)6]
5
. This leads to synthesize another novel opioid derivative, a 
pseudomorphine derivative, which has a rigid structure and two hydroxyl groups at the 
3 and 3’ position, respectively. Therefore, an interesting target compound series (I) 
could be subsequently synthesised by the reaction of the pseudomorphine derivative 
with POCl3. The other interesting synthetic chiral phosphoric acid based opioid 
derivative (II) in the route 2 can be achieved by coupling of desoxycodeine-A. 
Starting with β-bromocodide (6), which can also be synthesised from 
6-O-tosylcodeine (1).
46
 Using Zn in dry ethanol, cleavage of the tetrahydrofuran (E) 
ring in the β-bromocodide (6) gives the desoxycodeine-A with having a phenolic 
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reaction site.
4
 The two desoxycodeine-A units may then be linked at the 4 and 4’ 
position to form the target compound series (II) using POCl3. 
 
On the other hand, with regards to utilizing the thiourea and urea cores as 
hydrogen-bond donor catalysts,
47
 bifunctional squaramide moieties have appeared as 
powerful hydrogen-bonding groups for Lewis acid catalysis.
48-51
 Squaramides consist 
of a four-membered ring system and possess hydrogen-bond accepting and donating 
functionality via carbonyl and NH groups, respectively. Therefore, squaramide 
compounds have shown to be competent for many chemical reactions, including 
biomimetic transport,
50,52
 molecular recognition,
53,54
 ion sensing
55,56
 and 
organocatalysis.
57,58
 Hence, in order to extend the number of opioid derivatives and the 
study of their catalytic activities and selectivities in asymmetric organocatalysis, it is 
necessary to synthesise a squaramide-based dimeric opioid derivative alongside after 
the successfully synthesised thiourea- and urea-based opioid derivatives. With 
reference to the synthetic method of the dimerization of the cinchona alkaloid reported 
by Song et al.,
59
 which was mentioned in Chapter 1, the squaramide-based dimeric 
opioid derivative catalyst (III) could be simply achieved in one-step by the reaction of 
8-amioncodide (4) with dimethyl squarate at room temperature in the route 3. 
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Scheme 2.14 Retrosynthetic analysis routes to design novel opioid derivatives I, II and 
III (FGI: Functional Group Interconversion). 
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Chapter 3 
Catalytic Study of N,N’-disubstituted 
Thiourea Opioid Derivative in Michael 
Addition Reactions 
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3.1 Introduction 
Naturally occurring cinchona alkaloids and their derivatives have been developed as 
organocatalysts for many catalytic asymmetric reactions, such as oxidations and 
carbon-carbon bond formation reactions. Due to the multiple functionalities in the 
cinchona backbone, a wide array of novel organocatalysts has been synthesised 
without extensive and time-consuming chiral resolution, which are often involved in 
other catalysts’ syntheses. Therefore, there is no doubt that further development of 
cinchona-based organocatalysts for asymmetric reactions will continue to have a major 
impact on chemistry research. The opiates are a similar class of alkaloids. However, 
they have rarely been used despite their potential in organocatalytic reactions. The 
majority of this research is to evaluate the catalytic potential of a small number of 
opioid derivatives which have been derived from sustainable alkaloids such as codeine. 
Hypothetically, with five asymmetric center carbons and a heterocyclic ring structure, 
the increased steric bulk from the opiate scaffold may give increased 
enantioselectivity. 
 
 
3.2 Catalysis of Michael addition reaction by Takemoto catalyst                                                                                                                                                                 
Asymmetric organocatalysis has contributed as a powerful and mild methodology for 
accelerating reactions and synthesis of enantiomerically pure products in an efficient 
and environmentally friendly approach.
1
 Particularly, thiourea and urea derivatives 
represent a large and very important group of organocatalysts and provide explicit 
double hydrogen-bonding interactions to coordinate and activate hydrogen-bond 
accepting substrates.
2
 Furthermore, the bifunctional compounds which consist of both 
a thiourea/urea moiety and an amine group on a chiral scaffold have been applied as 
useful organocatalysts for numerous applications in organic synthesis.
1
 On the other 
hand, among the numerous asymmetric C-C bond formation reactions, the conjugate 
Michael reaction plays an important role, because it is a highly versatile synthetic tool 
to join two chemical entities together during the reaction.
3
 Examples mentioned in 
chapter 1 are the bifunctional thiourea catalysts based on cinchona for catalysis of the 
Michael addition reaction of nitroolefins. The first enantioselective Michael addition 
was reported by Takemoto’s group using a bifunctional amine thiourea-organocatalyst 
(26) which they reported in 2003.
4
 The bifunctional organocatalyst has a thiourea 
moiety and an amino group on a cyclohexane ring (chiral scaffold), which has a double 
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activation function: activating both the nitroolefin and nucleophile simultaneously, and 
controlling the approach of the nucleophile to the nitroolefin.
5
 Furthermore, in order to 
investigate the effects of the amino group on the reactivity and selectivity of the 
reaction, two additional thiourea catalysts were synthesised: one (49) has no amino 
group on the cyclohexane ring and the other (50) is an achiral bifunctional 
organocatalyst. Evaluation of their catalytic abilities in the catalysis reaction compared 
to the Takemoto catalyst (26) was carried out.
5
 Under the optimised conditions (room 
temperature in toluene) the Takemoto catalyst efficiently promoted the Michael 
reaction of diethyl malonate to trans-β-nitrostyrene to afford an 86% yield and 
excellent enantioselectivity (93% ee), whereas not only were moderate yields obtained 
from the other two catalysts (49 and 50), no enantioselectivity was observed (Scheme 
3.1).
5
 
 
 
 
Scheme 3.1 Catalysis of Micheal addition reaction of diethyl malonate to 
trans-β-nitrostyrene by double activation Takemoto catalyst (26) and two other thiourea 
derived catalysts.
4,5
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Therefore, based on the results, a plausible reaction mechanism for chiral 
amine-thiourea catalysis was proposed to demonstrate how the bifunctional catalyst 
enhances the reaction rate and enantioselectivity more effectively than a monofunctional 
catalyst (Scheme 3.2).
5
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Scheme 3.2 Plausible reaction mechanism of Michael addition reaction of diethyl 
malonate to trans-β-nitrostyrene by Takemoto catalyst (26).4 
 
According to the mechanism above, the amino group of the Takemoto catalyst (26) 
first deprotonates an acidic proton from the six-membered cyclic enol form of diethyl 
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malonate to generate the binary complex A. Meanwhile, trans-β-nitrostyrene is 
activated by the thiourea moiety on the Takemoto catalyst via hydrogen-bonding, to 
form a new ternary complex B or complex C. Based on the absolute configuration of 
the final product, Takemoto suggested that complex B should give nitronate complex 
D, bearing an R configuration via transition state I, rather than giving S enantiomer 
through transition state I’. This is because the chiral scaffold of the catalyst restricts 
the approach of diethyl malonate to trans-β-nitrostyrene. The final step in the reaction 
is the regeneration of the catalyst through deprotonation of the amino group by the 
nitronate moiety to give the product.
5
 
 
The mechanism of this reaction was also investigated through density functional theory 
(DFT) computations by Pápai et al..
6
 They proposed an alternative mechanistic route 
using acetylacetone as a substrate. In their double activation mode (transition state II 
and II’), trans-β-nitrostyrene preferred to coordinate with quaternary ammonium 
through single hydrogen-bonding interactions, while the enolate forms 
hydrogen-bonding with thiourea moiety of the catalyst. As seen in Fig. 3.1, although this 
scenario was distinct from the Takemoto study, substrates in both transition state I and II 
are aligned in a staggered conformation along the forming C-C bonds, which can 
minimize steric intermolecular interactions, whereas the C-C bonds of the two substrates 
are nearly eclipsed to destabilize the complex E and F in transition state I’ and II’. 
Therefore, the R enantiomer is proposed to be preferred over the S enantiomer in both 
mechanisms for the Michael addition reaction.
6
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Fig. 3.1 Plausible transition states of Michael addition reaction: a) Transition state I and 
I’ by Takemoto et al.5 b) Transition state II and II’ by Pápai et al..6 
 
In order to evaluate the catalytic ability of N,N’-disubstituted thiourea (5) for the 
Michael addition reaction, the bifunctional Takemoto catalyst (26) was used as a 
reference for the reaction. The Takemoto catalyst (26) and N,N’-disubstituted thiourea 
(5) both containing a thiourea moiety. They also have amino groups on the chiral 
scaffolds, with the only difference between them being that there is only one chiral 
scaffold in the Takemoto catalyst (26), whereas there are two symmetric chiral opiate 
scaffolds on the N,N’-disubstituted thiourea (5), which could confer an advantage in 
enhancing enantioselectivity (Fig. 3.2). 
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Fig. 3.2 a) Description of structure of bifunctional amine thiourea-organocatalyst.
1
 b) 
Comparison of Takemoto catalyst (26) and N,N’-disubstituted thiourea (5) (common 
features are highlighted in colour). 
 
 
3.3 Evaluation of N,N’-disubstituted thiourea in the Michael addition 
reaction 
The procedure used for the study of the Michael addition reaction was described by 
Takemoto et al. (Scheme 3.3).
4,5
 The products were formed using the Takemoto catalyst 
under literature conditions to optimize the HPLC conditions before catalyst screening, 
including the racemate which was formed by the use of KOtBu (5 mol%).
7
 In order to 
ensure reproducible reactions and results in the laboratory, reference data was initially 
produced by repeating the catalysis reaction with the Takemoto catalyst (26) in toluene 
and the obtained isolated yield (90.8%) and enantioselectivity (91.6% ee) were in 
agreement with the data from the literature paper (86% yield, 93% ee).
4,5
 Catalysis of 
the Michael addition reaction of diethyl malonate with trans-β-nitrostyrene by the 
N,N’-disubstituted thiourea catalyst (5) was subsequently investigated focusing on the 
effects of various parameters such as the type of solvent, reagent ratio and catalyst 
loading (Scheme 3.3). 
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Scheme 3.3 Catalysis of Micheal addition reaction of diethyl malonate to 
trans-β-nitrostyrene by Takemoto catalyst (26) and N,N’-disubstituted thiourea catalyst 
(5) for the initial solvent screening. 
 
3.3.1 Evaluation of the effects of selected solvents 
The polarity of a solvent can affect the isolated yield and even enantioselectivity in the 
catalysis reaction. Therefore, investigation of the catalytic activity of the 
N,N’-disubstituted thiourea catalyst (5) in selected solvents was carried out as a primary 
test. The solvents selected to screen for the catalysis reaction ranged from non-polar to 
polar solvents. Generally, the monofunctional (thio)ureas exhibit low solubility in 
nonpolar solvents due to strong intermolecular hydrogen-bonding. However, as well as 
having a similar structure to the Takemoto catalyst (26), the N,N’-disubstituted thiourea 
catalyst derivative (5) catalyst has two tertiary amine groups from the piperidine rings 
(D-ring) on both sides of the opiate scaffold. This leads to the formation of another 
intermolecular hydrogen-bond between the amino group and the N-H groups of the 
thiourea moiety, leading to a potential increased solubility in nonpolar solvents. Indeed, 
the N,N’-disubstituted thiourea catalyst (5) was soluble in toluene. All the solvent screen 
studies were carried out with 10 mol% catalyst loading and a 2:1 reagent ratio (diethyl 
malonate:trans-β-nitrostyrene = 2:1). The reaction condition was controlled at room 
temperature and under an inert atmosphere. The conversion was monitored by NMR 
after 6 hours and 24 hours and enantioselectivity was determined by chiral HPLC after 
24 hours. 
 
From Table 3.1, all the reactions for the solvent study were almost complete after 24 
hours. However, in nonpolar solvents such as hexane, N,N’-disubstituted thiourea 
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catalyst (5) efficiently promoted the reaction to afford the product within 6 hours even 
though it is insoluble in hexane; the reaction with toluene was also completed after 6 
hours and afforded a high yield (86.4% yield in hexane; 89.8% yield in toluene). Both 
results from non-polar solvents confirmed that less polar solvents enhance the thiourea 
catalytic activity and generate a higher yield and faster reactions. A moderate yield 
was obtained from DCM as well as no enantioselectivity being observed. Polar 
solvents such as THF and MeCN, which could undergo hydrogen-bonding with the 
N,N’-disubstituted thiourea catalyst (5) or potential transition states, had a reduced 
reaction rate compared to the non-polar solvents. Thus, the conversions and yields of the 
polar reactions were relatively lower: 63.4% conversion (after 6 h) with a final isolated 
yield of 80.4% yield for THF and 77.6% conversion (after 6 h) and final isolated yield of 
82% yield for MeCN. MeOH is an exception as it gave a 91.2% conversion after 6 hours. 
 
Table 3.1 The initial solvent screening of N,N’-disubstituted thiourea catalyst (5) for the 
Michael reaction of diethyl malonate to trans-β-nitrostyrene.[a] 
Exp.
Set 
Catalyst Loading 
(10 mol%) 
Solvent 
(4 mL) 
Time 
(h) 
Conversion 
(%)
[b]
 
Yield 
(%)
[c]
 
ee 
(%)
[d]
 
Ref.  Takemoto Catalyst 
(26) 
Toluene 6, 24  6 h: 96 
24 h: 100 
90.8 91.6 
(R) 
1 N,N’-disubstituted 
thiourea (5) 
Hexane 6, 24 6 h: 100 
24 h: 100 
86.4 3.3 
(S) 
2 N,N’-disubstituted 
thiourea (5) 
Toluene 6, 24 6 h: 97 
24 h: 100 
89.8 9.6 
(S) 
3 N,N’-disubstituted 
thiourea (5) 
DCM 6, 24 6 h: 88.5 
24 h: 100 
79.6 0 
4 N,N’-disubstituted 
thiourea (5) 
THF 6, 24 6 h: 63.4 
24 h: 100 
80.4 6.5 
(S) 
5 N,N’-disubstituted 
thiourea (5) 
MeOH 6, 24 6 h: 91.2 
24 h: 100 
74.3 6.5 
(S) 
6 N,N’-disubstituted 
thiourea (5) 
MeCN 6, 24 6 h: 77.6 
24 h: 97.7 
82 4.2 
(S) 
[a]: Reactions were carried out with diethyl malonate (0.4 mmol), trans-β-nitrostyrene 
(0.2 mmol) and the catalyst (0.02 mmol) under N2 at room temperature, using selected 
dry solvents (0.4 mL). 
[b]: By NMR.  
[c]: Isolated yields after flash column chromatography: Ethyl Acetate:Hexane (1:12 to 
1:5) after 24 h. 
[d]: The % ee values were determined via chiral HPLC using a Phenomenex chiral 
column (Lux 5μ, cellulose-2, 250 x 4.60 mm). 
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Compared to the Takemoto catalyst, modest values of enantioselectivity were obtained 
from all selected solvents with the highest from toluene, which is close to 10% ee. Based 
on these results, toluene was used as the optimised solvent for the subsequent reactions. 
It is interesting that the configuration of the product obtained is the S isomer when using 
the N,N’-disubstituted thiourea catalyst (5), rather than the R isomer which is obtained 
when using the Takemoto catalyst. As seen from Fig. 3.3, the minor peak of the S isomer 
from the Takemoto catalyst run has a tail, which appears at a slightly longer retention 
time. It might be caused by the presence of impurities in the product or the column. If the 
tailing is caused by an impurity, it stands to reason that it is possible for the true ee value 
to be higher with respect to the R isomer if this is factored out. However, with the control 
providing similar enantioselectivity (91.6% ee) to the literature value (93% ee), a void 
that forms in the inlet of the column could be considered as a possible cause of this 
issue and may lead to peak tailing.
8
 This issue was pervasive throughout all HPLC runs 
performed under the column conditions used. (Appendix B). 
 
 
 
Fig. 3.3 Comparison of chromatogram of isomers from Takemoto catalyst (26) and 
N,N’-disubstituted thiourea catalyst (5). 
 
 
 
 
 
10 mol% Takemoto 
catalyst (26) in toluene: 
91.6% ee (R). 
 
10 mol% N,N’-disubstituted 
thiourea catalyst (5) in 
toluene: 9.6% ee (S). 
(S) isomer  
 
(R) isomer 
 
(S) isomer  
 
(R) isomer 
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3.3.2 Evaluation of the effects of reagent ratios 
In order to measure the efficiency of the Michael addition reaction with the 
N,N’-disubstituted thiourea catalyst (5), the determination of yields and 
enantioselectivities based on the limiting reagent were also carried out as part of the 
study of the catalysis reaction. It is plausible that a base-containing catalyst would 
enhance the reaction rate by assisting in the deprotonation of the nucleophile. This 
would potentially offer some improvements over catalyst system which required a 
large excess of malonate.
9
 Therefore, using the reagent ratio for the Takemoto catalyst 
(diethyl malonate:trans-β-nitrostyrene = 2:1) as a standard where diethyl malonate is 
used in excess, efficiency of the reactions with N,N’-disubstituted thiourea catalyst (5) 
was determined using lower quantities of diethyl malonate, with reagent ratios for the 
tests being 2:1, 1.5:1 and 1:1 (Table 3.2). 
 
Table 3.2 Reagent ratios of N,N’-disubstituted thiourea catalyst (5) for the Michael 
reaction of diethyl malonate to trans-β-nitrostyrene.
[a]
  
Exp. 
Set 
Reagent Ratio 
(Mal : N-Styr/mmol) 
Time 
(h) 
Conversion 
(%)
[b]
 
Yield 
(%)
[c]
 
ee 
(%)
[d]
 
1 0.4 mmol : 0.2 mmol 6, 24 6 h: 94.8 
24 h: 100 
89.8 9.6 (S) 
2 0.3 mmol : 0.2 mmol 6, 24 6 h: 94.8 
24 h: 100 
85.3 7.3 (S) 
3 0.2 mmol : 0.2 mmol 6, 24 6 h: 95.4 
24 h: 100 
86.8 5.3 (S) 
[a]: Reactions were carried out with 10 mol% N,N’-disubstituted thiourea catalyst (5) 
(0.02 mmol) and toluene (0.4 mL) under N2 at room temperature, using reagent ratios of 
diethyl malonate and trans-β-nitrostyrene: 0.4 mmol:0.2 mmol, 0.3 mmol:0.2 mmol 
and 0.2 mmol:0.2 mmol, respectively. 
[b]: By NMR. 
[c]: Isolated yields after flash column chromatography: Ethyl Acetate:Hexane (1:12 to 
1:5) after 24 h. 
[d]: The % ee values were determined via chiral HPLC using Phenomenex chiral 
column (Lux 5μ, cellulose-2, 250 x 4.60 mm). 
 
With a different ratio of diethyl malonate and trans-β-nitrostyrene, all the reactions 
were ca. 95% completed after 6 hours with similar yields. According to the graph in 
Fig. 3.4, interestingly, the quantities of reagents used did not affect the conversion of 
the reaction very much, but slightly affected the enantioselectivity. It should be noted 
that lower enantioselectivity was obtained with decreasing quantities of diethyl 
malonate used. It is reasonable that deprotonation of the diethyl malonate occurs more 
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quickly at higher reaction concentration and thus results in more probabilities of 
formation of (S)-product by the direct conjugate addition of enolate to nitroolefin.
9
 
Therefore, the optimized ratio of diethyl malonate and trans-β-nitrostyrene is 
considered to be 0.4 mmol:0.2 mmol. 
 
 
 
Fig. 3.4 Graph of effect on yield (%) and enantioselectivity (%) by reagent ratios. 
 
3.3.3 Evaluation of the effects of catalyst loading 
In a catalytic enantioselective reaction, the amount of catalyst needed is an important 
factor in determining the practicality of the methodology, especially when the catalyst 
requires many steps to be synthesised or is expensive. The investigation into optimum 
catalyst loading was conducted at four different catalyst loadings in the range of 10 
mol% to 1 mol% (Table 3.3). The 10 mol% of catalyst loading provides 100% 
conversion of the reaction within 6 hours. However, with reducing quantities of 
catalyst used, the reaction rate decreased, especially with 1 mol% of catalyst loading 
which produced only 39.3% conversion after 6 hours, however, the reaction reached 
nearly full conversion after 24 hours. This result proves that hydrogen-bond formation 
is a factor controlling the reaction rate. Decreased catalyst loadings not only resulted in 
a slowing down of the reaction rate, but also had a large effect on the enantioselectivity 
of the reaction with decreasing in the probability of correlation between catalyst and 
substrate. Enantioselectivities at 10 mol% loading decreased from 9.6% ee to 4.6% ee 
at 5 mol% loading and to 2.6% ee at 2.5 mol% loading. Although the precise reason 
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for the effect of less catalyst loading on the enantioselectivity is not clear at this time, it 
can be hypothesized that with higher catalyst loading, there are more availabilities of 
stable pro-S enantiomer complex in the reaction solution and this result in the 
formation of desired product, even if only with low enantioselectivity. This also 
reveals thiourea catalyst’s one of significant drawbacks: frequently necessitating high 
catalyst loading, due to having relatively weak activity.
10
 Therefore, as seen in Table 
3.3, those needs of long reaction time to achieve a satisfactory yield. Another reason 
may be a second competitive reaction pathway which leads to racemic product. At 
high catalyst loadings (10 mol%) the reaction attains 95% conversion within 6 hours, 
compared to only 39% conversion with 1 mol% catalyst. The racemic product formed 
would have a greater reduction in the ee of the product in the latter case due to the 
longer time to attain high conversion. As shown in graph (Fig. 3.5), it is clear that a 
direct relationship between enantioselectivity and catalyst loading was observed, rather 
than the inverse relationship.
11
 
 
Table 3.3 Catalyst loading of N,N’-disubstituted thiourea catalyst (5) for the Michael 
reaction of diethyl malonate to trans-β-nitrostyrene.
[a] 
Exp 
Set 
Catalyst Loading 
 
Time 
(h) 
Conversion 
(%)
[b]
 
Yield 
(%)
[c]
 
ee 
(%)
[d]
 
1 10 mol% of N,N’-disubstituted 
thiourea (5) 
6, 24 6 h: 94.8 
24 h: 100 
89.8 9.6 (S) 
2 5 mol% of N,N’-disubstituted 
thiourea (5) 
6, 24 6 h: 86.7 
24 h: 100 
86.3 4.6 (S) 
3 2.5 mol% of 
N,N’-disubstituted thiourea (5) 
6, 24 6 h: 47.1 
24 h: 95.1 
85.8 2.6 (S) 
4 1 mol% of N,N’-disubstituted 
thiourea (5) 
6, 24 6 h: 39.3 
24 h: 94.3 
85.2 2.3 (S) 
[a]: Reactions were carried out with diethyl malonate (0.4 mmol), trans-β-nitrostyrene 
(0.2 mmol) and toluene (0.4 mL) under N2 at room temperature with loading 10 mol%, 5 
mol%, 2.5 mol% and 1 mol% of N,N’-disubstituted thiourea catalyst (5), respectively. 
[b]: By NMR. 
[c]: Isolated yields after flash column chromatography: Ethyl Acetate:Hexane (1:12 to 
1:5) after 24 h. 
[d]: The % ee values were determined via chiral HPLC using Phenomenex chiral 
column (Lux 5μ, cellulose-2, 250 x 4.60 mm). 
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Fig. 3.5 Graph of effect on yield (%) and enantioselectivity (%) by catalyst loading. 
 
 
3.4 Discussion 
The N,N’-disubstituted thiourea catalyst (5) efficiently promoted the Michael addition 
reaction to give a full conversion with high yields after 24 hours, but gave low 
enantioselectivities. The crystal structure of the Takemoto catalyst (26) (Fig. 3.6) 
indicates that the amino group and N-H of the thiourea moiety orient to the same 
direction, which leads the nucleophiles to approach nitroolefins in an ideal way when 
the thiourea moiety and amino group interact with nitroolefins and nucleophiles 
respectively.
5,12 
However, according to the crystal structure of the N,N’-disubstituted 
thiourea catalyst (5) in Fig. 3.7, the N-H of the thiourea moiety and the two tertiary 
amine groups orient in a different direction, with the thiourea H-N perpendicular to each 
of the tertiary amine groups. Thus, this might be preventing the nucleophile from 
approaching the nitroolefins. Moreover, the N-H of the thiourea moiety is too far 
removed from the two tertiary amine groups. In contrast, in the Takemoto catalyst, the 
N-H of the thiourea moiety is relatively close to the amino group of the cyclohexane 
rings (Fig. 3.6). Therefore, the distance between the amine groups and the thiourea N-H 
could be another factor that could influence the enantioselectivity of the catalyst. 
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Fig. 3.6 Crystal structure of Takemoto catalyst (26).
5,12 
 
 
 
 
Fig. 3.7 Crystal structure of the N,N’-disubstituted thiourea catalyst (5). 
 
 
 
 
 
amino group and thiourea N-H orient toward the same direction. 
amino groups and thiourea N-H orient face different directions. 
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3.5 Future work 
Due to limitations regarding the chiral HPLC system used, the other synthesised 
N,N’-disubstituted urea (6) derivative was unable to be evaluated for its catalytic 
activity in the same reaction. In further work, it should be considered for primary testing. 
On the other hand, it appears that the N,N’-disubstituted thiourea catalyst (5) did not 
successfully catalyse the Michael addition reaction as a bifunctional catalyst as low 
enantioselectivity was observed possibly due to the orientation of the amino group on 
the natural state of opiate scaffold, although the conversion reached 100% after 24 hours. 
The same result was also obtained from a previously studied thiourea based opioid 
derivative (51).
13
 This thiourea catalyst has one opiate scaffold and a 
1,3-bis(trifluoromethyl)benzene group, which has a similar structure to the Takemoto 
catalyst. However, low enantioselectivity was also obtained with this compound in the 
Michael addition reaction (Fig. 3.8). According to the crystal structure (Fig. 3.9), the 
N-H of the thiourea moiety is far away from the tertiary amine group and both also 
orient in a different direction and perpendicular to each other which is exactly same as 
the N,N’-disubstituted thiourea (5). 
 
 
 
Fig. 3.8 Structure of N,N’-disubstituted thiourea catalyst (5) and thiourea catalyst (51)13 
and their yields and enantioselectivites in Michael addition reaction. 
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Fig. 3.9 Crystal structure of the thiourea catalyst (51).
13 
 
Therefore, it is certain that the tertiary amine groups from both thiourea derivatives do 
not perform as well as the Takemoto catalyst in the Michael addition reaction due to the 
orientation stereochemistry of the tertiary amine group. Therefore, in order to improve 
the selectivity of reaction, it may be required to modify the structures of both thiourea 
derivatives by substitution of an additional amino group or a hydroxyl group at the C7 or 
C6 position on the C-ring of the opiate scaffold after removal of the double bond. Thus, 
the long distance between the N-H of thiourea moiety and the amino group is shortened 
and both the N-H of the thiourea moiety and the amino group are orientated in the same 
direction. 
 
 
 
Fig. 3.10 Possible modification of thiourea opioid derivatives. 
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Chapter 4 Experimental 
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4.1 Chemicals and instruments 
Chemicals: 
Toluene-4-sulfonyl chloride, sodium azide, potassium thiocyanate, diethyl carbonate, 
diethyl malonate, trans-β-nitrostyrene, lithium aluminium hydride solution (1.0 M in 
THF), potassium tert-butoxide, 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) and 
1-[3,5-bis(trifluoromethyl)phenyl]-3-[(1R,2R)-(−)-2(dimethylamino)cyclohexyl]- 
thiourea (Takemoto catalyst) were purchased from Sigma Aldrich. Merck Silica gel 
(pore size 60 Å, 220-440 mesh, 35-75 μm) was used for flash chromatography. All 
solvents used were distilled and dried over molecular sieves (3 Å and 4 Å) before use. 
 
NMR Analysis: 
All NMR analysis was carried out on a Bruker 400 MHz spectrometer, operating at 
400 MHz for 
1
H NMR and 100 MHz for 
13
C NMR or on a Bruker 600 MHz 
spectrometer, operating at 600 MHz for 
1
H NMR and 150 MHz for 
13
C NMR. All 
spectra were recorded in deuterated chloroform (CDCl3) or DMSO-d6. Chemical shifts 
are reported in parts per million (ppm) and coupling constants (J ) are measured in 
Hertz (Hz).When stating multiplicity of peaks in NMR the following abbreviations are 
used: s: singlet; d: doublet; t: triplet; q: quartet; dd: doublet of doublets; dt: doublet of 
triplets; td: triplet of doublets; m: multiplet; br: broad. 
 
FT-IR analysis: 
All IR analysis was performed by a Perkin Elmer 100 FT-IR spectrometer with ATR. 
Weak (w), medium (m), strong (s), narrow (n), very strong (vs), broad (b) and sharp (sh) 
are used to describe the appearance and intensities absorption bands. 
 
Melting point: 
All melting points were determined using a Griffin melting point apparatus and values 
are expressed in degrees Celsius (ºC). 
 
Chiral HPLC: 
Percent enantiomeric excess was determined by Waters HPLC Automated System and a 
Phenomenex HPLC chiral column (Lux 5 μm, cellulose-2, 250 x 4.60 mm). Mobile 
phase: Hexane/Isopropanol=90/10; λ=254 nm; flow rate: 1.0 mL/min. 
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Optical Rotation: 
All optical rotation measurements were carried out on a Perkin Elmer 343 Polarimeter 
in chloroform at 20 ºC. 
 
 
4.2 Preparation of opioid derivatives 
6-O-Tosylcodeine (1) 
(4R,4aR,7aR,12bS)-9-Methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobe
nzofuro[3,2-e]isoquinlin-7-yl 4-methylbenzensulfonate (1) 
The procedure followed was according to the literature.
1,2 
Codeine (6.00 g, 20.0 mmol) was dissolved in dry DCM (4 mL) 
and dry pyridine (5 mL) was added. Tosyl chloride (4.81 g, 
25.2 mmol) in pyridine (5 mL) was added dropwise to the 
stirred codeine solution at 0 ºC. The reaction mixture was 
stirred for a further 2 h at this temperature and refrigerated for 
24 h. It was then poured into a saturated aqueous NaHCO3 
solution (500 mL) and extracted with DCM (3 x 100 mL). The 
DCM solution was washed with deionized water (3 x 300 mL), 
dried with MgSO4 and evaporated to dryness. The oily product was triturated with 
diethyl ether to give the title product (1) as red/pink crystals in 84% yield (7.61 g, 16.8 
mmol). 
 
Molecular formula: C25H27NO5S 
Molecular weight: 453.55 g/mol. 
m.p.: 126 ºC, Lit. m.p.: 121 ─ 125 ºC.2 
[α]20D: −213.0 (1.0 c, CHCl3), Lit. [α]
20
D: −209.0 (0.99 c, dioxane).
2
 
 
IRmax (neat): 2945 (w), 1598 (m), 1498 (m, sh), 1440 (m), 1359 (s, sh), 1174 (s, sh), 
973 (s, sh), 866 (vs, sh), 650 (vs, sh). IR spectrum is in agreement with the literature.
3 
 
1
H NMR (400 MHz, CDCl3) δ ppm 7.82 (2H, d, J = 8.2 Hz, H20, H20’), 7.28 (2H, d, J 
= 8.2 Hz, H21, H21’), 6.56 (1H, d, J = 8.2 Hz, H2), 6.44 (1H, d, J = 8.2 Hz, H1), 5.50 
(1H, br d, J = 9.9 Hz, H7), 5.30 (1H, dt, J = 10.0, 2.7 Hz, H8), 4.88 ─ 4.84 (1H, m, H6), 
4.79 (1H, dd, J = 6.2, 1.2 Hz, H5), 3.76 (3H, s, H18), 3.27 (1H, dd, J = 3.1, 2.5 Hz, H9), 
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2.95 (1H, d, J = 18.5 Hz, H10β), 2.58 (1H, br t, J = 2.5 Hz, H14), 2.49 (1H, dd, J = 8.4, 
4.2 Hz, H16a), 2.38 (3H, s, H17), 2.35 (3H, s, H23), 2.30 (1H, td, J = 8.5, 3.2 Hz, H16b), 
2.20 (1H, dd, J =12.4, 6.5 Hz, H10α), 1.92 (1H, td, J = 7.7, 5.0 Hz, H15a), 1.77 (1H, m, 
H15b). 
13
C NMR (100 MHz, CDCl3) δ ppm 147.0 (C4), 144.9 (C22), 142.1 (C3), 133.7 (C19), 
130.9 (C8), 130.4 (C12), 129.8 (C21, C21’), 128.1 (C20, C20’), 127.5 (C7), 126.9 (C11), 
119.4 (C1), 114.6 (C2), 89.1 (C5), 74.4 (C6), 58.8 (C9), 57.0 (C18), 46.3 (C16), 43.3 
(C13), 43.1 (C17), 40.9 (C14), 35.5 (C15), 21.7 (C23), 20.4 (C10). 
1
H and 
13
C NMR 
spectra are in agreement with the literature.
3
  
 
 
8-Isothiocyanocodide (2)  
(4R,4aR,5S,7aS,12bS)-5-Isothiocyanato-9-methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-
1H-4,12-methanobenzofuro[3,2-e]isoquinoline (2) 
The procedure was followed as per a previously established 
method.
3
 6-O-tosylcodeine (1) (3.06 g, 6.75 mmol) and 
potassium thiocyanate (1.31 g, 13.5 mmol) were dissolved in 
dry acetone (50 mL). The reaction was refluxed at 56 ºC for 4 
h. After cooling, the reaction mixture was filtered and the 
solvent was removed. The residue was purified by flash 
column chromatography (SiO2, DCM: MeOH: NH4OH = 98:1:1). The column purified 
material was triturated with hexane to give a white solid (2) in 61% yield (1.40 g, 4.11 
mmol). 
 
Molecular formula: C19H20N2O2S. 
Molecular weight: 340.44 g/mol. 
m.p.: 108 ─ 110 ºC, Lit. m.p.: 109 ─ 111 ºC.3 
[α]20D: +145.1 (1.0 c, CHCl3), Lit. [α]
20
D: +151.7 (0.5 c, CHCl3).
3
 
 
IRmax (neat): 2925 (m, sh), 2911 (m), 2788 (w), 2163 (m), 2115 (m, br), 1606 (w), 1500 
(s, sh), 1275 (s, sh), 1156 (s, sh), 1076 (s, sh), 1029 (s, sh), 887 (vs, sh). IR spectrum is in 
agreement with the literature.
3
 
 
1
H NMR (400 MHz, CDCl3) δ ppm 6.64 (1H, d, J = 8.2 Hz, H2), 6.58 (1H, d, J = 8.2 
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Hz, H1), 5.80 ─ 5.71 (2H, m, H7, H6), 4.93 ─ 4.88 (1H, m, H5), 3.77 (3H, s, H18), 3.72 
(1H, d, J = 10.5 Hz, H8), 3.42 (1H, dd, J = 3.2, 2.7 Hz, H9), 3.04 (1H, d, J = 19.1 Hz, 
H10β), 2.51 ─ 2.44 (2H, m, H14, H16a), 2.42 ─ 2.34 (4H, m, H17, H10α), 2.20 (1H, td, 
J = 8.6, 3.6 Hz, H16b), 1.87 (1H, td, J = 7.4, 5.1 Hz, H15a), 1.75 (1H, dd, J = 7.2, 1.7 Hz, 
H15b). 
13
C NMR (100 MHz, CDCl3) δ ppm 144.4 (C4), 143.4 (C3), 135.0 (C19), 133.3 (C12), 
131.5 (C6/C7), 128.2 (C11), 126.3 (C6/C7), 119.3 (C1), 113.6 (C2), 86.2 (C5), 56.3 
(C18), 56.2 (C9), 53.1 (C8), 46.8 (C14/C16), 46.5 (C14/C16), 43.2 (C17), 40.9 (C13), 
35.3 (C15), 19.7 (C10).
1
H and 
13
C NMR spectra are in agreement with the literature.
3
  
 
 
8-Azidocodide (3) 
(4R,4aR,5S,7aS,12bS)-5-Azido-9-methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-1H-4,12
-methanobenzofuro[3,2-e]isoquinoline (3) 
The procedure was followed according to the literature.
4
 
6-O-tosylcodeine (1) (3.00 g, 6.61 mmol) and sodium azide 
(0.86 g, 13.2 mmol) were dissolved in DMF (10 mL). The 
reaction was refluxed at 90 ºC for 3 h. After cooling, the 
precipitate was formed by adding water (200 mL). The mixture 
was extracted with diethyl ether (3 x 100 mL). The ether phase 
was washed with brine (100 mL) and dried with MgSO4. After removal of ether, 
recrystallization from acetone to give a pale yellow crystalline solid (3) in 64% yield 
(1.37 g, 4.22 mmol). 
 
Molecular formula: C18H20N4O2 
Molecular weight: 324.38 g/mol. 
m.p.: 135 ─ 138 ºC, Lit. m.p.: 138 ─ 139 ºC.3 
[α]20D: −19.7 (1.0 c, CHCl3), Lit. [α]
20
D: −18.6 (1.1 c, CHCl3).
3
 
 
IRmax (neat): 2927 (w, sh), 2802 (w, sh), 2098 (m, sh), 1601 (w), 1505 (s, sh), 1448 (s, 
sh), 1276 (vs, sh), 1156 (s, sh), 1015 (s, sh), 905 (vs, sh), 891 (s, sh), 784 (s, sh). IR 
spectrum is in agreement with the literature.
3 
 
1
H NMR (400 MHz, CDCl3) δ ppm 6.64 (1H, d, J = 8.2 Hz, H2), 6.57 (1H, d, J = 8.2 
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Hz, H1), 5.87 ─ 5.74 (2H, m, H7, H6), 4.95 ─ 4.85 (1H, m, H5), 3.77 (3H, s, H18), 3.42 
(1H, dd, J = 3.2, 2.7 Hz, H9), 3.21 (1H, d, J = 10.2 Hz, H8), 3.02 (1H, d, J = 18.8 Hz, 
H10β), 2.51 ─ 2.44 (1H, dd, J = 8.3, 3.8 Hz, H16a), 2.42 ─ 2.32 (4H, m, H17, H10α), 
2.28 (1H, dd, J = 7.4, 2.8 Hz, H14), 2.18 (1H, td, J = 8.4, 3.7 Hz, H16b), 1.87 (1H, td, J 
= 7.4, 5.0 Hz, H15a), 1.74 (1H, m, H15b). 
13
C NMR (100 MHz, CDCl3) δ ppm 143.1 (C4), 142.3 (C3), 130.5 (C6/C7), 127.8 
(C12), 126.2 (C6/C7), 125.8 (C11), 118.1 (C1), 112.3 (C2), 85.4 (C5), 55.5 (C18), 55.3 
(C9), 55.1 (C8), 45.6 (C16), 44.4 (C14), 42.2 (C17), 39.8 (C13), 34.2 (C15), 18.8 (C10).
 
1
H and 
13
C NMR spectra are in agreement with the literature.
3
 
 
 
8-Aminocodide (4) 
(4R,4aS,5S,7aS,12bS)-9-Methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-1H-4,12- 
methanobenzofuro[3,2-e]isoquinolin-5-amine (4) 
8-Azidocodide (3) (1.00 g, 3.08 mmol) was dissolved in dry 
THF (4 mL) and added dropwise to a LiAlH4 solution in THF 
(12.3 mL, 1.0 M) under an N2 atmosphere. The reaction was 
refluxed for 3 h. After cooling, the reaction was quenched by 
slow addition of aqueous THF (50 mL) and ice water (50 mL) 
over an ice bath, and then the resultant alumina solid was 
removed by filtration. After removal of THF, the reaction solution was extracted with 
chloroform (3 x 100 mL) and dried over MgSO4. Solvent was removed and the residue 
was purified by flash column chromatography (SiO2, DCM : MeOH : NH4OH = 94:5:1) 
to give an oily compound (4) in 46% yield (0.42 g, 1.41 mmol).
3
 
 
Molecular formula: C18H22N2O2 
Molecular weight: 298.39 g/mol. 
m.p.: 126 ─ 129 ºC, Lit. m.p.: 128 ─ 129 ºC.5 
[α]20D: −75.5 (1.0 c, CHCl3), Lit. [α]
20
D: −79.2 (0.5 c, EtOH).
5
 
 
IRmax (neat): 3353 (w, br), 2921 (m, br), 2837 (w), 2567 (w), 2073 (w, br), 1603 (w), 
1506 (s), 1450 (s), 1440 (s), 1277 (vs, sh), 1189 (m), 1161 (m), 1140 (m), 1102 (m), 
1089 (m), 1069 (vs, sh), 1019 (s), 905 (vs, sh), 855 (s, sh), 804 (s, sh). IR spectrum is in 
agreement with the literature.
3
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1
H NMR (400 MHz, CDCl3) δ ppm 6.63 (1H, d, J = 8.2 Hz, H2), 6.55 (1H, d, J = 8.2 
Hz, H1), 5.67 (1H, dd, J = 8.9, 1.5 Hz, H7), 5.60 (1H, dt, J = 10.1, 4.4 Hz, H6), 4.90 (1H, 
dd, J = 3.9, 1.9 Hz, H5), 3.78 (3H, s, H18), 3.51 (1H, dd, J = 3.2, 2.7 Hz, H9), 3.00 (1H, 
d, J = 18.2 Hz, H10β), 3.21 (1H, dd, J = 7.9, 1.9 Hz, H8), 2.43 (1H, dd, J = 10.1, 3.5 Hz, 
H16a), 2.42 ─ 2.33 (4H, m, H17, H10α), 2.22 (1H, td, J = 8.2, 3.8 Hz, H16b), 1.96 (1H, 
dd, J = 9.9, 2.9 Hz, H14), 1.84 (1H, td, J = 7.4, 4.9 Hz, H15a), 1.75 (1H, dd, J = 6.8, 2.0 
Hz, H15b), 1.18 (2H, br s, NH2). 
13
C NMR (100 MHz, CDCl3) δ ppm 144.3 (C4), 143.2 (C3), 139.5 (C7), 129.8 (C12), 
127.3 (C11), 123.7 (C6), 118.8 (C1), 112.9 (C2), 87.5 (C5), 56.3 (C18), 56.2 (C9), 49.4 
(C14), 46.9 (C16), 46.3 (C8), 43.2 (C17), 41.09 (C13), 35.6 (C15), 19.8 (C10).
1
H and 
13
C NMR spectra are in agreement with the literature.
3
  
 
 
N,N’-disubstituted thiourea (5) 
1,3-Bis[(4R,4aS,5S,7aS,12bS)-9-methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-1H-4,12-
methanobenzofuro[3,2-e]isoquinolin-5-yl]thiourea (5) 
A mixture of 8-isothiocyanocodide (2) 
(0.39 g, 1.15 mmol) and 8-aminocodide 
(4) (0.34 g, 1.15 mmol) was stirred in 
dry THF (8 mL) and heated under 
reflux conditions for 24 h. After 
removal of the solvent, the residue was purified by column chromatography (SiO2, 
DCM : MeOH : NH4OH = 96:3:1) to give a white solid after drying (5) in 44% yield 
(0.32 g, 0.50 mmol).
3
 
 
Molecular formula: C37H42N4O4S 
Molecular weight: 638.83 g/mol. 
m.p.: 226 ─ 230 ºC. 
[α]20D: −61.01 (1.0 c, CHCl3). 
MS (ESI) calculated for [M+H]
 +
, C37H42N4O4S
+
 requires 639.2900, found 639.2977. 
 
IRmax (neat): 3351 (w, br), 2908 (m, br), 2837 (w), 1636 (w), 1606 (w), 1527 (s), 1502 
(vs, sh), 1439 (m, br), 1247 (vs), 1155 (vs, sh), 1096 (s), 984 (w), 938 (w), 889 (vs), 855 
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(s), 791 (s), 702 (s). 
 
1
H NMR (600 MHz, DMSO-d6) δ ppm 7.50 (1H, br s, NH), 6.74 (1H, d, J = 8.2 Hz, 
H2), 6.63 (1H, d, J = 8.2 Hz, H1), 5.66 (2H, s, H7, H6), 4.98 (1H, d, J = 1.9 Hz, H5), 
4.48 (1H, br s, H8), 3.74 (3H, s, H18), 3.10 (1H, dd, J = 3.2, 2.7 Hz, H9), 2.91 (1H, d, J 
= 18.5 Hz, H10β), 2.64 (1H, dd, J = 12.8, 5.4 Hz, H10α), 2.43 (1H, dd, J = 9.3, 4.3 Hz, 
H16a), 2.28 (3H, s, H17), 2.18 (1H, dd, J = 9.8, 2.5 Hz, H14), 2.09 (1H, td, J = 9.3, 2.9 
Hz, H16b), 1.86 (1H, td, J =7.6, 4.8 Hz, H15a), 1.60 (1H, d, J = 11.2 Hz, H15b). 
13
C NMR (150 MHz, DMSO-d6) δ ppm 183.2 (C19), 143.9 (C4), 142.5 (C3), 135.3 
(C6/C7), 129.1 (C12), 127.4 (C11), 124.8 (C6/C7), 118.8 (C1), 113.6 (C2), 85.9 (C5), 
55.9 (C18), 55.5 (C9), 48.8 (C8), 46.2 (C16), 45.4 (C14), 42.8 (C17), 40.4 (C13), 34.8 
(C15), 20.0 (C10). 
 
 
N,N’-disubstituted urea (6) 
1,3-Bis[(4R,4aS,5S,7aS,12bS)-9-methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-1H-4,12-
methanobenzofuro[3,2-e]isoquinolin-5-yl]urea (6) 
A solution of 8-aminocodide (6) (0.39 g, 
1.30 mmol) and TEA (0.55 mL, 3.92 
mmol) in dry DCM (2 mL) was added 
dropwise to a solution of triphosgene 
(0.14 g, 0.46 mmol) in dry DCM (0.5 
mL) at 0 ºC under an N2 atmosphere . 
After 1 h of stirring at 0 ºC, the addition of the second portion of 8-aminocodide (6) 
(0.39 g, 1.30 mmol) in DCM (2 mL) was added slowly into the flask and the mixture 
was further stirred at room temperature for 72 h.  The reaction mixture was washed 
with a saturated aqueous NaHCO3 solution (10 mL) and the organic layer was dried with 
MgSO4 and concentrated. The crude product was purified by column chromatography 
(SiO2, DCM: MeOH: NH4OH = 96:3:1) to give a white solid (8) in 28% yield (0.23 g, 
0.37 mmol).
6,7 
 
 
Molecular formula: C37H42N4O5 
Molecular weight: 622.77 g/mol. 
m.p.: 235 ─ 239.9 ºC. 
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[α]20D: −11.7 (1.0 c, CHCl3). 
MS (ESI) calculated for [M+H]
 +
, C37H42N4O5
+
 requires 623.3200, found 623.3202. 
 
IRmax (neat): 3372 (w, br), 2923 (m, br), 2837 (w), 1700 (w, br), 1635 (m), 1605 (w), 
1538 (s), 1501 (vs, sh), 1439 (vs, sh), 1275 (vs, sh), 1248 (s, sh), 1155 (s, sh), 1037 (vs, 
sh), 901 (vs ,sh), 857 (s), 790 (s), 751 (s), 732 (s). 
 
1
H NMR (600 MHz, DMSO-d6) δ ppm 6.72 (1H, d, J = 8.2 Hz, H2), 6.61 (1H, d, J = 
8.2 Hz, H1), 6.03 (1H, d, J = 9.4 Hz, NH), 5.63 (2H, m, H7, H6), 4.96 (1H, d, J = 1.9Hz, 
H5), 3.73 (3H, s, H18), 3.62 (1H, dt, J = 9.6 Hz, H8), 3.09 (1H, dd, J = 3.2, 2.7 Hz, H9), 
2.85 (1H, d, J = 18.5 Hz, H10β), 2.46 (1H, dd, J = 12.5, 6.1 Hz, H10α), 2.40 (1H, dd, J 
= 7.6, 4.2 Hz, H16a), 2.25 (3H, s, H17), 2.06 (2H, m, H14, H16b), 1.82 (1H, td, J = 7.5, 
5.0 Hz, H15a), 1.57 (1H, d, J = 11.0 Hz, H15b). 
13
C NMR (150 MHz, DMSO-d6) δ ppm 158.4 (C19), 144.5 (C4), 143.0 (C3), 137.2 
(C6/C7), 129.8 (C12), 128.2 (C11), 125.2 (C6/C7), 119.2 (C1), 114.2 (C2), 86.7 (C5), 
56.5 (C18), 56.0 (C9), 46.9 (C14), 46.7 (C16), 44.8 (C8), 43.3 (C17), 41.0 (C13), 35.4 
(C15), 19.9 (C10). 
 
 
α-Chlorocodide (7) 
(4R,4aR,7R,7aR,12bS)-7-Chloro-9-methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,1
2-methanobenzofuro[3,2-e]isoquinoline (7) 
Method 1: SOCl2 (2.74 mL, 37.8 mmol) was added to a 
solution of codeine (1.13 g, 3.77 mmol) in dry DCM (3 mL). 
The solution was stirred for 1 h at 0 ºC. The reaction solution 
was quenched with H2O (10 mL) and then made alkaline (pH 
approx. 8) with a saturated aqueous NaHCO3 solution. The 
aqueous mixture was extracted with diethyl ether (3 x 20 mL) 
and the organic extracts were washed with water (3 x 20 mL). The ether layer was 
reduced down and the resultant solid was collected and washed with a small amount of 
cold ethanol to remove trace impurities and dried, giving a white solid (7) in 86% yield 
(1.03 g, 3.24 mmol).
8,9 
Method 2: To a stirred solution of codeine (0.30 g, 1.00 mmol) and pyridine (3 mL) in 
Schlenk tube under an N2 atmosphere (1 atm) at 0 ºC. POCl3 (0.05 mL, 0.50 mmol) was 
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added dropwise. The solution stirred at room temperature for 6 h. H2O (10 mL) was then 
added and the mixture was stirred at room temperature for 2 h. The reaction solution 
was then extracted with DCM (3 x 30 mL) and the organic layer was washed with 
deionised water (3 x 30mL). The organic layer was dried over MgSO4 before being 
reduced down. The resultant oily product was triturated with diethyl ether to give a 
white solid in 88% yield (0.28 g, 0.88 mmol). 
 
Molecular formula: C18H20ClNO2 
Molecular weight: 317.81 g/mol. 
m.p.: 150 ─ 153 ºC, Lit. m.p.: 149 ─ 151 ºC.10 
[α]20D: −363.8 (1.0 c, CHCl3), Lit. [α]
20
D: −381.1 (0.78 c, CHCl3).
11
 
 
IRmax (neat): 2935 (w), 2911 (w), 1636 (w), 1605 (m), 1503 (s), 1498 (m, sh), 1450 (m), 
1331 (m, sh), 1275 (s, sh), 1153 (s, sh), 1057 (s, sh), 935 (s, h), 803 (vs, sh), 757 (vs, sh), 
738 (vs, sh). 
 
1
H NMR (400 MHz, CDCl3) δ ppm 6.69 (1H, d, J = 8.2 Hz, H2), 6.59 (1H, d, J = 8.2 
Hz, H1), 6.00 (1H, m, H7), 5.69 (1H, d, J = 9.8 Hz, H8), 5.05 (1H, dd, J = 6.2, 1.2 Hz, 
H5), 4.55 (1H, dt, J = 9.8, 2.6 Hz, H6), 3.85 (3H, s, H18), 3.39 (1H, dd, J = 3.2, 2.4 Hz, 
H9), 3.17 (1H, br t, J = 2.6 Hz, H14), 3.09 (1H, d, J = 18.6 Hz, H10β), 2.62 (1H, dd, J = 
8.2, 4.1 Hz H16a), 2.45 (3H, s, H17), 2.40 (1H, td, J = 8.7, 3.5 Hz, H16b), 2.35 (1H, dd, 
J =12.4, 6.5 Hz, H10α), 2.19 (1H, td, J = 7.4, 5.0 Hz, H15a),1.88 (1H, m, H15b). 
13
C NMR (100 MHz, CDCl3) δ ppm 145.8 (C4), 141.9 (C3), 135.3 (C8), 130.1 (C12), 
128.7 (C7), 127.4 (C11), 119.3 (C1), 112.9 (C2), 93.9 (C5), 58.7 (C9), 56.3 (C18), 53.9 
(C6), 46.7 (C16), 44.5 (C13), 43.2 (C17), 40.0 (C14), 36.3 (C15), 20.3 (C10). 
1
H and 
13
C NMR spectra are in agreement with the literature.
9
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β-Bromocodide (8) 
(4R,4aR,5S,7aS,12bS)-5-Bromo-9-methoxy-3-methyl-2,3,4,4a,5,7a-hexahydro-1H-4,1
2-methanobenzofuro[3,2-e]isoquinoline (8) 
A mixture of 6-O-tosylcodeine (1) (2.27 g, 5.00 mmol) and 
lithium bromide (2.82 g, 32.5 mmol) was stirred in dry acetone 
(10 mL) at reflux for 3 h. Water (200 mL) was poured into the 
reaction solution and extracted with toluene (3 x 100 mL). 
After removal of toluene, the residue was recrystallized in 
ethanol and dried to give a white solid (8) in 80% yield (1.45 g, 4.00 mmol).
11
 
 
Molecular formula: C18H20BrNO2 
Molecular weight: 362.27 g/mol. 
m.p.: 158 ─ 160 ºC, Lit. m.p.: 156─159 ºC.12 
[α]20D: +50.2 (1.0 c, CHCl3), Lit. [α]
20
D: +47.6 (1.4 c, CHCl3 : EtOH = 9:1).
12 
 
IRmax (neat): 2931 (w, br), 2795 (w, br), 1636 (w), 1605 (w), 1503 (s), 1450 (s), 1275 
(vs, sh), 1153 (m), 1057 (s), 1029 (m), 935 (s, sh), 803 (vs, sh), 757 (vs, sh), 738 (s, sh), 
687 (m). 
 
1
H NMR (400 MHz, CDCl3) δ ppm 6.73 (1H, d, J = 8.2 Hz, H2), 6.66 (1H, d, J = 8.2 
Hz, H1), 6.00 (1H, dt, J = 8.04, 1.2 Hz, H7), 5.69 (1H, dt, J = 8.04, 2.8 Hz, H6), 5.05 
(1H, m, H5), 4.14 (1H, dd, J = 8.04, 2.0 Hz, H8), 3.86 (3H, s, H18), 3.58 (1H, dd, J = 6.5, 
2.5 Hz, H9), 3.09 (1H, d, J = 18.75 Hz, H10β), 2.73 (1H, dd, J = 7.1, 2.8 Hz, H14), 2.55 
(1H, dd, J = 8.6, 3.8 Hz, H16a), 2.50 ─ 2.42 (4H, m, H17, H10α), 2.29 (1H, td, J = 8.6, 
3.6 Hz, H16b), 1.95 (1H, td, J = 7.4, 5.0 Hz, H15a), 1.75 (1H, td, J = 7.4, 1.8 Hz, H15b).  
13
C NMR (100 MHz, CDCl3) δ ppm 144.0 (C4), 143.4 (C3), 135.4 (C7), 128.4 (C12), 
126.8 (C11), 125.7 (C6), 119.2 (C1), 113.4 (C2), 86.4 (C5), 57.0 (C9), 56.3 (C18), 49.2 
(C14), 47.1 (C8), 46.7 (C16), 43.2 (C17), 42.8 (C13), 35.3 (C15), 19.5 (C10). 
1
H and 
13
C NMR spectra are in agreement with the literature.
13
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4.3 Study of Michael addition reaction 
General procedure  
The procedure was followed according to the literature
14 
and the enantiomeric excess 
was determined and compared to the literature value.
14
 
 
Catalysis reaction using the Takemoto catalyst 
To a stirred solution of trans-β-nitrostyrene (29.8 mg, 0.20 
mmol) and diethyl malonate (2.0 eq., 0.06 mL, 0.40 mmol) 
in dry toluene (0.40 mL) under an N2 atmosphere, 
Takemoto (thiourea) catalyst (42) (0.1 eq., 8.3 mg, 0.02 
mmol) was added. The reaction was monitored after 6 h 
and 24 h and conversion was calculated by NMR analysis. The residue was purified by 
flash chromatography (Ethyl acetate : Hexane = 1:12 to 1:5) to afford the conjugate 
addition product: (R)-diethyl 2-(2-nitro-1-phenylethyl) malonate (9) in 90.8 % yield 
(56.2 mg, 0.18 mmol). HPLC retention time of the two isomers of product (9): Sminor= 
12.90 min, Rmajor=16.69 min, 91.6 % ee.
14
  
 
Catalysis reaction using N,N’-disubstituted thiourea catalyst (5) 
To a stirred solution of trans-β-nitrostyrene (29.8 mg, 0.20 mmol) and diethyl malonate 
(2.0 equiv., 0.06 mL, 0.40 mmol) in dry selected solvent (0.40 mL) under an N2 
atmosphere, N,N’-disubstituted thiourea catalyst (0.1eq., 12.8 mg, 0.02 mmol) was 
added. The reaction was monitored after 6 h and 24 h and conversion was calculated by 
NMR analysis. The residue was purified by flash chromatography (Ethyl acetate : 
Hexane = 1:12 to 1:5) to afford conjugate addition product: (S)-diethyl 
2-(2-nitro-1-phenylethyl) malonate (9) in 74.3 % (45.9 mg, 0.15 mmol) ─ 89.8 % (55.6 
mg, 0.18 mmol) and 0 % ─ 9.6 % ee (Table 3.1). HPLC retention times of peaks of two 
isomers are shown in Appendix B and listed in Table 3.4. The corresponding racemic 
product was synthesised using potassium tert-butoxide (KOtBu 5 mol%) in dry toluene 
(0.40 mL) according to a literature method.
15 
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Table 4.1 Retention time of isomeric product: diethyl 2-(2-nitro-1-phenylethyl) 
malonate (9) in selected dry solvents. 
selected dry solvent Retention time of two isomers of conjugate addition 
product (9) 
Hexane Smajor= 12.5 min, Rminor= 16.2 min 
Toluene Smajor= 12.6 min, Rminor= 17.0 min 
THF Smajor= 12.6 min, Rminor= 16.4 min 
DCM Smajor= 12.6 min, Rminor= 17.1 min 
MeOH Smajor= 12.7 min, Rminor= 16.6 min 
MeCN Smajor= 13.1 min, Rminor= 17.9 min 
 
Diethyl 2-(2-nitro-1-phenylethyl) malonate (9) 
1
H NMR (400 MHz, CDCl3) δ ppm 7.36 ─ 7.18 (5H, m, H1 ─ H5), 4.97 ─ 4.80 (2H, 
m, H7), 4.30 ─ 4.14 (3H, m, H15, H10), 4.00 (2H, q, J = 7.2 Hz, H9), 3.81 (1H, d, J = 
9.4 Hz, H12), 1.26 (3H, t, J = 7.3 Hz, H8), 1.04 (3H, t, J = 7.3 Hz, H11). 
13
C NMR (100 MHz, CDCl3) δ ppm 167.5 (C13), 166.8 (C14), 136.2 (C6), 129.0 
(C2/C4), 128.4 (C3), 128.0 (C1/C5), 62.2 (C7), 61.9 (C9/C10), 54.9 (C12), 42.9 (C15), 
13.9 (C8), 13.7 (C11). 
1
H and 
13
C NMR spectra are in agreement with the literature.
14
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Appendix A: NMR Spectra 
 
 
 
 
 
 
 
 
 
 iii 
6-O-Tosylcodeine (1) 
 
 
 
 
Fig. A1 
1
H NMR spectrum (400 MHz) of 6-O-tosylcodeine (1) in CDCl3. 
 
 
 
 
 
Fig. A2 
13
C NMR spectrum (100 MHz) of 6-O-tosylcodeine (1) in CDCl3. 
 
 
 iv 
8-Isothiocyanocodide (2) 
 
 
 
 
Fig. A3 
1
H NMR spectrum (400 MHz) of 8-isothiocyanocodide (2) in CDCl3. 
 
 
 
 
 
Fig. A4 
13
C NMR spectrum (100 MHz) of 8-isothiocyanocodide (2) in CDCl3. 
 
 
 
 v 
8-Azidocodide (3) 
 
 
 
 
Fig. A5 
1
H NMR spectrum (400 MHz) of 8-azidocodide (3) in CDCl3. 
 
 
 
 
 
 
Fig. A6 
13
C NMR spectrum (100 MHz) of 8-azidocodide (3) in CDCl3. 
 
 
 
 vi 
8-Aminocodide (4) 
 
 
 
 
Fig. A7 
1
H NMR spectrum (400 MHz) of 8-aminocodide (4) in CDCl3. 
 
 
 
 
Fig. A8 
13
C NMR spectrum (100 MHz) of 8-aminocodide (4) in CDCl3. 
 
 
 vii 
N,N’-disubstituted thiourea (5) 
 
 
 
Fig. A9 
1
H NMR spectrum (600 MHz) of N,N’-disubstituted thiourea (5) in DMSO-d6. 
 
 
 
 
Fig. A10 
13
C NMR spectrum (150 MHz) of N,N’-disubstituted thiourea (5) in 
DMSO-d6. 
 
 
 
 viii 
N,N’-disubstituted urea (6) 
 
 
 
Fig. A11 
1
H NMR spectrum (600 MHz) of N,N’-disubstituted urea (6) in DMSO-d6. 
 
 
 
Fig. A12 
13
C NMR spectrum (150 MHz) of N,N’-disubstituted urea (6) in DMSO-d6. 
 
 
 
 ix 
α-Chlorocodide (7) 
 
 
 
 
Fig. A13 
1
H NMR spectrum (400 MHz) of α-chlorocodide (7) in CDCl3. 
 
 
 
 
Fig. A14 
13
C NMR spectrum (100 MHz) of α-chlorocodide (7) in CDCl3. 
 
 
 x 
β-Bromocodide (8) 
 
 
 
 
Fig. A15 
1
H NMR spectrum (400 MHz) of β-bromocodide (8) in CDCl3. 
 
 
 
 
Fig. A16 
13
C NMR spectrum (100 MHz) of β-bromocodide (8) in CDCl3. 
 
 
 
 xi 
Diethyl 2-(2-nitro-1-phenylethyl) malonate (9) 
 
 
 
 
Fig. A17 
1
H NMR spectrum (400 MHz) of diethyl 2-(2-nitro-1-phenylethyl) malonate 
(9) in CDCl3. 
 
 
 
 
Fig. A18 
13
C NMR spectrum (100 MHz) of diethyl 2-(2-nitro-1-phenylethyl) malonate 
(9) in CDCl3. 
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Appendix B: HPLC Chromatograms 
(Solvent Tests) 
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HPLC trace of isomeric compound: diethyl 2-(2-nitro-1-phenylethyl) malonate (9) 
in selected solvents 
 
 
 
 
Fig. B1 Chromatogram of isomeric product (9) with 10 mol% Takemoto catalyst in 
toluene (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 mmol). 
 
 
 
Fig. B2 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in hexane (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
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Fig. B3 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in toluene (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
 
 
 
Fig. B4 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in THF (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
 
 
 xv 
 
 
Fig. B5 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in DCM (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
 
 
Fig. B6 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in MeOH (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
 
 
 
 xvi 
 
 
Fig. B7 Chromatogram of isomeric product (9) with 10 mol% N,N’-disubstituted 
thiourea catalyst (5) in MeCN (diethyl malonate:trans-β-nitrostyrene = 0.4 mmol:0.2 
mmol). 
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Appendix C: Crystal data and structure 
refinement for N,N’-disubstituted thiourea 
and urea derivatives 
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Table C1 Crystal data and structure refinement for N,N’-disubstituted thiourea 
derivative (5). 
 
Crystal data of N,N’-disubstituted thiourea derivative (5) 
Chemical formula C37H42N4O4S·9(H2O) 
Formula weight Mr 800.95 
Crystal system, space group Orthorhombic, P212121 
Temperature (K) 150 
Unit cell dimensions a, b, c (Å) 8.6271(3),15.0275 (6), 31.0543(11) 
Volume (Å
3
) 4026.0 (3) 
Z (number of formula units per cell) 4 
Radiation type Mo Kα 
μ (mm-1) 0.15 
Crystal size (mm) 0.27 × 0.15 × 0.10 
Data collection 
Diffractometer Apex II CCD area detector diffractometer 
Absorption correction Multi-scan 
SADABS v2008/1, Sheldrick, G.M., (2008) 
Tmin, Tmax 0.641, 0.746 
No. of measured, independent and 
observed [I > 2(I)] reflections 
55033, 9967, 8369 
Rint 0.052 
(sin /)max (Å
-1
) 0.668 
Refinement 
R[F
2
 > 2σ(F2)], wR(F2), S 0.039, 0.095, 1.03 
No. of reflections 9967 
No. of parameters 554 
No. of restraints 27 
H-atom treatment H atoms treated by a mixture of 
independent and constrained refinement 
max, min (e Å
-3
) 0.23, -0.20 
Absolute structure Flack x determined using 3284 quotients 
[(I+)-(I-)]/ [(I+) + (I-)] (Parsons, Flack and 
Wagner, Acta Cryst. B69 (2013) 249-259). 
Absolute structure parameter -0.02 (3) 
 
 
 
 xix 
Table C2 Crystal data and structure refinement for N,N’-disubstituted urea derivative 
(6). 
 
Crystal data of N,N’-disubstituted urea derivative (6) 
Chemical formula C37H42N4O5·3(H2O) 
Formula weight M  676.79 
Crystal system, space group Orthorhombic, C2221 
Temperature (K) 100 (2) 
Unit cell dimensions a, b, c (Å) 8.1075(3), 14.4775(6), 29.3808(12)  
Volume (Å
3
) 3448.6(2) 
Z (number of formula units per cell) 4 
Density (calculated) 1.304 Mg/m3 
Absorption coefficient 0.752 mm-1 
F(000) 1448 
Crystal size 0.380 x 0.260 x 0.050 mm3 
Theta range for data collection 3.008 to 68.370°. 
Index ranges -9 ≤ h ≤ 9, -16 ≤ k ≤17, -35 ≤ l ≤35 
Reflections collected 38660 
No. of measured, independent and 
observed [I > 2(I)] reflections 
3152 [R(int) = 0.0423] 
Completeness to theta = 67.679° 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. & Min. transmission 0.7531 and 0.6292 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3152 / 0 / 241 
Goodness-of-fit on F2 1.050 
Final R indices [ I >2σ(I) ] R1 = 0.0299, wR2 = 0.0819 
R indices (all data) R1 = 0.0304, wR2 = 0.0824 
Largest diff. peak and hole 0.163 and -0.177 e. Å-3 
Absolute structure parameter 0.06 (5) 
 
 
